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 List of Figures 
Figure 1.1 (A - C) Schematic of conventional probes for in vivo neurochemical monitoring 
with comparison of probe sizes. A) Electrochemical microelectrode with 10 µm 
diameter, 50 µm long. B) Concentric microdialysis probe with 1 mm long 
polyacrylonitrile (PAN) membrane with 230 µm o.d. C) push-pull probe, made by 
assembly of 20 µm i.d./90 um o.d. capillaries side-by-side, sheathed with 180 µm 
i.d./220 µm o.d. polyimide tubing. Models were drawn to scale for comparison of 
probe size and regions of chemical monitoring (at exposed electrode surface for (A), 
membrane surface for (B), and space between orifices for (C). (D - E) Exampled 
SEM images of a cylindrical carbon fiber microelectrode (D), highlighting a tip size 
of < 10 µm diameter (reproduced with permission from22); and a concentric dialysis 
tubing (E), AN 69 membrane, the inset shows a zoom in highlighting tortuous paths. 6 
Figure 1.2 Examples of probes with multisite electrochemical sensors. A, i) Multi-channel 
(256-site 32-channel array) “Michigan Probes” for electrophysiological recording; 
SEM images of probe tips fabricated by using wet etching with boron-etch stop (A,ii) 
or dry etching (A, iii). The developed fabrication process for the Michigan probes 
formed the basis for development of other neural interfaces, including 
electrochemical probes; B) Silicon probe for neurochemical monitoring (white 
rectangular sites) integrated with electrophysiological recording sites (small black 
dots). C) Ceramic probe for neurochemical recording. The shank length is ~10 mm. 
The recording sites are 15 µm × 333 µm. The inset shows an SEM image of the probe 
tip. A, © 2008 IEEE, reproduced with permission from77; B, reproduced with 
permission from87; C, reproduced with permission from92,97. .................................... 11 
Figure 1.3 Microfabricated push-pull probe for in vivo neurochemical monitoring. A) 
Packaged sampling device including the probe and connected standard fused-silica 
capillaries for sample collection. The inset shows a SEM image of the probe tip 
consisting of two orifices for push-pull sampling. B) Schematic of an experimental 
setup for low-flow push-pull perfusion. A vacuum pump was used to withdraw the 
sample while a syringe pump was used to add a make-up aCSF. Perfusion rates were 
50 nL/min for push and pull modes. C) Representative chromatogram of in vivo 
monitoring. The assay allowed multiplexed monitoring of various neurotransmitters 
and metabolites. Reproduced with permission from115. © 2013 American Chemical 
Society......................................................................................................................... 15 
Figure 1.4 A) Example of highly-ordered AAO membrane. SEM images show top view (A, i) 
and cross-sectional view (A, ii) of a membrane with pore size of ~65 nm. B) SEM 
images of microfabricated dialysis needle. The array dots in (B, i) were 2 µm 
lithographically fabricated pores. Zoom-in image (B, ii) highlighted a 30 nm diffusion 
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passage between two layers of microporous Si membrane. A, reproduced with 
permission from129; and B, reproduced with permission from143. .............................. 18 
Figure 1.5 A) Illustration of segmented flow sampling coupled to direct infusion MS assay; 
A, i) Dialysate is perfused into a 4-way fluidic device (at bottom inlet) while 
fluorinated oil and internal standard solution are pumped into the device at separate 
inlets (left and top inlets). Resulting droplet train is moved to the right arm; A, ii) 
Sample droplets (~32 nL) were coalesced into bigger droplets (~160 nL) before 
pumping to the ESI source for online MS analysis (A, iii). HV denotes high voltage. 
B) in vivo neurochemical monitoring using the system in A; Figures show 
simultaneous recording of i) acetylcholine (ACh), ii) internal standard, d4-
acetylcholine (d4-ACh), and iii) drug, neostigmine (Neo). Arrows indicated 
beginning of each drug microinjection. The inset shows a magnified view for 
detection of Neo during the first microinjection, highlighting fast response time 
possible. Reproduced with permission from163. © 2012 American Chemical Society
..................................................................................................................................... 20 
Figure 2.1 Layout of microfabricated microdialysis probe. A probe has 3 ports including 
inlet, outlet, and spare for other potential uses (it was not used at this probe). (A) 
SEM image of cross-section of channels showing semicircular shape and thin 
polysilicon top layer. (B) SEM image of AAO membrane over sampling area. (C) 
SEM image of sampling probe tip showing the channel pattern. ............................... 29 
Figure 2.2 Illustration of microfabrication process for microdialysis probe. The channel line 
was patterned on 2 µm thick SiO2 grown Si wafer (A). Semicircular shaped channels 
with 60 µm wide and 30 µm high were etched by XeF2 (B) and sealed with 
polysilicon (C). After 1 µm thick SiO2 was deposited, probe shape was patterned and 
etched by DRIE (D). Sampling area at the tip of the probe was opened and etched by 
DRIE to be 2 µm thick layer (E). 400 nm Al layer was deposited and anodized 
electrochemically forming nanoporous AAO membrane (F). Polysilicon layer was 
etched through AAO membrane by DRIE (G) and 400 nm AAO membrane was 
removed (H).  For physical strength of sampling area, 3 µm AAO membrane was 
fabricated by the deposition and electrochemical anodization of Al layer (I). Finally, 
thinned probes were released in hot water after backside etching (J). ........................ 31 
Figure 2.3 Overall setup of AAO process. After deposition of 400 nm Al layer over the 
wafer, the Al coating was anodized at 60 V in 0.3 M oxalic acid for 15 min at 15 °C. 
Platinum mesh was used as a counter electrode, which was aligned parallel to the Al 
coated wafer. The device wafer was facing toward and 1inch apart from the platinum 
mesh. ........................................................................................................................... 32 
Figure 2.4 Fabrication of Probe Holder. The probe holder has guides to connect probe ports 
and capillaries. Probe holders were fabricated from a silicon wafer with growth of a 1 
µm silicon dioxide layer. The 2 mm wide rectangle for a guide of probe connection 
ports was patterned by lithography and SiO2 layer was removed by BHF. A second 
lithography step was performed to pattern 360 µm wide trenches for a guide of 
capillaries and DRIE etched 50 µm deep. Photoresist on the wafer was removed by 
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positive resist stripper (PRS 2000; Avantor Performance Materials, PA) and 40 µm 
deep trenches and rectangles were additionally etched by DRIE. To connect fluidic 
capillaries to microchannels in a probe, a union capillary of 1 cm length with 180 μm 
i.d. and 360 μm o.d. was glued on the guiding trenches of a probe holder with epoxy 
gel resin. (A) Probe ports were inserted into union capillaries and 12 cm length of 100 
μm i.d. and 150 μm o.d. fluidic capillaries were joined to inlet and outlet probe ports 
through the union capillary. Finally, all assembled devices were sealed with epoxy gel 
resin. The probe glued to the holder as shown in (B). ................................................ 33 
Figure 2.5 Scanning electron micrographs of fabricated microchannels with pores. Drawing 
at left indicates where the probe sampling tip was broken to expose channels. Images 
show AAO and polysilicon membranes overlaid. Lowest image shows that pores go 
through the polysilicon base layer over the open channel. ......................................... 37 
Figure 2.6 Determination of the dynamic response time of the microfabricated probe to step 
change in sampled concentration, and the relationship between perfusion flow rate 
and relative recovery. (A) Illustration of experimental setup. Probe was inserted into a 
solution of water and then switched to a solution of 50 µM fluorescein as the sample. 
Fluorescence was monitored downstream on the outlet capillary. (B) Trace shows 
representative example for detection fluorescent change with time beginning at switch. 
Delay time is 14.5 min, which corresponds to the internal volume of ~1400 nL at the 
perfusion rate of 100 nL/min. Inset shows the 10% to 90% response time. Average 
was 47 ± 2 s (n = 7). (C) Scatter plot shows an inverse relationship between flow rate 
and relative recovery from the microfabricated probe sampling. ............................... 39 
Figure 2.7 A) Comparison of relative recoveries of analytes between in vitro and in vivo 
experiments. The bar chart represents averaged relative recovery with SEM. * 
indicates different with p < 0.05, ** indicates p < 0.001 obtained by the two-tailed 
Student’s t-test test. B) Multiple reaction monitoring mass chromatograms of a 
representative fraction (1.5 µL) collected from the striatum of an anesthetized rat 
through the microfabricated probe. The chromatogram shows the trace for 14 
detectable neurochemicals. Abbreviations used are: acetylcholine (ACh), choline 
(Cho), taurine (Tau), glutamine (Gln), serine (Ser), glucose (Gluc), glutamate (Glu),  
phenylalanine (Phe), 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), 
tyrosine (Tyr), ............................................................................................................. 42 
Figure 2.8 Comsol modeling and simulation of 1 mM dopamine diffusing through the 
membrane of microfabricated probe. The microfabricated probe was constructed in 
COMSOL Multiphysics 4.4 (Burlington, MA) to model its recovery. The fabricated 
probe has semi-circular fluidic channels; but for ease of modeling, the channels were 
designed as 60 µm x 24 µm rectangles which gave the same cross-sectional area as 
the actual probes. The total length of the channels was 8 mm in a ‘U’ shape like the 
actual probe. The porous membrane was designed as a polysilicon rectangle, 5 µm x 
60 µm, overlaid the channels. A large box was connected to the external boundary of 
the membrane region for simulating the probe in a well-stirred solution. The ‘Free 
and Porous Media Flow’ and ‘Species Transport in Porous Media’ physics models 
were applied to the channel and membrane regions. Navier-Stokes equations modeled 
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the fluid (water) in the open channel with a flow rate of 100 nL/min. Fluid movement 
in the porous region was defined by the Brinkman equation and a permeability of 50 
nm2 was used. The porosity variable was modified to match experimental data. For 
the transport of chemical species, the diffusion coefficient of dopamine, 6 x10-10 m2/s 
was used. The exterior probe volume used ‘Laminar Flow’ and ‘Transport of Diluted 
Species’ physics with a flow rate of 10 mL/min to simulate a well-stirred solution. 
Images below show cross section of probe at the middle and end of the probe color 
coded for DA concentration. A) Recovery for probe with 30% porosity and B) for 0.9% 
porosity. ...................................................................................................................... 43 
Figure 2.9 Dual probe microdialysis of rat striatum showing effects of AMPH (5 mg/kg, IP) 
on DA release and other neurochemicals sampled by a concentric microdialysis probe 
(MD) and microfabricated probe (µFab). Both probe types have similar performance 
on response to dynamic in vivo chemical changes. Lines indicates when AMPH was 
present (fractions at 60 and 80 min). Data were converted to percent of baseline 
measurement to normalize pre-drug levels to 100 percent. Student’s t-test indicates a 
significant change (*p < 0.05) between basal and post drug levels. Results are the 
mean ± SEM, n = 3 animals. For other measured neurochemicals, their post drug 
levels did not significantly change. ............................................................................. 46 
Figure 2.10 A) Horizontal histological section of the brain. The zoomed in images in the 
insets indicates the probe tract areas of both µFab and MD probes. As shown, the 
µFab probe tract is 83% smaller than the MD probe tract. B) The brain was cut into 
40 µm coronal sections and Nissl stained to show overall brain structure with probe 
tracts (boxes with dashed line). C) Dotted lines indicates tracts overlaid on a rat brain 
atlas diagram, corresponding to (A). ........................................................................... 47 
Figure 3.1 A) Overview of probe shape and channels. B) SEM images of microfabricated 
push pull probe with additional channel for microinjection. The images show cross 
section of the probe (i); top view of an integrated tee after backside etch to reveal the 
channels (ii); and tip of the probe (iii) with an estimated sampling area (yellow 
dashed) of 1200 µm2. .................................................................................................. 54 
Figure 3.2 Illustration of fabrication and design of a PDMS manifold. The device was 
designed to minimize dead volume while allowing pre-alignment of fluidic capillaries 
and ensuring no leakage during vacuum applied. Fabrication was based on replication 
of PDMS from a microfabricated SU-8 mold (A) and a polyimide-coated glass 
capillaries (B), yielding a combination of microchannels with appropriate shapes and 
dimensions (C). Further molding step (D) was employed in forming guides for ease of 
capillary insertion. Top view of the device (E) and its 3D view (F) are also shown. An 
actual image of the complete device after tubing connection can be seen in the inset 
of Figure 3.3B. ............................................................................................................ 56 
Figure 3.3 Overview of experimental setup for monitoring brain chemical dynamics with 
high spatiotemporal resolution. (A) Microfabricated push-pull probe with 3 channels. 
The first and second channels were used for pushing regular aCSF and microinjection 
of K+-aCSF. The last channel was used for pulling sample. The inset showed 
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microfluidic interface between the probe and a “fluidic” capillary. This capillary was 
used for sample transfer prior to connecting with a microfabricated manifold for 
simultaneous flow segmentation and reagent addition (B). Generated droplets were 
collected in a Teflon storage tubing prior to an offline analysis. The inset showed a 
microscopic photograph of the flow segmentation with reagent addition. Food dyes 
were added to sample and reagent for visualization. (C) Photograph of the probe 
connected to the droplet-based device. ....................................................................... 58 
Figure 3.4 Test of temporal resolution. A) Schematic of a segmented flow sampling; B) step 
changes of fluorescein concentration revealing temporal resolution of ~6 s at a 
sampling rate of 100 nL/min; C) Resulting calibration from the above sampling 
experiment. Each point was the average of 25 standard droplets ............................... 60 
Figure 3.5 Clogged channel by adhesive used during the backside etching. ......................... 62 
Figure 3.6 In vitro characterization of sampling coupled to segmented flow and reagent 
addition. Samples were a mixture of standards in aCSF and reagents contained 
fluorescein and a mixture of internal standards. A) Detection of for fluorescein in 
droplets yielded peak heights with RSD of 3% (n = 3 device sets). An example of a 
step change of ACh during switching concentration is shown in (B) along with related 
I.S. added at the same period. C) Calibration curves from ratio of signal traces of 
standards to internal standards. Linear calibration curves were achieved. ................. 68 
Figure 3.7 In vivo monitoring of response to microinjection of 100 mM K+ aCSF (infused at 
100 nL/min for 1 min) in the rat striatum. Arrows indicate beginning of 
microinjection. Data are expressed as percentage of baseline (mean ± SEM, n = 4 rats) 
upon switching to microinjection of high potassium. Responses of glutamine (A), 
glutamate (B), GABA (C) and acetylcholine (D). Rise times could be observed within 
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Figure 4.1 Thin microfabricated push-pull probe .................................................................. 78 
Figure 4.2 A) Illustration of the droplet generator with reagent additions, driven by a vacuum 
(the image was not drawn to scale). B) A photograph of the manifold connected to a 
microfabricated push-pull probe. The holder was made by 3D-printing. C) An 
experiment with food dyes was performed to aid visualization. When sample was 
switched from a blank to red dye, color change was observed within 1 - 2 droplets (D) 
Switching of Glu concentration, resulting in a rise time of ~3-5 s at a sampling rate of 
50 nL/min. ................................................................................................................... 80 
Figure 4.3 Fabrication of a Teflon-based device for droplet extraction. A) Insert Teflon 
tubing into “Tee1”, B) Drill a 150 µm diameter hole on Teflon tubing, C) Clean 
debris, D) Insert the tubing into “Tee 2”. All the procedures were carried out under a 
microscope. “Tee 1” was used to hold Teflon tubing in place and aid the drilling 
process. Fused-silica capillary was used to reinforce Teflon tubing and protect the 
tubing wall from damage. “Tee 2” was used to seal the device and align drilled Teflon 
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tubing with the fused-silica extraction capillary that was attached to the CE chip 
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Figure 4.4 Schematic of droplet extraction device coupled to microchip CE ....................... 84 
Figure 4.5 Effects of organic solvent contents on droplet formation..................................... 87 
Figure 4.6 A) Illustration of a side-view of the Teflon-fused-silica interface for droplet 
extraction. B) An example of droplet extraction, series of images showed extraction 
of aqueous droplets when it contacted the fused-silica surface. ................................. 91 
Figure 4.7 A) an example of electropherogram for separation of fluorescence-labelled amino 
acids and fluorescein. B) In vitro monitoring of neurochemical dynamics. The 
integrated system was used for sampling, flow segmentation, reagent addition, droplet 
extraction, and microchip CE analysis........................................................................ 93 
Figure 4.8 Calibration curves resulting from Figure 4.7B. Each point was an average of ~30 
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Figure 4.9 Dead volume at the CE inlet caused diffusion and mixing prior to CE injection. 
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Figure 5.1 Summary of the original process for membrane fabrication. A & B) 400 nm thick 
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 Abstract 
 Monitoring neurochemical dynamics has played a crucial role in elucidating brain 
function and related disorders. An essential approach for monitoring neurochemicals is to 
couple sampling probes to analytical measurements; however, this approach is inherently 
limited by poor spatial and temporal resolution. In this work, we have developed 
miniaturized sampling probes and analytical technology to overcome these limitations.    
 Conventional sampling probes were handmade and have several disadvantages, 
including large sizes (over 220 µm in diameter) and limited design flexibility. To address 
these disadvantages, we have used microfabrication to manufacture sampling probes. By 
bulk micromachining of Si, microchannels and small sampling regions can be fabricated 
within a probe, with an overall dimension of ~100 µm. For development of a dialysis probe, 
nanoporous anodic aluminum oxide was adapted for monolithically embedding a membrane. 
Coupling the probe to liquid chromatography-mass spectrometry, multiple neurochemicals 
were measured at basal conditions, including dopamine and acetylcholine. Comparing to 
conventional dialysis probes, the microfabricated dialysis probe provided at least 6-fold 
improvement in spatial resolution and potentially had lower tissue disruption. 
 Furthermore, we have continued the development of a microfabricated push-pull 
probe. We enhanced functionality of the probe by integrating an additional channel into the 
probe for chemical delivery. Further, we demonstrated that the probe can feasibly be coupled 
to droplet microfluidic devices for improved temporal resolution. Nanospray ionization mass 
spectrometry was used for multiplexed measurements of neurochemicals in nanoliter droplet 
xxiv 
 
samples. Utility of the integrated system was demonstrated by monitoring in vivo dynamics 
during potassium stimulation of 4 neurochemicals, including glutamate and GABA. The 
probe provided unprecedented spatial resolution and temporal resolution as high as ~5 s. 
Additionally, we highlighted versatility of the method by coupling the probe to another high-
throughput assay, i.e., droplet-based microchip capillary electrophoresis for rapid separation 
(less than 3 s) and measurement of multiple amino acid neurochemicals. 
 This collection of work illustrates that development of the microfabricated sampling 
probes and their compatible microfluidic systems are highly beneficial for studying brain 
chemistry. The integrated miniaturized analytical technology can potentially be useful for 
solving other problems of biological significance. 
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Chapter 1  
Introduction 
Submitted, in part, as a review article in ChemPhysChem, Special Issue on Neurochemistry and 
Neuroengineering. Editorial contributions from co-authors: Thomas S. White and Dr. Robert T. Kennedy 
 
 Brain chemicals are highly diverse. Over two hundred different compounds have been 
identified as neurotransmitters, including amino acids, peptides, purines, lipids, monoamines, 
and other small molecules (e.g., acetylcholine)1,2. These chemicals participate in neural 
activity and are involved in various physiological functions, such as learning, memory, mood, 
and movement3–5. Abnormal levels or dynamics of neurotransmitters also link to mental 
illnesses and neurological disorders, such as Alzheimer’s6,7 and Parkinson’s diseases8–11. It is 
therefore of interest to study dynamics of neurotransmitters and their metabolites in the brain 
extracellular space. Besides these compounds, other chemicals including metabolic 
intermediates and drugs are also important for brain functions. Energy metabolites (e.g., 
glucose) provide fuel for neurons12, and measuring their concentrations has proven useful for 
diagnostics in traumatic brain injury13–15. Drugs or psychopharmacological substances can 
have effects on neurotransmission in many different ways, such as enhancing or inhibiting 
transmitter release16.   
 Measuring brain chemistry in vivo has proven indispensable in better understanding 
chemical neurotransmission, which can be correlated to brain functions, behavior and 
pharmacology17–20,16. Probe techniques, such as electrochemical sensors21–23 and 
microdialysis sampling24–28, have remained predominant for in vivo neurochemical 
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monitoring. In these techniques, needle-like probes are implanted into live brain tissues for 
direct chemical measurements. First generation probes were handmade and have several 
limitations, including variability, low reproducibility, and limited design flexibility. The 
probe size can be bulky for the sampling probes in particular, leading to poor spatial 
resolution and substantial tissue damage. To overcome these limitations, several efforts have 
been devoted to using microfabrication. Microfabrication techniques ultimately allows 
development of miniature, multiplexed and highly-precise probes for studying brain 
chemistry. Other advantages also include a wide choice of materials, scalability, and batch 
fabrication29. Furthermore, microfabrication offers unique opportunities for incorporating 
multiple functions into a single probe, such as electrophysiological recording, drug delivery, 
and optical stimulation30–34. 
 The objective of this chapter is to provide a background and a review on 
microfabricated probes for monitoring brain chemistry. While this dissertation focuses on 
microfabricated sampling probes, this chapter will also discuss microfabricated 
electrochemical sensors as the two techniques offer complementary strengths and weaknesses. 
Moreover, assays coupled to sampling probes for improving temporal resolution will be 
highlighted. Finally, an overview of this dissertation will be given. 
 
Current Monitoring Technology 
 Criteria for evaluating methodology for in vivo neurochemical monitoring include 
sensitivity, selectivity, spatial resolution, temporal resolution, and multiplexing23,25,35–38. 
Sensitivity and selectivity are crucial to neurochemical measurements as the brain 
extracellular space is a complex mixture of chemicals with concentrations from picomolar 
(pM) to millimolar (mM). Spatial resolution is important due to the heterogeneity and small 
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size of the brain structures. Temporal resolution is essential because neurochemical levels 
can alter rapidly (i.e., on millisecond time scale during exocytosis39,40 or second time scale 
during behavior or stimuli41–44). Finally, simultaneous measurement of multiple chemicals is 
often needed when one would like to study multiplexed transmission or interactions between 
neurotransmitters, metabolites and drugs45. Therefore, it is desirable to develop technology 
that allows multiplexed neurochemical monitoring with long-term stability and high spatial 
and temporal resolution. In vivo neurochemical monitoring has been performed by non-
invasive imaging techniques, such as positron emission tomography (PET), functional 
magnetic resonance spectroscopy (fMRS), and genetically-encoded biosensors, or by 
invasive techniques, such as electrochemical sensors and microdialysis sampling, that 
involve probe insertion into brain tissue.  
 
Non-invasive Imaging Techniques 
 Predominant neurochemical imaging techniques include PET and fMRS. In PET, 
radioactive tracers (i.e., positron-emitting radionuclides) are intravenously injected into the 
bloodstream for labeling interested molecules in the brain prior to scanning46–48. Even though 
this technique is highly effective, it has limited spatial (2 - 3 mm at state of the art49,50) and 
temporal resolution (several seconds to minutes)51–53. fMRS uses a magnetic field to resolve 
1H spectra for identification and measurement of brain chemicals54,55. This technique has 
spatial55 and temporal resolution56–58 within the scales that are comparable to those of PET. 
The advantage of fMRS mainly stems from its non-requirement of tracers, but this technique 
suffers inherently poor sensitivity. Although administration of a contrast agent may improve 
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sensitivity, it still remains insufficient for detecting many neurotransmitters at basal 
concentration.  
 Imaging brain chemicals via genetically-encoded biosensors is an emerging 
technology based on introduction of fluorescent markers into the tissue of interest59–61. This 
technique allows chemical measurement with superior spatial (µm-scale) and temporal 
resolution (ms to s). Despite this advantage, this technology is still in its infancy. Thus far 
only glutamate can be studied in vivo by this approach with a sub-micromolar (µM) limit of 
detection (LOD). Engineering a marker to efficiently yield a fluorescent signal for a specific 
molecule is also a long and difficult process. Due to several limitations of the imaging 
techniques, the probe techniques remain popular for in vivo neurochemical monitoring. 
 
Electrochemical Sensors 
 Electrochemical detection of neurotransmitters relies on use of microelectrodes. 
Commonly, a microelectrode is made by aspirating a carbon fiber or a metal wire (~10 µm 
diameter) into a glass capillary before pulling the glass capillary and manually trimming the 
electrode site to a length of 50 - 100 µm (Figure 1.1A & D). Using electrochemical 
methods23,62, such as amperometry or fast-scan cyclic voltammetry (FSCV), electroactive 
molecules (e.g., dopamine and serotonin) can be detected directly via a redox reaction at the 
exposed electrode site. For detection of non-electroactive molecules (e.g., glutamate and 
glucose), the surface of electrode is treated with a selective enzyme/ membrane to generate 
an electroactive product63,64, such as H2O2 via oxidase reaction, or nicotinamide adenine 
dinucleotide (NADH) via dehydrogenase reaction. Microelectrodes can allow in vivo 
monitoring with high spatial (10 - 100 µm) and temporal resolution (ms to s). Due to this 
advantage, electrochemical sensors are popularly used for real-time monitoring of transient 
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neurochemical changes during behavior and/or stimulation. Selectivity, sensitivity, and 
LODs of the electrochemical sensors rely on several factors, such as electrode design, 
materials for electrode and selective-membrane, fabrication procedures, and detection 
method. Advances in technique and instrumentation, better control of electrode surface 
chemistry, and development of new materials and methods for electrode modification have 
improved overall selectivity and sensitivity. This improvement has allowed detection of 
neurochemicals with lower LODs (e.g., below 500 nM for glutamate65, and below 20 nM for 
dopamine66,67). Despite this improvement, development of sensors with sufficient sensitivity 
and selectivity for in vivo monitoring has remained challenging for many neurochemicals. 
Furthermore, electrochemical sensors are generally incapable of multiplexed neurochemical 
measurements.  
 Development of microelectrode arrays has become a topic of interest since it allows 
study of networks and chemical heterogeneity68 within singular closely-spaced brain regions. 
Moreover, the multisite platform can be useful in multiplexed monitoring if each electrode 
has a different selectivity. Traditionally, multisite in vivo monitoring may be performed by 
implanting several individual microelectrodes with the aid of a stereotaxic system for manual 
alignment69. An alternative approach is to create electrode arrays either by bundling of 
microwires or placing carbon fibers into multi-barrel pulled glass capillaries39,70. Although 
these two approaches seem to be effective, they have limitations in term of reproducibility 
and spatial control. Scalability has remained a challenge. Simultaneous recording at 
vertically-spaced different spots is also not possible highlighting the inflexibility of design of 
manually prepared electrodes. Several efforts have resorted to microfabrication to overcome 
these problems. 
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Figure 1.1 (A - C) Schematic of conventional probes for in vivo neurochemical monitoring with comparison of 
probe sizes. A) Electrochemical microelectrode with 10 µm diameter, 50 µm long. B) Concentric microdialysis 
probe with 1 mm long polyacrylonitrile (PAN) membrane with 230 µm o.d. C) push-pull probe, made by 
assembly of 20 µm i.d./90 um o.d. capillaries side-by-side, sheathed with 180 µm i.d./220 µm o.d. polyimide 
tubing. Models were drawn to scale for comparison of probe size and regions of chemical monitoring (at 
exposed electrode surface for (A), membrane surface for (B), and space between orifices for (C). (D - E) 
Exampled SEM images of a cylindrical carbon fiber microelectrode (D), highlighting a tip size of < 10 µm 
diameter (reproduced with permission from22); and a concentric dialysis tubing (E), AN 69 membrane, the inset 
shows a zoom in highlighting tortuous paths. 
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Sampling Methods 
 Microdialysis is a popular sampling method for in vivo studies. In microdialysis, an 
implantable probe (Figure 1.1B & E) is constructed by sheathing inlet and outlet capillaries 
with a hollow-fiber, semi-permeable membrane which is plugged at one end (220 - 500 µm 
in diameter, 1 - 4 mm long)25–27. During sampling, the inlet is infused with a buffer that 
matches the ionic composition of extracellular fluid at 0.1 - 3 µL/min. Sampling occurs at the 
membrane where analytes are extracted from the extracellular space according to their 
concentration gradients. The buffer with extracted analytes, called dialysate, is collected in 
fractions before chemical analysis with an appropriate analytical technique. Microdialysis 
sampling is widely used for in vivo chemical monitoring due to its versatility and feasibility 
for coupling to various analytical techniques37,71, such as liquid chromatography with mass 
spectrometry (LC-MS), immunoassay, and capillary electrophoresis with laser-induced 
fluorescence (CE-LIF). This feature allows measurement of any neurochemicals and drugs 
with high sensitivity and selectivity, and multi-analyte capability. 
 An inherent weakness of microdialysis sampling is poor spatial resolution due to a 
large size of membrane tubing, which correlates to an active sampling region. An alternative 
sampling method with higher spatial resolution is miniaturized push-pull sampling or “low-
flow push-pull perfusion”72,73. In this approach, the probe (Figure 1.1C) is constructed by 
mounting two 20 µm inner diameter (i.d.)/ 220 µm outer diameter (o.d.) fused-silica 
capillaries side-by-side, then sheathed with a 180 µm i.d./ 220 µm o.d. polyimide tubing. 
Sample is pulled from one capillary using low flow rates (typically at 50 nL/min) and a 
make-up fluid is pushed from another capillary at the same flow rate. The push-pull probes 
consequently sample only from the probe tip, resulting in substantially better spatial 
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resolution, as compared to microdialysis probes. However, the overall size of the push-pull 
probe remains bulky due to the assembly process. This large size precludes experiments in 
many small brain regions. It can also cause tissue damage that may confound measurement in 
vivo74. These size limitations highlight the need for use of microfabrication to construct 
sampling probes. Another traditional weakness of the sampling methods is poor temporal 
resolution (order of mins); however, advancement in analytical methods and microfluidic 
technology has allowed in vivo neurochemical monitoring with temporal resolution of less 
than 10 s. This subject will be discussed further in the later section, “Assays for Improved 
Temporal Resolution”.  
 
Microfabricated Electrochemical Sensors 
 The field of neuro Microelectromechanical Systems, or “neuroMEMS” (see historical 
reviews and recent technological advancement32,33,75,76) has well-established technologies for 
fabricating neural probes to investigate electrical activity at multiple different sites. 
Advancement in microfabrication tools and materials allowed development of small, highly 
reproducible, highly integrated, and high density neural probe arrays (see Figure 1.2A for an 
example of 256-site probes; up to 1024 sites have been made75,77). The microfabrication 
process has more recently been adopted to construct probes with sensor arrays for 
neurochemical recording. Careful considerations of material for substrate and electrodes, and 
surface architectures are required to achieve desired performance78.  
 
Electrodes 
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 A key component in electrochemical detection is the electrode site. By 
microfabrication, electrodes can be deposited as thin films (less than a few hundred nm) by 
various techniques, such as sputtering and low pressure chemical vapor deposition (LPCVD), 
prior to insulation. Choices of materials for insulating the electrodes include SiO2, Si3N4, SU-
8, and polyimide. For detection of the H2O2 product from enzyme sensors, Pt is normally 
used due to its electrocatalytic property, long-term biocompatibility, and ease of fabrication. 
For direct detection of electroactive molecules (monoamines in particular), carbon is a more 
suitable material because it has less charging current, more favorable electrocatalytic 
properties for these molecules, and relatively wide potential window. Since direct deposition 
of carbon (i.e., via sputtering or evaporation) typically resulted in low-quality film, it is 
preferable to use pyrolysis of photoresists in the microfabrication of carbon electrodes79,80. 
The surface area of an electrode is also another important parameter in designing 
neurochemical probes. Enlarging this surface area increases sensitivity; however, a large 
surface area can increase probe size and compromises spatial resolution. In the 
microfabricated probes79,81–94, electrode surface areas ranged from 500 - 1000 µm2 for direct 
electrochemical detection of dopamine, and 5000 - 10000 µm2 for detection of non-
electroactive species by enzyme-coated electrodes. Methods to increase surface roughness 
without overall size are an approach to increase sensitivity for a given size electrode. The gap 
between electroactive sites was typically kept at 50 – 200 µm in order to limit cross-talk. 
 Surface modification of electrodes, with selective membranes, is generally required to 
improve selectivity and sensitivity. For detection of non-electroactive molecules, enzymes 
mixed with bovine serum albumin (BSA) are typically immobilized on electrodes by 
crosslinking with glutaraldehyde. Thickness of the enzyme coating is critical to performance 
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of the electrode as the substrates and products must move through the membrane layers. 
Excessive thickness could lead to slow response time95 of the electrode and higher degree of 
cross-talk between electrodes96. On the other hand, overly thin membranes may lead to 
insufficient sensitivity and non-uniformity; that could be detrimental to stability and 
reliability of the electrode. Therefore, the thickness of the membrane should be well-
controlled and optimized. For example, the enzyme thicknesses on the microfabricated 
electrodes were reported to be approximately 5 – 10 µm thick84,91. Rise times of the 
microfabricated electrodes ranged from ~1 – 8 s79,81–94. Microfabrication techniques (i.e., 
lithographic patterning of polymers/ resists) also made it possible to create microwells which 
encompassed the planar electrodes (for example, see Figure 1.2C, inset). Not only did these 
microwells act as an effective insulator, but they also allowed precise immobilization and 
stable formation of the selective membranes86,94,97. 
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Figure 1.2 Examples of probes with multisite electrochemical sensors. A, i) Multi-channel (256-site 32-channel 
array) “Michigan Probes” for electrophysiological recording; SEM images of probe tips fabricated by using wet 
etching with boron-etch stop (A,ii) or dry etching (A, iii). The developed fabrication process for the Michigan 
probes formed the basis for development of other neural interfaces, including electrochemical probes; B) 
Silicon probe for neurochemical monitoring (white rectangular sites) integrated with electrophysiological 
recording sites (small black dots). C) Ceramic probe for neurochemical recording. The shank length is ~10 mm. 
The recording sites are 15 µm × 333 µm. The inset shows an SEM image of the probe tip. A, © 2008 IEEE, 
reproduced with permission from77; B, reproduced with permission from87; C, reproduced with permission 
from92,97. 
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Stiff Probe 
 Si is the most widely used substrate due to its mechanical and electrical properties, 
and relatively simple processing. Standard lithography allows patterning of microprobe 
structures and recording sites with fine features. Wet etching or dry etching, particularly 
deep-reactive ion etching (DRIE) based on the “Bosch process”98, are employed in defining 
probe outline and thickness99. Ultimately, silicon micromachining allows fabrication of very 
thin neural probes (~10-15 µm, see Figure 1.2A) with precisely-defined tapered tip77. 
Different designs of microfabricated Si probes have been developed by several groups for 
monitoring several neurochemicals, including dopamine79,81, glutamate82–84, lactate and 
glucose86 with LODs of sub-µM. In all of these probe designs, at least 4 electrode sites were 
integrated on a single probe, enabling concurrent recording of a target analytes at high 
spatially different locations. For example, the microfabricated probes were employed in 
recording stimulated dopamine in 4 different sites (at 100 – 200 µm vertically spaced) in rat 
striatum by FSCV79 or amperometry81. These results revealed heterogeneity of the stimulant 
effect on dopamine release, indicating necessary use of the microfabricated probes. With 
multi-site probes, simultaneous detection of multiple analytes in different target areas could 
also be achieved precisely84,86. At an additional electrode site, direct integration of a 
reference electrode can be performed via electrodeposition83,84. Further, parallel 
electrophysiological recording was also made feasible by adding extra electrodes81,87. Figure 
1.2B shows an example of a single probe consisting of 8 electrochemical sites (60 µm × 125 
µm) and 6 electrophysiological sites (15 µm diameter). This microfabricated probe was used 
for concurrent recording of glutamate and electrophysiology in rat striatum.  
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 Other types of stiff substrates for microfabricating neurochemical probes have also 
been explored. The Gerhardt group has extensively developed probes with electrode arrays 
based on 125 µm thick ceramic wafers (Figure 1.2C)100. Probe shapes with ultra-fine tip were 
created by using a diamond dicing saw and a laser cutter. Although thinner ceramic wafers 
(25 – 50 µm) were also commercially available, they were too fragile and difficult to process. 
The ceramic-based probes were treated with specific enzymes for monitoring glutamate88,89, 
lactate90, choline, acetylcholine91, and glucose92. A self-referencing recording approach was 
also used to remove interferents101. Chronic measurements in freely moving animals were 
also demonstrated with adequate sensitivity and selectivity, illustrating a potential advantage 
of biocompatibility with this substrate102.  
 
Polymer Probe  
 Interest in developing neural probes using “soft” materials like polymers, has recently 
grown as matching the Young’s modulus of the probe material to the soft brain is thought to 
minimize tissue damage103–106. Choices of soft materials in order of their respective stiffness 
(from high to low) included polyimide, SU-8, parylene, and polydimethylsiloxane (PDMS). 
However, soft implants normally require the use of needle guide or stiff coating (such as 
polyethylene glycol (PEG)107,108 or biodegradable silk109,110) for aiding tissue penetration and 
trajectory to deep brain tissue. Otherwise, soft implants were designed for primary use at the 
brain surface, or at depths up to a few millimeters (in the case of polyimide and SU-8). At 
present, only a few studies have been reported on using polymeric substrates to 
microfabricate neurochemical probes93,94. One example was to microfabricate polyimide-
based probes for detecting glutamate and lactate94. The polymer probe consisted of Pt 
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electrodes with integrated reference and counter electrodes. The final probe size was 500 µm 
wide × 100 µm thick, and 5.5 mm or 16 mm long. Utility of the more durable probe (5.5 mm 
long) was demonstrated in vivo by monitoring glutamate in rat cortex at 1.7 mm depth.  
 
Microfabricated Sampling Probes 
 Microfabrication has been employed to embed microfluidic channels into neural 
probes30,111,112. Small channels with different shapes and material types can be constructed by 
a variety of techniques, such as surface micromachining using sacrificial layer, and bulk 
micromachining using buried channel technology113,114 or wafer bonding. Using 
microfabrication technologies, various microfluidic neural probes have been developed for 
neurological studies and treatments. Their features as well as manufacturing processes are 
well summarized in a recent review by Sim et al34. Most of the work in microfabricating 
fluidic probes aimed to improve microinjection or chemical delivery to brain tissues. 
Nevertheless, the similar technology can be adapted to fabricate sampling probes. 
 
Push-pull/ Direct Sampling 
 Over the past few years, our group has developed the first, functional sampling 
probes for in vivo monitoring of brain chemistry115. Based on the buried channel technology, 
microfabrication in Si was used to construct push-pull sampling probes with 20 µm diameter 
channels. The microfabricated push-pull probes are 85 µm wide × 70 µm thick × 11 mm long, 
consisting of two 20 µm orifices at the probe tip for push-pull sampling (Figure 1.3). The 
overall size of the microfabricated probes was 6-fold smaller than the capillary-based probes, 
thus potentially reducing tissue damage. Sampling at 50 nL/min from rat striatum, the 
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microfabricated push-pull probe was coupled to a benzoyl-chloride LC-MS assay45 for 
monitoring of multiple neurotransmitters and metabolites (Figure 1.3C). Despite the 
advantage of small probe size, the requirement of low flow rate compromised on temporal 
resolution. In our previous report, to collect 1 µL fractions required for the LC-MS assay, 
temporal resolution was limited to 20 min. 
 
 
Figure 1.3 Microfabricated push-pull probe for in vivo neurochemical monitoring. A) Packaged sampling 
device including the probe and connected standard fused-silica capillaries for sample collection. The inset 
shows a SEM image of the probe tip consisting of two orifices for push-pull sampling. B) Schematic of an 
experimental setup for low-flow push-pull perfusion. A vacuum pump was used to withdraw the sample while a 
syringe pump was used to add a make-up aCSF. Perfusion rates were 50 nL/min for push and pull modes. C) 
Representative chromatogram of in vivo monitoring. The assay allowed multiplexed monitoring of various 
neurotransmitters and metabolites. Reproduced with permission from115. © 2013 American Chemical Society 
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 Other groups have recently also investigated microfabrication of sampling probes. 
Besides sampling, other features were further implemented in these probes. One such probe 
was a silicon-based probe designed for sampling with three integrated electrodes for 
sensing116. Another work showed a probe that contained microfluidic channels for sampling 
as well as electrodes for stimulating and recording in one package117 This probe was 
constructed by polyimide and SU-8. The resulting shank size of 240 µm wide × 86 µm thick. 
Through a single inlet, direct sampling was performed at 300 nL/min without adding a 
makeup fluid into the sample. In vitro tests revealed the probe capable of segmented-flow 
sampling, on-chip detection, and functional electrical capabilities. Both designs sought to 
miniaturize sampling probes with integrated functions through microfabrication techniques. 
However, it remains to be determined how these probes will function for monitoring 
neurochemicals in vivo. 
 
Membrane Integration 
 Although microfabricated push-pull probes allow sampling with high spatial 
resolution, they are more susceptible to clogging than microdialysis probes due to the 
absence of membranes. Proteins and debris that enter the sampling channels may also 
interfere with the downstream analytical assays. Integration of nanoporous membranes into 
the miniaturized sampling probes can be performed to circumvent these potential issues.  
 A wide variety of techniques has been used to fabricate nanoporous membranes118–120, 
e.g., ion-track etching121,122, focused ion beam drilling123, rapid annealing124, anodization of 
silicon125,126, and anodization of aluminum127–130. The widely used and appealing method is 
anodization of aluminum to form porous anodic aluminum oxide (AAO). In this method, the 
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formation of nanopores is a self-assembling process by anodizing an aluminum film in an 
acidic solution (e.g. oxalic acid, sulfuric acid, or phosphoric acid). Comparing to the other 
fabrication techniques, AAO process is relatively simple and inexpensive as it does not 
required sophisticated equipment. Further, the process can yield membrane with high density 
and straight pores (Figure 1.4A). By altering electrolyte, electrolyte concentration, anodizing 
potential and temperature, the process can also be tuned to fabricate membranes with a wide 
range of porosity (108-1012 pores/cm2 or 5 - 50% )127,128, thicknesses (100 nm - 200 µm 
range)131,132 and pore sizes (5 - 400 nm range)127,133,134. Due to these reasons, interests in 
AAO membranes have been renewed in the recent years119,127,135–137. Their applications are 
diverse, including patterning of functional nanostructures138,139, filtering or size-based 
separation134,140,141, and drug delivery142.       
 Most of the previous work on membrane integration are designed for microfluidic 
devices rather than microprobe structures124,126,143–152. Embedding membranes in microfluidic 
neural probes is challenging because 1) the small support structures may lead to collapse of 
the membrane during fabrication, and 2) the limited surface area increases the difficulty of 
membrane attachment. Membranes should also contain sufficient porosity to allow suitable 
extraction efficiency/ recovery of analytes while having sufficient strength to avoid rupture 
as fluid infuses into the microchannels. Zahn et al has reported microfabrication of dialysis 
probes (Figure 1.4B)143. Preliminarily, a permeable polysilicon (100 nm thick with 5 – 20 nm 
pore defects) was fabricated on top of a 10 µm tall × ~150 µm wide channel. Although the 
membrane was successfully formed over the channel, according to the authors, the thin 
membrane was too fragile to be effectively used. An alternative approach was to employ a 
sacrificial oxide spacer layer in creating 30 nm diffusion passage (Figure 1.4B, ii), 
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sandwiched between two layers of lithographically-patterned porous membranes (2 µm pores 
with a total thickness of 2-3 µm). Even though this probe proved its utility for in vitro 
sampling of a fluorescent dye, its capability for in vivo neurochemical sampling has not been 
tested. The membrane also had low porosity (i.e., 1.5%) which may limit recovery. The 
narrow flow passage may potentially lead to stiction issues153. Nevertheless, this pioneering 
work suggested possibility of miniaturization of dialysis sampling probe. 
 
 
Figure 1.4 A) Example of highly-ordered AAO membrane. SEM images show top view (A, i) and cross-
sectional view (A, ii) of a membrane with pore size of ~65 nm. B) SEM images of microfabricated dialysis 
needle. The array dots in (B, i) were 2 µm lithographically fabricated pores. Zoom-in image (B, ii) highlighted a 
30 nm diffusion passage between two layers of microporous Si membrane. A, reproduced with permission 
from129; and B, reproduced with permission from143.  
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Assays for Improved Temporal Resolution 
 In sampling techniques, temporal resolution is limited by mass sensitivity and 
throughput of analytical methods coupled to the sampling probe28,71. Particularly, the use of 
low flow rates (< 100 nL/min) in the microfabricated sampling probes can compromise 
temporal resolution as a long period is required to collect enough sample volume for the 
subsequent assay. Miniaturized analytical methods, such as microbore LC or CE, may be 
utilized for improved temporal resolution. However, as samples travel from probes to 
analytical system, the temporal resolution is also limited by broadening of concentration 
zones due to Taylor dispersion154. This reduction in temporal resolution depends inherently 
on flow rates and capillary dimensions. The band-broadening may be mitigated by using high 
sampling flow rate (> 1 µL/min) and short, small-bore connecting tubing. As a result, 
temporal resolution of 3 - 30 s could be achieved41,155–157. In spite of this improvement, this 
approach was limited to only anesthetized subjects. It is also not suitable for the miniaturized 
probes where low sampling flow rates are required.  
 Another effective approach for improved temporal resolution is to use segmented-
flow or droplet microfluidics158–160. In this approach, a sample flow is segmented into a train 
of discrete aqueous droplets by an immiscible fluorinated oil (see Figure 1.5A, i). By flow 
segmentation, sample droplets do not mix by diffusion during transport, and the temporal 
resolution is hence preserved. In vitro studies have shown that chemical sampling with sub-
second time resolutions could be attained by using segmented flow73,117,159. Furthermore, 
droplet technology facilitates handling and manipulation of small-volume samples collected 
at short intervals. Integration with other microfluidic devices was also made feasible for 
further analytical procedures161,162.  
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Figure 1.5 A) Illustration of segmented flow sampling coupled to direct infusion MS assay; A, i) Dialysate is 
perfused into a 4-way fluidic device (at bottom inlet) while fluorinated oil and internal standard solution are 
pumped into the device at separate inlets (left and top inlets). Resulting droplet train is moved to the right arm; 
A, ii) Sample droplets (~32 nL) were coalesced into bigger droplets (~160 nL) before pumping to the ESI 
source for online MS analysis (A, iii). HV denotes high voltage. B) in vivo neurochemical monitoring using the 
system in A; Figures show simultaneous recording of i) acetylcholine (ACh), ii) internal standard, d4-
acetylcholine (d4-ACh), and iii) drug, neostigmine (Neo). Arrows indicated beginning of each drug 
microinjection. The inset shows a magnified view for detection of Neo during the first microinjection, 
highlighting fast response time possible. Reproduced with permission from163. © 2012 American Chemical 
Society  
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 Analysis of droplets may be performed by a variety of high throughput analytical 
methods164. Particularly, suitable analytical techniques for neurochemical analysis of droplets 
included enzyme assay, microchip CE, and direct infusion electrospray ionization (ESI)-MS. 
Low-flow push-pull perfusion with segmented flow was coupled to an enzyme assay for 
analysis of glutamate, with 7 s resolution and a LOD of 300 nM73. Microchip CE with LIF 
detection was used for simultaneous measurement of amino acids in droplet dialysates with 
LODs of 80 - 100 nM165,166. By using an offline analysis, droplets could be generated at a 
high frequency (2 nL droplet at ~0.5 s interval) before pumping them into the chip at a 
slower rate. Each droplet was therefore analyzed without loss of temporal resolution although 
the separation time was 50 s. As a result, 9 s temporal resolution was achieved in vivo. Using 
ESI-MS assay, acetylcholine in dialysate droplets (160 nL at 5 s interval) was monitored with 
5 s temporal resolution and a LOD of 5 nM (see Figure 1.5)163. In addition, choline and the 
acetylcholine esterase inhibitor were simultaneously detected. In principle, the MS assay 
offers the most versatile route to analyze droplet samples. This assay provides many 
advantages, such as high sensitivity and selectivity, label-free detection, and multi-analyte 
capability. In contrast to the CE assay, flow desegmentation prior to ESI-MS was also not 
necessary when using suitable oils and optimized flow rate and voltage167. Further, 
enhancement of MS sensitivity and reduction of matrix effects can be achieved by using 
nanospray ionization168–170. This approach has enabled compatibility of the assay with much 
smaller sample volume (i.e., analysis of < 5 nL droplets have been made possible), thus 
facilitating neurochemical sampling at low flow rates while providing high temporal 
resolution.  
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Dissertation Overview 
 The overall goal of this dissertation is to use microfabrication to miniaturize sampling 
probes for studying neurochemistry at high spatial resolution. Further, microfluidic interfaces 
are developed to enable integration of the microfabricated probes with droplet-based 
platforms before coupling to high-throughput assays for diminishing the temporal resolution 
disadvantage of the method. The resulting integrated systems offer spatial and temporal 
resolution approaching those of electrochemical sensors while preserving the capability of 
multiplexed chemical measurements. Even though the focus of this work is on monitoring 
brain chemistry, the technology developed herein could potentially be useful for a variety of 
bioanalytical applications.   
 In Chapter 2, a novel approach to microfabricate dialysis probes is described. Bulk 
micromachining was used to create a microfluidic Si probe for sampling. Additionally, 
anodic aluminum oxide processing was adapted to develop a method for direct formation of 
nanoporous membranes on microchannels. The final probe size was 160 μm wide × 45 µm 
thick × 11 mm long, containing a buried 30 μm deep × 60 µm wide U-shaped channel. The 
probe was monolithically embedded with a 4 mm long × 5 μm thick nanoporous membrane 
with pore sizes of 50 – 70 nm. Compared to standard dialysis probes, the microfabricated 
probe provided over 6-fold improved spatial resolution and has potentials for low-invasive 
measurement. The probe yielded 2 - 20% relative recovery at 100 nL/min perfusion rate for a 
variety of small molecules. Coupling the probe to LC-MS, 14 neurochemicals were reliably 
monitored in vivo, including acetylcholine and dopamine. 
 Chapters 3 and 4 focus on continued development of the microfabricated push-pull 
probes. An additional channel was integrated in the probe for chemical delivery without 
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increasing overall probe dimension. The sampling area of these probes was comparable to 
that of a single carbon fiber electrode. Several microfluidic devices were developed to 
perform further analytical procedures. Interfaces that enabled interconnections between 
different devices were also created. In Chapter 3, the probe was integrated with the device for 
simultaneous segmented flow and addition of internal standard solution prior to a direct 
infusion MS assay. Utility of the system was demonstrated by monitoring dynamics of 4 
physiologically important neurochemicals, including glutamate and GABA. The integrated 
system yielded temporal resolutions of 6 s in vitro and 15 s in vivo at a sampling rate of 100 
nL/min. In Chapter 4, a thinner probe was further made; the final probe size was 85 μm wide 
× 50 μm thick × 11 mm long. This chapter demonstrated versatility of the method by 
coupling the segmented flow sampling to another throughput assay, i.e. a CE-LIF assay. A 
novel Teflon-based droplet extraction device was developed to facilitate the assay. The CE 
chip with a miniaturized separation channel was employed in enabling rapid separation (< 3 s) 
of multiple amino acid neurochemicals.  
 Chapter 5 explores refinement in the microfabrication process of the dialysis probes 
to enhance recovery. This chapter also reports possible sources of currently limited recovery 
and suggest potential strategies to improve upon the present fabrication process. In Chapter 6, 
several future directions are proposed to further increase performance and utility of the 
microfabricated probes. The first project is to make the probes even tinier than the current 
probes and to internally integrate a segmented flow system with the probes. These 
approaches will yield the next generation probes with unprecedented spatial and temporal 
resolution. The second project is to scale up a number of channels and to integrate more 
functions into the probes. More channels will allow simultaneous drug delivery, flow 
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segmentation, and multi-site samplings. The sampling probes can potentially be built with 
other neural interfaces including optogenetics. Such development will result in innovative 
tools that empower researchers to precisely elucidate and control brain function.  
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Chapter 2  
Microfabrication and in Vivo Performance of a Microdialysis Probe  
with Embedded Membrane 
Reproduced with permission from Lee, Ngernsutivorakul, et al. Analytical Chemistry 2016, 88 (2), 1230-1237. 
© 2016 American Chemical Society. Equal authorship was awarded to Lee and Ngernsutivorakul. Specific 
contributions to this work from Ngernsutivorakul included device fabrication, performing in vitro and in vivo 
characterizations, and assisting in Comsol modeling. 
 
Introduction 
 Microdialysis is widely used for in vivo sampling. In this technique, a semi-
permeable membrane probe is inserted into tissue or fluid and perfused with an isotonic 
solution. Chemicals in the tissue diffuse across the membrane according to their 
concentration gradient and are collected in fractions for analysis27,171,172. The popularity of 
microdialysis stems from its favorable properties. Samples are continuously removed from a 
well-defined space without net fluid loss from the tissue. The membrane prevents large 
molecules and debris from being collected that might interfere with downstream assays. 
Collection of a series of fractions allows changes in tissue chemistry to be monitored over 
time. The probe can also be used for local delivery of chemicals. Microdialysis is versatile 
because it can be used to sample from organs, tissues, tumors, and body fluids20,25,173–175.  
 Despite the advantages, the size of microdialysis probes creates some limitations. 
Probes are generally made by coupling capillaries to preformed dialysis tubing resulting in a 
cylindrical shape with a diameter defined by the dialysis tubing, typically no smaller than 
220 µm. The relatively large probe diameter prevents sampling from microenvironments 
such as small brain nuclei. This problem is especially acute in smaller subjects, like mice, 
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which are often preferred for research because of the extensive genetic tools and models 
available. Tissue damage with potentially confounding effects on measured chemicals is 
another issue that is likely worse with larger diameter probe176. Finally, in clinical 
applications, smaller probes are desirable to minimize discomfort and increase precision143.  
 A route to miniaturizing microdialysis probes is by microfabrication. Microfabricated 
needles without membranes have been applied for drug delivery177–180 and sampling181–184. 
We have reported a 70 µm wide by 85 µm thick microfabricated “push-pull” probe for in 
vivo sampling115. Sampling occurred by pulling fluid through one channel while pushing an 
equal volume out the other at 50 nL/min. A limitation of push-pull and needle-type sampling 
is that proteins and debris can enter the sampling channel potentially interfering with assays 
or clogging channels. Another issue is that pull-flow connections must be made at the probe. 
The pull connection complicates sample collection, especially at the low sampling rates used. 
This plumbing requirement is in contrast to microdialysis where fluids are pumped into the 
inlet leaving the outlet free for sample collection. Finally, the push and pull flows must be 
balanced to avoid net fluid loss or gain around the probe. Fluid balancing is challenging at 
such low flow rates but is not necessary in microdialysis. 
 A key challenge in microfabricating a microdialysis probe is forming a membrane 
over an open channel. A variety of semi-permeable membranes have been formed as part of 
microfluidic systems (see Table 2.1 for summary)122,126,143,144,146–152. Most of these 
membranes were designed for on-chip sample processing and only a few have been designed 
as implantable probes.  In one example, a cellulose membrane was cast over a parylene 
channel; however, this probe was actually larger than a conventional dialysis probe and was 
not demonstrated for sampling144. Microdialysis probes have also been fabricated in Si with 
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permeable polysilicon or fabricated pores as the permeable layer143,146,147. The polysilicon 
membrane was too fragile to use with pressure-driven fluid flows in microchannels. Probes 
with fabricated pores showed excellent promise in vitro although low pore density may limit 
recovery. These pioneering designs suggest the potential for in vivo microscale sampling; 
however, microfabricated dialysis probes with high pore density and suitable recovery have 
yet to be demonstrated for in vivo sampling. 
 We have developed a procedure to microfabricate a microdialysis probe in Si. The 
membrane is formed by electrochemical etching of a porous anodic aluminum oxide (AAO) 
layer to yield a high density of straight pores with controllable size127,185,186. The porous 
AAO is used as a mask for deep reactive ion etching (DRIE) of a polysilicon layer that is 
underneath the AAO and over a microfluidic channel. Utility of the probes was demonstrated 
by monitoring neurotransmitters in the brain of live animals.  
 
Table 2.1 Examples of materials and fabrication processes of semi-permeable membranes on a microfluidic 
devices. 
Device type Device 
material 
Membrane 
material 
Membrane fabrication Process Ref # 
Probe Polyimide Polyimide Ion irradiation and chemical 
etching by sodium 
hypochlorite152 
122 
Silicon Silicon Sacrificial oxide spacer layer146 
or permeable polysilicon 
143 
Parylene Cellulose 
acetate 
Spin coating and drying 144 
Biocapsule Silicon Silicon Sacrificial oxide spacer layer  146 
Microchip 
 
Glass Zwitterionic 
polymer  
laser-patterning techniques149 150 
PDMS Polycarbonate Oxygen plasma 151 
PDMS Silicon- 
silicon nitride 
Thermal annealing 148 
Silicon Silicon Electrochemical etching 126 
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Experimental 
Chemicals and materials 
 Unless specified otherwise, all chemicals were purchased from Sigma Aldrich (St. 
Louis, MO) or Fisher Scientific (Fairlawn, NJ) and were certified ACS grade or better. 
Solutions were prepared with HPLC-grade water or water purified by a Milli-Q system 
(Millipore, MA). Fused silica capillaries were purchased from Molex (Phoenix, AZ). Epoxy 
glues were purchased from ITW Devcon (Danvers, MA) and Loctite (Westlake, OH). 
Crystalbond Adhesive was purchased from Structure Probe (West Chester, PA).  Artificial 
cerebrospinal fluid (aCSF) consisted of 145 mM NaCl, 2.68 mM KCl, 1.10 mM MgSO4, 1.22 
mM CaCl2, 0.50 mM NaH2PO4, and 1.55 mM Na2HPO4, adjusted pH to 7.4 with 0.1 M 
NaOH. Unions for 360 µm outer diameter (o.d.) capillaries were purchased from Idex Health 
and Science (P-772, Oak Harbor, WA).   
 
Microfabrication of microdialysis probe with embedded nanoporous membrane  
 Overview. The scheme for microdialysis probes was designed in L-EDIT software 
(Tanner EDA). All processing was performed at the Lurie Nanofabrication Facility (LNF) at 
the University of Michigan. The overall probe layout is shown in Figure 2.1. Probes were 11 
mm long × 45 μm thick with a shank that narrowed to 160 μm wide at the tip. A 
microchannel with semicircular cross-section (60 x 30 µm) ran the length of the probe to 
form an inlet and outlet was fabricated in the surface (Figure 2.1A). A 4 mm length of the 
probe at the tip was made porous by DRIE though an electrochemically etched AAO 
membrane (Figure 2.1B) that was overlaid the thin Si layer shown in Figure 2.1A.  
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Figure 2.1 Layout of microfabricated microdialysis probe. A probe has 3 ports including inlet, outlet, and spare 
for other potential uses (it was not used at this probe). (A) SEM image of cross-section of channels showing 
semicircular shape and thin polysilicon top layer. (B) SEM image of AAO membrane over sampling area. (C) 
SEM image of sampling probe tip showing the channel pattern.  
 
 Channel formation. Probes were fabricated on 4 inch p-type wafers (Silicon Valley 
Microelectronics, Santa Clara, CA) using the process outlined in Figure 2.2. A 2 µm SiO2 
layer was grown on a wafer by wet oxidation using a Tempress TS 6604 S3 tool. The initial 
line for channel etching was patterned by lithography in 3 µm of SPR220 photoresist (Dow, 
Marlborough, MA), see Figure 2.2A. The exposed SiO2 was removed with DRIE using the 
Bosch process (which uses C4F8 as a passivation material) with a STS Deep Silicon Etcher 
(Figure 2.2A) and semicircular shaped channels (Figure 2.2B) were formed using a SPTS 
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Xactix XeF2 etcher (Allentown, PA). Channels were sealed by chemical vapor deposition 
(Tempress TS 6604 S3/T3) of 3 µm of polysilicon. The polysilicon layer on the wafer 
surface was etched by DRIE until the buried SiO2 layer was exposed and then removed by 
treatment with buffered HF (Transene Co Inc, Danvers, MA) for 20 min. An additional 2 µm 
polysilicon layer was deposited followed by the deposition of a 1 µm SiO2 layer for recovery 
of potential damage during the polysilicon removal process (Figure 2.2C). The probe shape 
was patterned by a second lithography step and exposed SiO2 was removed by DRIE. After 
photoresist removal in PRS 2000 (Avantor Performance Materials, Phillipsburgh, NJ), a 
sampling area at the probe tip was patterned by a third lithography step. The outline of the 
probe was etched by DRIE to 150 µm depth and the SiO2 layer on the channel was removed 
by buffered HF (Figure 2.2D). Finally, polysilicon thickness on the sampling area was 
reduced to 2 µm by DRIE (Figure 2.2E).  
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Figure 2.2 Illustration of microfabrication process for microdialysis probe. The channel line was patterned on 2 
µm thick SiO2 grown Si wafer (A). Semicircular shaped channels with 60 µm wide and 30 µm high were etched 
by XeF2 (B) and sealed with polysilicon (C). After 1 µm thick SiO2 was deposited, probe shape was patterned 
and etched by DRIE (D). Sampling area at the tip of the probe was opened and etched by DRIE to be 2 µm 
thick layer (E). 400 nm Al layer was deposited and anodized electrochemically forming nanoporous AAO 
membrane (F). Polysilicon layer was etched through AAO membrane by DRIE (G) and 400 nm AAO 
membrane was removed (H).  For physical strength of sampling area, 3 µm AAO membrane was fabricated by 
the deposition and electrochemical anodization of Al layer (I). Finally, thinned probes were released in hot 
water after backside etching (J). 
 
 Membrane formation and probe release from wafer. A 400 nm Al layer was 
deposited over the wafer using an e-beam evaporator (Denton Vacuum, Moorestown, NJ), 
Figure 2.2F. The Al coating was anodized at 60 V and 15 °C in 0.3 M oxalic acid solution for 
15 min using Pt mesh (Alfa Aesar, Ward Hill, MA) as a counter electrode (see Figure 2.3). 
The wafer was rinsed with DI water and then treated with 5% H3PO4 at room temperature for 
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50 min to widen the pores (Figure 2.2F). The polysilicon layer overlying the microchannel 
was etched by DRIE at -15°C using the AAO layer as a mask (Figure 2.2G). The AAO 
membrane was removed by treating with 5% H3PO4 at 65 °C for 1 h (Figure 2.2H). A fresh 3 
µm Al layer was deposited using the Enerjet evaporator. (For this step, the wafer was tilted to 
a 45° angle in order to prevent blocking of previous etched holes on polysilicon layer by Al 
metal vapor.) The Al layer was anodized at 60 V and 15 °C in 0.3 M oxalic acid solution for 
45 min and pores widened by treating with 5% phosphoric acid at room temperature for 90 
min (Figure 2.2I). The results of each process were imaged by scanning electron microscopy 
(Hitachi SU8000 SEM). The wafer with embedded AAO membrane was bonded to a carrier 
wafer with Crystalbond 555 (Structure Probe, Inc., West Chester, PA) and backside etched 
by DRIE until the probe thickness reached 40 µm (Figure 2.2J). Individual probes were 
released in hot water.   
 
 
Figure 2.3 Overall setup of AAO process. After deposition of 400 nm Al layer over the wafer, the Al coating 
was anodized at 60 V in 0.3 M oxalic acid for 15 min at 15 °C. Platinum mesh was used as a counter electrode, 
which was aligned parallel to the Al coated wafer. The device wafer was facing toward and 1inch apart from the 
platinum mesh. 
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 Probe holder fabrication and assembly. Resulting probes were too small and fragile 
to be conveniently handled and plumbed to connection tubing; therefore, a holder was 
microfabricated similar to that described previously for push-pull probes115. Full description 
of holder fabrication and assembly is given in Figure 2.4. 12 cm lengths of 100 μm i.d./ 360 
μm o.d. capillary were connected to the inlet and outlet. The outlet capillary was then joined 
to a 22 cm long, 50 μm i.d./ 360 μm o.d. fused-silica capillary for fraction collection. Flow 
through probes was driven using a Chemyx syringe pump (Stafford, TX). 
 
 
Figure 2.4 Fabrication of Probe Holder. The probe holder has guides to connect probe ports and capillaries. 
Probe holders were fabricated from a silicon wafer with growth of a 1 µm silicon dioxide layer. The 2 mm wide 
rectangle for a guide of probe connection ports was patterned by lithography and SiO2 layer was removed by 
BHF. A second lithography step was performed to pattern 360 µm wide trenches for a guide of capillaries and 
DRIE etched 50 µm deep. Photoresist on the wafer was removed by positive resist stripper (PRS 2000; Avantor 
Performance Materials, PA) and 40 µm deep trenches and rectangles were additionally etched by DRIE. To 
connect fluidic capillaries to microchannels in a probe, a union capillary of 1 cm length with 180 μm i.d. and 
360 μm o.d. was glued on the guiding trenches of a probe holder with epoxy gel resin. (A) Probe ports were 
inserted into union capillaries and 12 cm length of 100 μm i.d. and 150 μm o.d. fluidic capillaries were joined to 
inlet and outlet probe ports through the union capillary. Finally, all assembled devices were sealed with epoxy 
gel resin. The probe glued to the holder as shown in (B). 
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In vitro characterization  
 To determine the dynamic response during sampling, probes were perfused with 
water at a flow rate of 100 nL/min and placed into a stirred vial of water (see Figure 2.6A). 
The flow rate and flow stability within a system was periodically validated using a 
microfluidic flow meter (SLG1430-025, Sensirion, Zurich, Switzerland). The solution was 
subsequently changed to a 50 μM fluorescein solution while recording fluorescence within 
the exit tubing using a fluorescence microscope.   
 For study of probe relative recovery, the microfabricated probe (“µFab”) was 
compared to a concentric microdialysis probe (“MD”) which was prepared as previously 
described187. The concentric probe had a regenerated cellulose membrane with 18 kDa 
molecular weight cut-off that was 4 mm long and 220 µm diameter (Spectrum Labs, Rancho 
Dominguez, CA). Probes were dipped into a well-stirred vial containing: 0.5 μM 
acetylcholine (ACh), dopamine (DA), 3-methoxytyramine (3-MT), and serotonin (5-HT); 1 
μM 3,4-dihydroxyphenylalanine (DOPA) and histamine (Hist); 10 μM 3,4-
dihydroxyphenylacetic acid (DOPAC), ɣ-aminobutyric acid (GABA), 5-hydroxyindoleacetic 
acid (5-HIAA), homovanillic acid (HVA), phenylalanine (Phe), and tyrosine (Tyr); 50 μM 
choline (Cho), serine (Ser), and taurine (Tau); and 1 mM glucose (Gluc) in aCSF at 37˚C. 
The aCSF was supplemented with 0.25 mM ascorbate to protect against oxidation of analytes. 
After an equilibration time of 30 min, dialysates were collected in 20 min fractions with a 
perfusion rate of 100 nL/min.  
 Dialysate samples were derivatized with benzoyl chloride and analyzed by LC-MS, as 
described previously45. Briefly, 1.5 µL of standards or fractions were mixed with 3 µL of 100 
mM sodium carbonate buffer at pH 11 and 3 µL benzoyl chloride (2% in acetonitrile, v/v). 
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The samples were mixed with 3 µL of [13C]-labeled or [d4]-labeled benzoylated internal 
standards, consisting of 5 nM [13C]-DA, [13C]-3-MT, [13C]-5-HT, and [13C]-DOPA; 10 nM 
[d4]-ACh and [d4]-Cho; 50 nM [13C]-GABA and [13C]-Hist; 125 nM [13C]-DOPAC, [13C]-5-
HIAA, and [13C]-Tyr; 0.5 μM [13C]-Tau, Glu and Gln; 1.25 μM [13C]-Phe and [13C]-Ser; and 
12.5 μM [13C]-Gluc in 50% acetonitrile v/v containing 1% H2SO4. Samples were analyzed 
using an Accela UHPLC interfaced to a TSQ Quantum Ultra triple quadrupole mass 
spectrometer (Thermo Fisher Waltham, MA) operated in multiple reaction monitoring mode.  
3 µL samples were injected onto a 2.1 mm x 100 mm Phenomenex biphenyl Kinetex HPLC 
column (Torrance, CA).  Mobile phase A was 10 mM ammonium formate with 0.15% formic 
acid, and mobile phase B was acetonitrile.  The mobile phase gradient was: initial, 0% B; 
0.01 min, 19% B; 1 min, 26% B; 1.5 min, 75% B; 2.5 min, 100% B; 3 min, 100% B; 3.1 min, 
5% B; and 3.5 min, 5% B at 0.45 mL/min. 
 
In vivo sampling  
 All procedures were conducted according to a protocol approved by the University 
Committee for the Use and Care of Animals (UCUCA). Male Sprague-Dawley rats weighing 
between 250-300 g, (Harlan, Indianapolis, IN, USA) were used for all experiments. Rats 
were housed in a temperature and humidity controlled room with 12 h light/dark cycles with 
access to food and water ad libitum. Measures were taken to prevent animal pain and 
discomfort throughout the experiment.  All animal experiments were within the guidelines of 
Animal Research Reporting in vivo Experiments (ARRIVE). Animals were anesthetized 
using 2-4% isoflurane and placed in a stereotaxic frame (David Kopf, Tujunga, CA). Two 
burr holes were drilled above the striatum +1.0 mm anterior-posterior and ± 3.0 mm lateral 
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from bregma.  The MD probe and µFab probe were lowered into opposite hemispheres – 
6.15 mm from the top of the skull.  Rats were maintained under anesthesia for the duration of 
the experiment using isoflurane. Both probes were perfused with aCSF at 100 nL/min. After 
1 h equilibration, two 20 min fractions were collected for basal concentrations (2 µL per 
fraction) and two more were collected after an amphetamine injection (5 mg/ kg, i.p). 
Following the experiment, the probes were withdrawn from the brain using the stereotaxic 
frame and the rat was euthanized.  Brains were extracted to confirm probe placement. 
 
Results and Discussion 
Probes 
 A challenge in fabricating microdialysis probes is embedding nanoporous membranes 
over channels while balancing the need for sufficient physical strength and good recovery 
across the membrane. The process described in Figure 2.2 allowed formation of a nanoporous 
membrane covering a total of 8 mm length of channel (but only 4 mm length of probe 
because the channel has a 180o turn at the tip). The resulting 5 µm thick membrane has 
straight pores that are 60 - 80 nm wide at a density of 8.4 ± 0.2 x 1013/m2 (n = 3), as shown in 
Figure 2.5. 50 - 70 probes (representing a 50% success rate) could be recovered from a single 
wafer. AAO membranes have been previously used as a photomask on a solid surface188; 
however, our approach is unique in using AAO as a DRIE mask directly over a microchannel. 
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Figure 2.5 Scanning electron micrographs of fabricated microchannels with pores. Drawing at left indicates 
where the probe sampling tip was broken to expose channels. Images show AAO and polysilicon membranes 
overlaid. Lowest image shows that pores go through the polysilicon base layer over the open channel. 
 
In preliminary experiments fabrication stopped at step G in Figure 2.2; however, we 
found that the resulting membranes were fragile and ruptured when attempting to flow 
through the probe. The additional 3 µm AAO membrane (Figure 2.2 I - J) gave the probes 
sufficient mechanical strength. A drawback of this approach is that the final AAO pores do 
not necessarily line up with the polysilicon pores; however, the pore density was sufficient to 
give enough overlap and allow molecular exchange as described below.  
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In vitro characterization 
The response of the µFab probe to a change in concentration was determined by 
switching the sampled solution from 0 µM to 50 µM fluorescein while monitoring 
fluorescence at the probe outlet (see Figure 2.6). Fluorescence signals began to increase 14.5 
min after switching. This delay is expected because the perfusion rate was 100 nL/min and 
the internal volume from sampling tip to detection point was ~ 1400 nL. The good agreement 
shows that leakage through the system was insignificant and allows accurate correlation of 
concentration changes in collected fractions and time of event in the sample. Once the 
fluorescence signal increased, it had a 10 - 90% rise time of 47 ± 2 s (n = 7). This rise time, 
which determines the best possible temporal resolution, is close to the estimated rise time of 
44 s using the combined diffusion and Taylor dispersion equation73. The predicted rise time 
is 1 s for probe channel and 43 s for combined outlet and collection capillaries. Because most 
of the dispersion is in the connecting channel, it may be possible to improve temporal 
resolution by using segmented flow or smaller connection capillaries73,163,166. We also tested 
relative recovery as a function of flow rate and found the expected relationship of decreasing 
recovery with increasing flow rate, similar to larger dialysis probes (see Figure 2.6C).  For 
further experiments we used 100 nL/min as a practical choice. Operating at much higher flow 
rates results in greater chance of rupturing the membrane or causing leaks in the system. 
Operating at lower flow rates might increase recovery but yields smaller samples to 
manipulate.       
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Figure 2.6 Determination of the dynamic response time of the microfabricated probe to step change in sampled 
concentration, and the relationship between perfusion flow rate and relative recovery. (A) Illustration of 
experimental setup. Probe was inserted into a solution of water and then switched to a solution of 50 µM 
fluorescein as the sample. Fluorescence was monitored downstream on the outlet capillary. (B) Trace shows 
representative example for detection fluorescent change with time beginning at switch. Delay time is 14.5 min, 
which corresponds to the internal volume of ~1400 nL at the perfusion rate of 100 nL/min. Inset shows the 10% 
to 90% response time. Average was 47 ± 2 s (n = 7). (C) Scatter plot shows an inverse relationship between 
flow rate and relative recovery from the microfabricated probe sampling. 
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 In vitro relative recovery of neurochemicals was evaluated by comparing dialysate 
samples with samples taken directly from the stirred vial (Table 2.2, Figure 2.7A). For the 
µFab probe, the recovery was from 2 to 21% for selected neurochemicals. The variation in 
recovery may be caused by differences in molecular structure, charge effects, hydrophobicity, 
and membrane interactions. These results can be contrasted with the nearly 100% relative 
recovery obtained using the traditional probe at 100 nL/min. Compared to the MD probe, the 
µFab probe provides lower relative recovery values, at least in part, because of its 6-fold 
smaller surface area of sampling. Table 2.2 also shows that different µFab probes had greater 
variability in recovery from probe to probe than conventional probes. The reason for higher 
variation is not clear. Some variation in conventional probes may be masked by operating 
near 100% recovery. For µFab probes, variability could be due to variations in the fabrication 
process or variability induced by handling and analyzing the smaller samples. Continued 
refinement of the process will likely reduce this effect. 
To gain more insight into the recovery, computational simulation of fluid flowing 
through the µFab probe was performed (see Figure 2.8). Initial modeling indicated that flow 
rate and membrane porosity are the main variables that significantly affect recovery. Using 
the diffusion coefficient for dopamine189, estimated porosity of 33% and flow rate of 100 
nL/min (Figure 2.8A), the simulated recovery was 98%, much larger than our observed value 
of 5 - 7% for dopamine. When porosity was lowered to 1%, the simulated and actual 
recovery matched (Figure 2.8B). These results suggest that porosity is lower than expected. 
This discrepancy may be due to several factors. The final overlaid AAO pores do not line up 
with the polysilicon pores resulting in lower porosity than measured by observing the top of 
the membrane surface. The polysilicon membrane may also trap air in the pores giving 
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reduced porosity. Some pores may also be clogged with particulates or wax (used for wafer-
mounting during back-side etching). Changes in probe processing or modifying surfaces may 
prove useful to improve recovery190,191.  
 
Table 2.2 In vitro recovery of selected neurochemicals at flow rate of 100 nL/min. The results from the 
microfabricated probes (µFab) are compared with the conventional dialysis probes (MD). Recovery values are 
given as mean ± 1 standard deviation for different probes (n = 4 probes). 
 
Analyte (tested concentration) 
     µFab 
% Recovery 
       MD 
% Recovery 
Acetylcholine (500 nM) 7 ± 1.2     105 ± 6 
Choline (50 μM) 6 ± 1.1     99 ± 12 
3,4-Dihydroxyphenylacetic acid (10 
μM) 
2 ± 0.6     92 ± 5 
3,4-Dihydroxyphenylalanine (1 μM) 3 ± 0.5     94 ± 9 
Dopamine (500 nM) 5 ± 0.9     100 ± 3 
ɣ-Aminobutyric acid (10 μM) 3 ± 1.2     109 ± 3 
Glucose (1 mM) 3 ± 0.6     95 ± 10 
Glutamate (10 μM) 21 ± 7.7     106 ± 10 
Glutamine (500 μM) 2 ± 0.5     105 ± 6 
Histamine (1 μM) 5 ± 1.0     109 ± 8 
5-Hydroxyindoleacetic acid (10 μM) 4 ± 0.5     99 ± 3 
Homovanillic acid (10 μM) 3 ± 1.1     105 ± 4 
3-Methoxytyramine (500 nM) 4 ± 0.8     95 ± 2 
Phenylalanine (10 μM) 4 ± 2.1     115 ± 6 
Serine (50 μM) 3 ± 0.9     111 ± 20 
Serotonin (500 nM) 4 ± 0.6     103 ± 4 
Taurine (50 μM) 4 ± 0.6     110 ± 4 
Tyrosine (10 μM) 4 ± 1.3     105 ± 7 
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Figure 2.7 A) Comparison of relative recoveries of analytes between in vitro and in vivo experiments. The bar 
chart represents averaged relative recovery with SEM. * indicates different with p < 0.05, ** indicates p < 0.001 
obtained by the two-tailed Student’s t-test test. B) Multiple reaction monitoring mass chromatograms of a 
representative fraction (1.5 µL) collected from the striatum of an anesthetized rat through the microfabricated 
probe. The chromatogram shows the trace for 14 detectable neurochemicals. Abbreviations used are: 
acetylcholine (ACh), choline (Cho), taurine (Tau), glutamine (Gln), serine (Ser), glucose (Gluc), glutamate 
(Glu),  phenylalanine (Phe), 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), tyrosine (Tyr),  
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Figure 2.8 Comsol modeling and simulation of 1 mM dopamine diffusing through the membrane of 
microfabricated probe. The microfabricated probe was constructed in COMSOL Multiphysics 4.4 (Burlington, 
MA) to model its recovery. The fabricated probe has semi-circular fluidic channels; but for ease of modeling, 
the channels were designed as 60 µm x 24 µm rectangles which gave the same cross-sectional area as the actual 
probes. The total length of the channels was 8 mm in a ‘U’ shape like the actual probe. The porous membrane 
was designed as a polysilicon rectangle, 5 µm x 60 µm, overlaid the channels. A large box was connected to the 
external boundary of the membrane region for simulating the probe in a well-stirred solution. The ‘Free and 
Porous Media Flow’ and ‘Species Transport in Porous Media’ physics models were applied to the channel and 
membrane regions. Navier-Stokes equations modeled the fluid (water) in the open channel with a flow rate of 
100 nL/min. Fluid movement in the porous region was defined by the Brinkman equation and a permeability of 
50 nm2 was used. The porosity variable was modified to match experimental data. For the transport of chemical 
species, the diffusion coefficient of dopamine, 6 x10-10 m2/s was used. The exterior probe volume used 
‘Laminar Flow’ and ‘Transport of Diluted Species’ physics with a flow rate of 10 mL/min to simulate a well-
stirred solution. Images below show cross section of probe at the middle and end of the probe color coded for 
DA concentration. A) Recovery for probe with 30% porosity and B) for 0.9% porosity. 
 
In vivo sampling  
 To determine their suitability for in vivo experiments, µFab probes were used to 
sample from the striatum of anesthetized rats. 14 neurochemicals were consistently detected 
in 20 min fractions with good signal to noise ratio (Figure 2.7). For comparison, we also 
sampled from the same animals with a MD probe operated at the same flow rate.  Basal 
concentrations from both types of probes are reported in Table 2.3. Concentrations were not 
corrected for recovery; however, the MD probes achieved nearly 100% recovery; therefore, 
these concentrations can be considered a good estimate of the in vivo concentration192. 
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Comparison of these concentrations with other reports of calibrated in vivo MD experiments 
reveals reasonable agreement for most neurochemicals163,192–198. Acetylcholine and dopamine 
are generally found in low nanomolar concentrations. Glutamate, phenylalanine, 5-HIAA, 
and tyrosine are typically in low micromolar range (< 10 µM) while glutamine, serine and 
taurine are in high micromolar range (> 10 µM). We observed about 5 times higher 
concentration of glucose than prior reports; however, our experiment was performed with 
anesthetized rats which may account for this difference. GABA, histamine, 3-MT and 5-HT 
were not detectable in dialysates from µFab probe sampling due to their low concentration 
and insufficient recovery to reach the instrument detection limit. 
 Because the MD probe recovery approaches 100% at 100 nL/min, the in vivo 
recovery of µFab probe could be estimated by dividing dialysate concentrations from µFab 
probes by dialysate concentrations from MD probes. This calculation assumes that the in 
vivo concentration is the same on both sides of the brain and at both probes. As shown in 
Figure 2.7, the in vitro recovery and estimated in vivo recovery of the µFab probe are 
comparable for 8 of the neurochemicals. For several compounds (Gln, HVA, Tyr, Ach, 
DOPAC, and Ser) the estimated in vivo recovery is significantly higher than in vitro recovery. 
The origin for this difference is not clear. It is possible that active processes and mass 
transport within the brain is sufficiently different from in vitro for these analytes to cause the 
in vitro recovery to differ from the in vivo recovery199,200.  Another interpretation is that the 
actual basal concentrations from the sampling site of µFab probe are higher than the 
concentrations from MD probe sampling. Such discrepancies could be due to differences in 
local concentrations (different areas were sampled) or to artifacts that result from different 
tissue reactions due to membrane material and probe size. 
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Table 2.3 Comparison basal extracellular concentration by the microfabricated probes, conventional probes with previous reports. The in vivo recovery for 
the microfabricated probes is estimated by finding the ratio between [µFab] and [MD].  All measurements are from sampling of the striatum of rats. Values 
given as mean ± SEM (n = 5 animals). In vivo recovery of µFab probe estimated by dividing µFab concentration by MD concentration, where recovery was 
estimated at 100%. n.d. stands for not detected. 
Analyte 
Previously-reported concentration 
(Anesthesia, Quantification method, Ref #) [MD]  [µfab]  
Estimated in vivo 
recovery, % 
ACh 10 ± 3.0 nM (Ketamine, 20% in vitro recovery, 163) 32 ± 4.5 nM 4.5 ± 0.46 nM  14 ± 0.4 
Choline   11 ± 0.93 μM 0.54 ± 0.022 μM  5 ± 0.2 
DOPAC 17.4 ± 2.6 μM (Awake, No-net-flux, 192) 8.9 ± 1.4 μM  0.74 ± 0.084 μM  8 ± 0.8 
DOPA 
 
150 ± 17 nM  5.6 ± 0.41 nM  4 ± 0.3 
Dopamine 10 ± 1.7 nM (Awake, No-net-flux, 192) 6.7 ± 0.62 nM 0.32 ± 0.046 nM 5 ± 0.3 
Glucose 350 ± 20 μM (Awake, No-net-flux, 195) 1431 ± 82 μM 56 ± 3.3 μM 4 ± 0.2 
GABA 120 ± 50 nM (Urethane, 20% in vitro recovery, 193)  780 ± 340 nM  n.d. - 
Glutamate 
 
7.5 ± 0.74 μM 1.5 ± 0.18 μM 21 ± 2 
Glutamine 385 ± 16 μM (Awake, No-net-flux, 197) 472 ± 24 μM  18 ± 2.2 μM 4 ± 0.3 
Histamine 
 
39 ± 16 nM  n.d. - 
5-HIAA 3500 ± 100 nM (Awake, Low-flow-rate, 192) 1200 ± 130 nM  95 ± 16 nM  8 ± 1.2 
HVA 17 ± 1.1 μM (Awake, Low-flow-rate, 192) 8.3 ± 1.1 μM  0.81 ± 0.097 μM 10 ± 0.9 
3-MT 
 
6.9 ± 0.46 nM   n.d. - 
Phe 2 ± 0.2 μM (Chloral Hydrate, Low-flow-rate, 194) 7.5 ± 0.49 μM  0.22 ± 0.012 μM 3 ± 0.1 
Serine 7 ± 0.5 μM (Awake, Corrected for in vitro recovery, 196) 36 ± 2.3 μM 1.8 ± 0.12 μM 5 ± 0.2 
5-HT 
 
19 ± 4.2 nM n.d. - 
Taurine 25 ± 5.1 μM (Halothane, No-net-flux, 198) 60 ± 4.9 μM 2.8 ± 0.21 μM 4 ± 0.1 
Tyrosine 3300 ± 900 nM (Chloral Hydrate, Low-flow-rate, 194) 6700 ± 330 nM 220 ± 1.1 nM 3 ± 0.1 
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 To assess the probe performance in response to dynamic in vivo chemical changes, 
the µFab and MD probes were simultaneously used to monitor concentration changes of DA 
and other neurochemicals after administration of AMPH. When expressing the changes as a 
percent of baseline, nearly identical changes are seen at both the MD and μFab probes as 
shown in Figure 2.9. The large change of about 4300% for DA is in agreement with expected 
effect of AMPH which inhibits uptake and promotes secretion of DA201. Other measured 
neurochemicals that have significant changes (p < 0.05, Student’s t-test) in their post drug 
levels were DOPAC, DOPA, HVA, 5-HIAA, and Tyr. The overall results show the μFab 
probe provides dynamic measurements nearly the same to a MD probe under the conditions 
of 100 nL/min flow rate and 20 min fractions.  
 
Figure 2.9 Dual probe microdialysis of rat striatum showing effects of AMPH (5 mg/kg, IP) on DA release and 
other neurochemicals sampled by a concentric microdialysis probe (MD) and microfabricated probe (µFab). 
Both probe types have similar performance on response to dynamic in vivo chemical changes. Lines indicates 
when AMPH was present (fractions at 60 and 80 min). Data were converted to percent of baseline measurement 
to normalize pre-drug levels to 100 percent. Student’s t-test indicates a significant change (*p < 0.05) between 
basal and post drug levels. Results are the mean ± SEM, n = 3 animals. For other measured neurochemicals, 
their post drug levels did not significantly change. 
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 Histological examination of the sampling sites from both types of probes were 
performed to visualize overall probe placement within the brain (see Figure 2.10). The µFab 
probe generates a much smaller tract than the MD probe as expected. This difference 
presumably results in lower tissue damage.  
 
 
Figure 2.10 A) Horizontal histological section of the brain. The zoomed in images in the insets indicates the 
probe tract areas of both µFab and MD probes. As shown, the µFab probe tract is 83% smaller than the MD 
probe tract. B) The brain was cut into 40 µm coronal sections and Nissl stained to show overall brain structure 
with probe tracts (boxes with dashed line). C) Dotted lines indicates tracts overlaid on a rat brain atlas diagram, 
corresponding to (A). 
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Conclusion 
 The in vivo results show that the µFab probe can be reliably used for studying 
neurochemicals and monitoring dynamic chemical changes in live animal brain. The chief 
advantage of the probes is that they have 79% smaller cross-section than conventional MD 
probes and therefore can be used in smaller subjects and brain regions. Despite the small size, 
the probes are strong enough to penetrate tissue without flexing or breaking. The low 
recovery at 100 nL/min is a drawback of these probes; however, preliminary experiments 
suggest that small changes in membrane fabrication will mitigate this issue. Fortunately, the 
excellent sensitivity of LC-MS allows many neurochemicals to be detected even at this 
recovery. A likely route to improve temporal resolution and detect less abundant analytes is 
to use miniaturized analytical methods like capillary LC, capillary electrophoresis, or droplet 
enzyme assays41,73,202–205. The sensitivity of such methods would allow good temporal 
resolution while preserving the advantages of better spatial resolution and lower tissue 
damage. The use of microfabricated probes may allow integration of other functionality such 
as electrodes for chemical or potential sensing, microfluidics for sample preparation (e.g. 
derivatization), or droplet formation for fraction collection at nanoliter scale. The probe may 
also be utilized for other applications that require continuous chemical sampling or delivery 
from microenvironments. 
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Chapter 3  
Microfabricated Push-Pull Probes Coupled to Droplet-Based Microfluidics and Mass 
Spectrometry for in Vivo Multiplexed Monitoring of Neurochemicals 
Thitaphat Ngernsutivorakul, Alec C. Valenta, Daniel J. Steyer, and Robert T. Kennedy, Manuscript in prep. 
Introduction 
 In vivo neurochemical monitoring provides valuable insights into chemical 
neurotransmission, which can be related to behaviors as well as brain functions and 
diseases206–209. One of the powerful approaches to perform such measurement is to couple 
sampling methods (i.e., microdialysis and push-pull perfusion) to suitable analytical 
techniques, such as liquid chromatography coupled to mass spectrometry (LC-MS), and 
capillary electrophoresis coupled to laser-induced fluorescence (CE-LIF)27,45,71,210. By this 
approach, chemical measurement can be conducted with excellent sensitivity and selectivity. 
Multiple compounds can also be measured simultaneously, allowing studies of drugs and 
interactions between neurotransmitter systems45,211. Although the method has proven 
extremely versatile and indispensable to neurochemical studies, it is limited in spatial and 
temporal resolution212,213. The aim of this study is to develop an analytical system that 
overcomes these limitations. 
 Spatial resolution is important because of small size and heterogeneity of the brain 
structures25,214. For in vivo neurochemical monitoring, spatial resolution is usually limited by 
probe size, which correlates with an active sampling area. In microdialysis, sampling occurs 
at the membrane tubing of the probe, which is typically 220-400 µm in diameter with a 1-4 
mm length24,26,215. These large sizes preclude high spatial resolution and experiments in 
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smaller brain regions. A more radical approach to achieve high spatial resolution is to use 
low-flow push-pull perfusion72,73,216. In this approach, artificial cerebrospinal fluid (aCSF) is 
pushed from one capillary at ~50 nL/min while a sample is pulled from another capillary at 
the same rate. An active sampling area is therefore restricted to only the space between the 
two orifices at probe tip, resulting in better resolution comparing to microdialysis. The use of 
low-flow push-pull perfusion for in vivo sampling resulted in at least 80-fold spatial 
resolution improvement over microdialysis73. Furthermore, our group has developed 
microfabrication procedures to further reduce the size of push-pull sampling probe115. The 
microfabricated probes provide not only even better spatial resolution, but also potential for 
less tissue disruption.  In addition, the microfabrication process offers the possibilities for 
mass production, flexibility in designs, and incorporating more functions into the probe.  
 Temporal resolution is important since neurochemical concentrations in the brain can 
alter rapidly during behavior or stimuli41,43,44. When coupling the probe to an analytical 
method, temporal resolution can be limited by different factors28, including time to collect 
enough sample volume required for the assay, separation time, sample handling, and zone 
broadening due to flow and diffusion (i.e., Taylor dispersion). Nanoscale analytical 
techniques, such as microbore LC and CE, can be used to reduce the collection volume and 
separation time to a few seconds41,156,194,217,218. Furthermore, segmented-flow sampling has 
proven to prevent Taylor dispersion from occurring during transfer. Droplet-based 
microfluidic systems have also provided a more convenient way to manipulate nanoliter 
fractions that are collected73,159,163,165,219,220. With these methods, previous works have shown 
in vivo neurochemical monitoring with improvement of temporal resolution from 10 - 30 min 
to less than 10 s. 
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 A versatile approach for droplet analysis is to use direct infusion MS. MS is a 
universal detector with high sensitivity, multi-analyte capability, and commercial availability. 
With multiple reaction monitoring (MRM) mode and addition of isotopically-labeled internal 
standards, quantitation of analytes in complex biological samples can be achieved with high 
selectivity. In addition, coupling nano-electrospray ionization (nESI) to MS provides 
enhancement in sensitivity. For droplet analysis, this method allowed direct introduction of 
the droplet stream without the need to remove an immiscible oil phase163,167. The method is 
also robust and salt-tolerant. Overall, the nESI-MS method is a versatile and attractive tool 
for analysis of sample droplets collected from push-pull perfusion in the brain.  
 A significant challenge in coupling the miniaturized probe to segmented flow is to 
develop compatible microfluidic interfaces that allow reliable sample transfer and droplet 
manipulation. In this work, we have successfully developed the interfaces and coupled 
microfabricated push-pull probes to droplet microfluidics. Arrays of nanoliter samples were 
transferred, segmented and simultaneously added with internal standards (I.S.) prior to an 
offline nESI-MS assay. The system was evaluated in vitro for multiplexed measurements of 4 
neurochemicals including acetylcholine (ACh), glutamate (Glu), glutamine (Gln) and γ-
aminobutyric acid (GABA), achieving ~6 s temporal resolution with a sampling rate of 100 
nL/min. Furthermore, by microfabrication, an additional channel was integrated to the probe 
for microinjection of a neural stimulant. Utility of the integrated system was demonstrated by 
monitoring multiple neurochemical dynamics in vivo at high spatiotemporal resolution. 
 
 
 
 
52 
 
Experimental 
Chemicals and materials 
Unless otherwise specified, chemicals were purchased from Fisher Scientific 
(Fairlawn, NJ) or Sigma Aldrich (St. Louise, MO) and were certified ACS grade or better. 
Solutions were prepared with HPLC-grade water, filtered and degassed prior to use. Teflon 
tubing were purchased from IDEX Health & Science (Oak Harbor, WA). Polyimide-coated 
glass capillaries were purchased from Molex (Phoenix, AZ). Epoxy glues were purchased 
from ITW Devcon (Danvers, MA) and Loctite (Westlake, OH). A commercial tee (100 µm 
i.d.) was purchased from Valco Instruments (Houston, TX). Polydimethylsiloxane (PDMS) 
was purchased from Curbell Plastics (Momentive® RTV 615, Livonia, MI). Crystalbond 555 
Adhesive was purchased from Structure Probe (West Chester, PA). Artificial cerebrospinal 
fluid (aCSF) consisted of 145 mM NaCl, 2.68 mM KCl, 1.01 mM MgSO4, 1.40 mM CaCl2, 
0.45 mM NaH2PO4, and 1.55 mM Na2HPO4, adjusted to pH of 7.4 with 0.1 M NaOH. High-
potassium (K+)-aCSF consisted of 100 mM KCl and 47.7 mM NaCl; the other components 
were the same as regular aCSF. 
 
Push-pull probe and holder  
Fabrication of probe. Probes were microfabricated on a 525 µm thick 4 inch wafer 
(University Wafer, MA) as described elsewhere115 with modification in probe design and 
additional step for removal of adhesive. Briefly, microfabrication of sampling probes was 
performed within a class 1000 cleanroom (Lurie Nanofabrication Facility at the University of 
Michigan). The probes were fabricated from 525 µm thick n-type 100 mm silicon wafers 
coated with SiO2 mask. A series of microchannels were masked on a wafer by 
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photolithography before the wafer was etched by deep reactive ion etching (DRIE) and XeF2 
etching. The wafer was sealed with poly Si using low pressure chemical vapor deposition. 
Lithography and DRIE were again used to assign and etch probe shapes and sampling 
orifices with desired dimensions. The wafer was mounted to a carrier wafer with Crystalbond 
555 adhesive and backside etched using DRIE prior to probe release in hot water. To ensure 
complete removal of the adhesive, probes were baked at 610 °C for 8 h in a laboratory kiln. 
Additional fabrication details are provided in Appendix A. 
The final probe size was 11 mm long, 84 µm wide × 70 µm thick. In this work, 
microfabricated probes included 3 channels of 20 µm i.d. One channel was used for pull flow. 
Another channel was used for push flow. For the probe with 3 channels, the third channel 
was merged with the channel for push flow at 0.5 mm from the probe orifice. The additional 
channel was used for microinjection. Schematics of the probe and its operation are shown in 
Figure 3.1 & Figure 3.3A. 
Probe holder and fluidic capillaries. A holder was used to handle and plumb the 
probes to connection tubing. A design of probe holder was the same as described 
previously115. A 0.5 cm of 150 µm i.d. / 360 µm o.d. tubing was mounted to each trench of a 
probe holder and used as the “union”. The holder was used as a guide for insertion of the 
probe into the union before gluing with epoxy gel resin. 5 cm of 50 µm i.d. / 150 µm o.d. 
fused-silica capillary was inserted into each union, joint to each probe post, and used as the 
“fluidic capillary” for delivery of fluid from/to the probe. To adapt these capillaries to 360 
µm fittings for pushing, fluidic capillaries were sheathed with 2 cm of 180 µm i.d./ 360 µm 
o.d. capillary.  
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Figure 3.1 A) Overview of probe shape and channels. B) SEM images of microfabricated push pull probe with 
additional channel for microinjection. The images show cross section of the probe (i); top view of an integrated 
tee after backside etch to reveal the channels (ii); and tip of the probe (iii) with an estimated sampling area 
(yellow dashed) of 1200 µm2. 
 
Droplet-based microfluidic chips  
 PDMS microchips were designed to couple the microfabricated sampling probes to 
segmented-flow and reagent addition (see Figure 3.2& Figure 3.3B). The droplet-based 
PDMS chips were fabricated using a combination of a standard soft lithography technique 
and a pour over method221. In all procedures, PDMS had a 10:1 base:curing agent ratio and 
was cured at 75˚C for 45 min. Briefly, a PDMS chip, replicated from a SU-8 mold with 125 
µm wide × 100 µm tall channels was first fabricated (Figure 3.2A). The device contained a 4-
way junction (manifold) for flow segmentation with simultaneous reagent addition. The 
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device channels were derivatized with 1H,1H,2H,2H-perfluorooctyltrochlorosilane (4% v/v 
in anhydrous hexadecane). The PDMS chip was cut under a microscope so that the end of 
each channel was ~ 0.5 mm long. A 100 µm o.d. capillary was then inserted through the 
PDMS channel and 230 µm o.d. capillaries were inserted into the other two channels (Figure 
3.2B). The PDMS chip with inserted capillaries were placed on a petri dish before pouring 
PDMS over and cure. After cure, all capillaries were removed and the chip was trimmed to 
size using a razor blade (Figure 3.2C). The capillary-molded channels were necessary as they 
ensure proper microfluidic sealing (i.e., no air leaks during vacuum applied). 100 µm 
cylindrical PDMS channels accommodated tight sealing with 150 µm o.d. tubing connected 
to sampling probe and reagent reservoir while 230 µm cylindrical PDMS channels 
accommodated a proper sealing with 360 µm o.d. tubing connected to oil reservoir and 
Teflon storage tubing. To facilitate device connection or removal during experiments, an 
additional step of molding of 360 µm o.d. tubing was carried out to form guiding channels 
for ease of device connection or removal (Figure 3.2D). The final design and configuration of 
the droplet-based PDMS device are shown in Figure 3.2E & F. The same procedures 
described herein was also utilized to fabricate a 3-way junction (tee) for flow segmentation 
only. 
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Figure 3.2 Illustration of fabrication and design of a PDMS manifold. The device was designed to minimize 
dead volume while allowing pre-alignment of fluidic capillaries and ensuring no leakage during vacuum applied. 
Fabrication was based on replication of PDMS from a microfabricated SU-8 mold (A) and a polyimide-coated 
glass capillaries (B), yielding a combination of microchannels with appropriate shapes and dimensions (C). 
Further molding step (D) was employed in forming guides for ease of capillary insertion. Top view of the 
device (E) and its 3D view (F) are also shown. An actual image of the complete device after tubing connection 
can be seen in the inset of Figure 3.3B.  
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In vitro characterization 
 Device operation. An outline of the integrated system is illustrated in Figure 3.3. 
Method for operation of the segmented-flow push-pull system73 was adapted for use in this 
work. One fluidic capillary was coupled to a gastight 100 µL syringe (Hamilton, Reno, NV) 
using a 360 µm o.d. Teflon union. A syringe pump (Chemyx, Stafford, TX) was used to 
generate the push flow. Prior to experiments, a flow meter (SLG1430-025, Sensirion, Zurich, 
Switzerland) was utilized to validate flow rate and stability. Before starting pull flow, the 
first inlet of the manifold was connected to the fluidic capillary of probe outlet. The second 
inlet of the tee was attached to a 4 cm long 50 µm i.d. capillary/ 360 µm o.d. capillary which 
was placed in a vial of oil (50:1 v/v PFD:PFO, viscosity of 5.1 cps). The third inlet of the tee 
was connected to a 40 cm length of 150 µm i.d./ 360 µm o.d. Teflon tubing for storage of 
droplets. A 4-way manifold was employed in simultaneous reagent addition. The first three 
inlets were connected with appropriate tubing, as described above. The fourth inlet of the 4-
way manifold was connected to a 1.8 cm of 20 µm i.d./ 150 µm o.d., which was place in a 
vial of a reagent containing fluorescein and a mixture of internal standards in water. For 
sampling, a microfabricated probe was placed in a stirred vial of an aCSF prior to addition of 
a mixture of standards. A set of standards included 0, 0.01, 0.05, 0.1, 0.2, and 0.4 µM ACh 0, 
0.05, 0.2, 0.4, 0.8 and 1.6 µM GABA, 0, 0.1, 0.5, 1, 2 and 4 µM Glu, and 0, 10, 50, 100, 200 
and 400 µM Gln. To generate pull flow, a vacuum was applied at the end of the Teflon 
storage tubing. Vacuum pressure was adjusted between – 100 mmHg to – 200 mmHg in 
order to achieve the pull flow of samples within the range of 50 nL/min to 100 nL/min, and 
~1:1.5 aqueous:oil droplets. Flow rate was determined by monitoring plug size and frequency.  
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Figure 3.3 Overview of experimental setup for monitoring brain chemical dynamics with high spatiotemporal 
resolution. (A) Microfabricated push-pull probe with 3 channels. The first and second channels were used for 
pushing regular aCSF and microinjection of K+-aCSF. The last channel was used for pulling sample. The inset 
showed microfluidic interface between the probe and a “fluidic” capillary. This capillary was used for sample 
transfer prior to connecting with a microfabricated manifold for simultaneous flow segmentation and reagent 
addition (B). Generated droplets were collected in a Teflon storage tubing prior to an offline analysis. The inset 
showed a microscopic photograph of the flow segmentation with reagent addition. Food dyes were added to 
sample and reagent for visualization. (C) Photograph of the probe connected to the droplet-based device. 
 
 Droplet analysis. Analysis of droplets was carried out offline using fluorescent 
microscopy for fluorescein detection and ESI-MS for neurochemical detection. After 
collection of droplets, the Teflon storage tubing was disconnected from the PDMS device 
before connecting with an oil-filled syringe in a syringe pump. Fluorescence of droplets were 
imaged by using an inverted fluorescence microscope (Olympus IX71) with a Xe arc lamp, 
appropriate filters, and a CCD camera (Hamamatsu ImageEM X2). When reagent addition 
was performed, a ratio of added reagents to samples was determined based on the fluorescein 
intensity in aqueous droplets.  
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 For the ESI-MS assay, the other end of the Teflon storage tubing was connected to a 
nanospray tip using a commercial union. (PicoClear, New Objective, Woburn, MA) The 
spray tip is pulled to 15 µm i.d. with conductive coating on its exterior. Sample droplets were 
perfused at 50 nL/min through the nanospray tip. The ESI voltage was 1.25 kV.  Samples 
were analyzed by using a Micromass (Waters, Milford, MA) Quattro Ultima triple-
quadrupole mass spectrometry, operated in multiple reaction monitoring (MRM) mode using 
conditions listed in Table 3.1. Data was recorded by Masslynx 4.1 (Waters, Milford, MA). 
Cutter222 was used for peak detection and determination of peak intensities. Ratio of the peak 
intensity to I.S. was then calculated and used for calibration.  
 
Table 3.1 MRM condition of analytes. Four analytes with their internal standards were simultaneously 
monitored in the droplets. Inter-channel delay time was 10 ms. Inter-scan delay time was 100 ms. Total MS 
cycle time was ~1.4 s. 
 
  
  
 Temporal resolution. To initially test temporal resolution of the sampling system, a 
probe was coupled to a microfabricated tee for testing flow segmentation only (Figure 3.4A). 
The probe was placed in a stirred vial of an aCSF solution containing a sample. During 
sampling, the concentration of sample was rapidly changed to higher concentrations via 
60 
 
pipette pouring. Temporal resolution of the system was determined by measuring 10% to 90% 
dynamic response time during step changes in sampled concentrations.  
 
 
Figure 3.4 Test of temporal resolution. A) Schematic of a segmented flow sampling; B) step changes of 
fluorescein concentration revealing temporal resolution of ~6 s at a sampling rate of 100 nL/min; C) Resulting 
calibration from the above sampling experiment. Each point was the average of 25 standard droplets 
 
In vivo experiments 
 Surgical procedures were similar to those described previously (see Chapter 2)223. 
Male Sprague-Dawley rats weighting between 250 - 350 g were anesthetized using 2 – 4% 
isoflurane, and placed in a stereotaxic frame (Koft Instrument, Tujunga, CA). Animals were 
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maintained under isoflurane over the entire experiment. Probes were stereotaxically inserted 
to the striatum at coordinates +1.5 mm anterior, ± 3.0 mm lateral to bregma, and a depth of 
4.5 mm ventral from dura. Probes were lowered slowly over 1 min. During probe insertion, 
probe channels were back-flushed at 200 nL/min to prevent clogging before immediately 
reducing flow rates to be 100 nL/min at depth. After 5 min of flow stabilization, an outlet of 
the pull channel was then connected to the PDMS manifold. To generate pull flow at 100 
nL/min, -200 mmHg of vacuum was applied at the end of the Teflon tubing previously filled 
with droplets. Pull flow rate was monitored by observation of plug frequency and 
measurement of volumetric flow rate. If necessary, optimization of flow rate was carried out 
by manually adjusting vacuum pressure. Push-pull flow was continued for at least 30 min 
following implantation for stabilization of baselines. At about an hour after probe 
implantation, K+ stimulation was performed by switching a push flow from a regular aCSF to 
high K+-aCSF through the integrated channel. High K+-aCSF was perfused at 100 nL/min for 
1 min before switching flow back to aCSF. After sample collection, the Teflon storage tubing 
was removed from the chip prior to droplet analysis.    
 
Results and Discussion 
Probe and microinjector 
 Micromachining of silicon based on buried channel technology was utilized to 
fabricate push-pull probes115. In this work, the method for microfabricating the probes was 
validated. Although the method was proven successful, it was still imperfect as ~30% of the 
final probes were either clogged or partially-clogged during the flow test. We found that this 
issue was due to the use of adhesive (i.e., Crystalbond mounting wax) during the backside 
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etching that may enter and clog probe channels (see Figure 3.5). In our previous work, the 
wax removed by soaking the probe in hot water and perfusing hot water through each 
channel. However, we experienced that this approach was inconvenient and did not guarantee 
complete removal of the adhesive. To address this problem, we have added a batch process 
of baking probes at 610 °C for 8 h to decompose the wax. As a result, the wax was 
completely removed and a fabrication yield was improved from 60% to 90% (~10% of the 
probes were broken during probe release and manual transfer). Overall, the current 
fabrication process was reliable, yielding smooth channels with high replication fidelity (see 
Figure 3.1). By processing a single 4 in. wafer, about 120 functional probes were obtained.  
 
 
Figure 3.5 Clogged channel by adhesive used during the backside etching. 
  
 Design of the probe was adapted from our previous report115. In this work, we 
integrated an additional channel to the probe for microinjection of a stimulant. As illustrated 
in Figure 3.1, the microfabricated probes were 80 µm wide × 75 µm thick, consisting of 3 
buried round channels with 20 µm diameter. The two main channels were used for push and 
pull flow. The additional channel was merged with the push channel, creating a tee-junction 
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at 500 µm above the orifice. Switching the flow at the tee junction allowed microinjection of 
a stimulant. A solved equation for calculating a 10% to 90% rise time required for a 
concentration step change can be expressed as shown below, by substituting the equation for 
the effective diffusion coefficient for Taylor dispersion into the equation for diffusion from a 
finite concentration step73.  
𝑅𝑖𝑠𝑒 𝑡𝑖𝑚𝑒 =
3.62
𝑉
√(1 +
𝑟2𝑉2
48𝐷2
) 𝐷𝑡 
where r is a capillary radius, V is an average flow velocity, D is a diffusion coefficient, and t 
is a time to flush the capillary (i.e., capillary volume divided by volumetric flow rate). At a 
flow rate of 100 nL/min, a rise time during flow switching for microinjection was estimated 
to be 72 ms with the flush time of 94 ms. Therefore, a time delay during microinjection 
should be minimal due to use of the microfabricated tee. At the probe tip, the orifices for 
push-pull sampling were rectangles with 20 µm square. Microfabrication allowed limiting a 
space between the two orifices to be merely ~20 µm, as shown in Figure 3.1. The active 
sampling area of the probe, defined as spatial resolution, was then approximately to be 20 µm 
× 60 µm or 0.0012 mm2. This sampling area is about 10-fold smaller than that of 
miniaturized push-pull probe made by hand assembly. Comparing to a conventional 
microdialysis probe with 2 mm long × 220 µm diameter membrane, spatial resolution of the 
microfabricated push-pull probe is approximately 1000-fold better.  
 
Probe connection 
 Probe holders were used for handling microfabricated probes and coupling the tiny 
probes to standard “fluidic” capillaries. A “union” capillary, pre-aligned on the probe holder, 
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was utilized to connect the probe port (1 mm long, 70 µm square with 20 µm buried channel) 
with a fluidic capillary prior to sealing (see Figure 3.3A, inset). Selecting proper dimensions 
of a union capillary and a fluidic capillary was critical to achieve reliable sample flow 
without compromising on temporal resolution. In this work, optimized dimensions were 8 
mm long, 150 µm i.d. / 360 µm o.d. for a union capillary and a 5 cm long, 50 µm i.d. / 150 
µm o.d. for a fluidic capillary. Using the rise time equation and a diffusion coefficient of  
5 × 10-10 m2/s, temporal resolutions of the coupled system were calculated to be 4.9 s at a 
perfusion rate of 100 nL/min and 7.2 s at a perfusion rate of 50 nL/min.  
 In principal, a relatively small tubing diameter (such as, 10 or 20 µm i.d.) could be 
used as a fluidic capillary to further minimize the effect of Taylor dispersion. However, too 
small diameter of tubing could also lead to mismatch between the lumen of a fluidic capillary 
and the port channel, resulting in even more dead volume and dispersion. Our initial study 
found that temporal resolution was instead worse when 20 µm i.d. was used as a fluidic 
capillary (data not shown). This result was in agreement with the previous report115. When a 
10 cm long, 20 µm i.d. / 90 µm o.d. capillary was used as a fluidic capillary, temporal 
resolution at a flow rate of 50 nL/min was found to be 26 s. In contrast, the theoretical rise 
time suggested that temporal resolution could be 1.9 s. Consequently, in practice, use of a 50 
µm i.d. fluidic capillary is more effective as it allows reliable sample transfer while still 
yielding adequate temporal resolution (less than 10 s resolution).  
 
PDMS device 
 In this work, we have developed PDMS microfluidic devices that were compatible 
with the microfabricated push-pull probe that allowed tubing connection for sample pulling, 
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flow segmentation, reagent addition, and droplet collection. Several requirements during the 
device development included ease of device removal and reconnection due to probe 
backflushing during in vivo experiments as well as proper sealing and tubing alignment. To 
achieve these requirements, we used a combination of soft lithography and pour-over 
methods to fabricate PDMS microchips containing suitable channel shapes and dimensions 
(see Figure 3.2F). The cylindrical channel features made by a pour-over method were 
necessary in order to create tight sealing. We found that 100 µm diameter and 230 µm 
diameter channels facilitated proper sealing with 150 µm o.d. tubing and 360 µm o.d. tubing, 
respectively. The resulting chips allowed tubing connection with ease of insertion and 
without any leaks during vacuum applied (tested up to -500 mmHg), allowing device 
operation at a wide range of sampling rates. On the other hand, our initial tests indicated that 
without the use of cylindrical channels for sealing, air leakage and device failure started 
occurring when applied vacuum was at -100 inHg. This leakage occurred because rectangular 
channels made from an SU-8 mold do not fit perfectly with standard cylindrical capillaries.   
 In our initial studies, we also attempted to use commercially available tee or manifold 
(C360QTPK4 or C360QXPK4, Valco, Houston, TX) for droplet manipulation. However, 
these devices often generated irreproducible droplets due to errors during manual tightening 
of the fitting. We also found that the dead volume of the commercial devices normally led to 
~3 s loss of temporal resolution, in agreement with a previous report73. On the other hand, 
loss of temporal resolution in the microfabricated devices were negligible (discussed in the 
next section). In addition, the smallest commercially available fitting permits connection of 
only 360 µm o.d. tubing, making it less flexible to change design of microfluidic interface. 
Hence, the devices developed in this work are more suitable for integrating with the 
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microfabricated push-pull probe as well as easily adapting to other miniaturized sampling 
probes223,224.  
 
In vitro characterization 
Droplet generation. The microfluidic system for segmented-flow sampling, reagent 
addition, and droplet collection is illustrated in Figure 3.3. Push flows for perfusion of aCSF/ 
K+-aCSF were operated by using programmable syringe pumps. Pull flows were obtained by 
using a vacuum pump applied at the end of collection tubing. Regulation of pull flow rates 
was achieved based on flow resistance of each tubing, which can be estimated by using a 
Poiseuille’s Equation. In other words, desired flows of sample, oil, and reagent could be 
achieved by selecting appropriate capillary geometries. In this work, a 4 cm long, 50 µm i.d. 
capillary was selected as an inlet for oil phase (viscosity of 5.1) and a 1.8 cm long, 20 µm i.d. 
capillary was selected as an inlet for aqueous reagent (viscosity of 0.89). As discussed above, 
a 5 cm long, 50 µm i.d. capillary was connected to a 1.1 cm long, 20 µm i.d. probe channel 
for aqueous-phase sampling. With all these parameters and a constant pressure applied, 
droplets with ~1: 1.5 aqueous:oil volume ratio were generated (see Figure 3.3B, inset), where 
the reagent was added at ~1:1.5 reagent:sample volume ratio. As shown in Figure 3.6A, 
robust and reliable sampling and reagent addition could be attained with an average of 3% 
RSD in peak height for serial sampling and reagent additions. By using a 150 µm i.d. Teflon 
tubing as a storage tubing, formation of regularly shaped aqueous droplets with fraction 
volume of ~5 nL were formed (3 s per droplet at 100 nL/min), collected and reliably 
transferred to the subsequent assay. This i.d. tubing also allowed sufficient storage time, 
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facilitated operation of pull flow within a practical range, and is readily compatible with our 
previously-developed assays73,163,221.   
Temporal resolution. To determine the temporal resolution of the system, the probe 
was coupled to a microfabricated tee for sampling of fluorescein (Figure 3.4A). As seen in 
Figure 3.4, step changes in concentrations of fluorescein were observed within 2 droplets at a 
sampling rate of 100 nL/min, corresponding to ~6 s temporal resolution. This resolution was 
nearly close to the theoretical temporal resolution (4.9 s) as determined above, indicating that 
the dead volumes at the union capillary and the droplet-based device were minimal.  
 Multiplexed chemical measurement. Direct infusion nESI-MS assay was utilized for 
analysis of multiple neurotransmitters in perfusate droplets with high sensitivity and 
selectivity. Analysis of droplets was performed in an offline fashion in order to accommodate 
the use of vacuum during sample collection and the MS speed. Using a MS flow rate of 50 
nL/min, droplets were reliably transferred to the electrospray tip via a commercial union 
without coalescence. This flow rate was chosen to ensure stable signals while providing 
enough data points per each droplet peak. Using a microfluidic manifold, I.S. of each analyte 
was also included in a reagent solution for normalizing the effect of matrix and instrument 
drift on signals. In contrast to our previous work that used a mixture of 1:1 acetonitrile:water 
as a solvent, water only was used in this work because we found that acetonitrile could lead 
to irreproducible reagent addition as well as causing coalescence during droplet transfer. 
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Figure 3.6 In vitro characterization of sampling coupled to segmented flow and reagent addition. Samples were 
a mixture of standards in aCSF and reagents contained fluorescein and a mixture of internal standards. A) 
Detection of for fluorescein in droplets yielded peak heights with RSD of 3% (n = 3 device sets). An example of 
a step change of ACh during switching concentration is shown in (B) along with related I.S. added at the same 
period. C) Calibration curves from ratio of signal traces of standards to internal standards. Linear calibration 
curves were achieved. 
In this work, we selected to study 4 physiologically important neurochemicals: Gln, 
Glu, GABA and ACh. Temporal resolution and sensitivity of the method were characterized 
in vitro by sampling from a stirred vial of a mixture of the 4 analytes in aCSF. An example of 
droplet analysis for monitoring ACh is illustrated in Figure 3.6B. As shown in the inset, a 
rise time during concentration change was observed within 2 droplets (~6 s resolution) at a 
perfusion rate of 100 nL/min. This rise time was in agreement with the above fluorescent 
result using the tee for flow segmentation only. Hence, the temporal resolution was not 
limited by the reagent addition as well as the MS assay. Using signal to noise ratio of 3, the 
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limit of detections (LODs) were found to be 140 nM for Gln, 95 nM for Glu, 35 nM for 
GABA, and 2.5 nM for ACh. The LOD of ACh was comparable to our previous report163. 
Nevertheless, in this work, nanospray ionization was used to enhance sensitivity, allowing 
analysis of much smaller sample volume (i.e., 5 nL droplets as compared to 160 nL droplets). 
Further, more analytes were measured in this study (i.e., 8 analytes as compared to 4 
analytes). The MS assay used here also did not require desegmentation of aqueous fractions 
prior to analysis163,167. Overall, the coupled system provided sufficient sensitivity and was 
robust, simple, and suitable for in vivo studies.  
 
In vivo monitoring of neurotransmitter dynamics 
 The integrated system (microfabricated push-pull probe with microinjection, droplet-
based chip with addition of I.S., and direct infusion MS assay) was used for in vivo 
neurochemical monitoring. In these in vivo studies, sampling flow rates were performed at 
100 nL/min as a means to better temporal resolution. Another purpose was to test feasibility 
of a relatively higher flow rate for in vivo low-flow push pull perfusion, which has not been 
previously reported72,73. At the perfusion rate of 100 nL/min, the in vitro recoveries of the 
probe were measured to be 83 ± 3%, 47 ± 10%, and 18 ± 7% (n = 5) by sampling fluorescein 
in a stirred vial, a non-stirred vial, and a 0.6% agarose gel225, respectively. To demonstrate 
the capability of the system for detection of rapid chemical changes, switching of the push 
flow to a microinjection of high K+-aCSF solution was performed to stimulate neurochemical 
releases in striatum. In this work, to minimize tissue damage226, microinjection was achieved 
at a low flow rate (i.e., 100 nL/min) as opposed to a typical high flow rate stimulation (i.e., 
short puff at over 1.5 µL/min73,165). As shown in Figure 3.7, microinjections of the high 
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potassium solution evoked release of all the four analytes. For the first injection, the changes 
at peak maximum from the baselines were 540 ± 140% for Gln, 860 ± 410% for Glu, 1800 ± 
1200% for GABA, and 640  ± 320% for ACh (mean ± SEM, n = 4 animals). Neurochemical 
levels returned to their baselines after switching the flow back to a regular aCSF. For the 
subsequent injection, the average increases were 460 ± 160% for Gln, 340 ± 140% for Glu, 
850 ± 440% for GABA, and 330 ± 110% for ACh. The percentages of increase in Glu were 
reasonably comparable to other previous work (see Table 3.2 for comparison41,73,89,166,205,227–
229). In addition, substantial effect of potassium stimulation on GABA levels was also in 
agreement with the previous studies166,202,205.  
 The rise time for potassium response was 15 - 20 s. This rise time is slower than the 
temporal resolution of the monitoring system. The delay in this rise time was due to the use 
of a syringe pump for microinjections, which typically required at least 5 – 10 s before 
reaching the desired perfusion rate. Rise times of below 10 s were reported in other work 
when using a gas pressure-pulse system “Picospritzer”73,89,165. Other factors that may also 
affect to differences in neurochemical response and rise time between this work and others 
included type of probe, type of anesthesia, position of microinjector, and dose of stimulant. 
The current work demonstrated utility of the integrated tee with a syringe pump for infusion 
of a stimulant. Although effective, variability in chemical responses between experiments 
was observed. We suspected that it was caused by interference between microinjection flow 
and pull flow. Development of a probe with a spaced shank for microinjection may allow 
chemical infusion that is more reliable. Our ongoing work is to engineer the probe with 
different microinjector designs that allow chemical delivery at high-spatially different 
locations as well as to explore the effect of infusion rates on neurochemical response. 
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Figure 3.7 In vivo monitoring of response to microinjection of 100 mM K+ aCSF (infused at 100 nL/min for 1 
min) in the rat striatum. Arrows indicate beginning of microinjection. Data are expressed as percentage of 
baseline (mean ± SEM, n = 4 rats) upon switching to microinjection of high potassium. Responses of glutamine 
(A), glutamate (B), GABA (C) and acetylcholine (D). Rise times could be observed within 15 - 20 s. 
72 
 
Table 3.2 Comparison of in vivo recording of Glu response to high potassium stimulation. 
Ref. # Probe type Sampling 
rate  [K
+
]  Delivery method 
Injection 
volume Injector, positioning Anesthesia Brain region 
Average of 
number-folds 
increase at max 
Rise time Assay 
This work µFab PP 0.1 µL/min 100 mM Syringe pump + 
microinjection 100 nL Push outlet, 20 µm spaced Isoflurane Striatum 
8.6 (1st) 
3.4 (2nd) 15 - 20 s Droplet MS 
227 PP 0.05 µL/min 75 mM Syringe pump + 
microinjection 500 nL Push outlet, 75 µm spaced Chloral hydrate Striatum 3.3 45 s CE-LIF 
73 PP 0.05 µL/min 70 mM Syringe pump + 
microinjection 100 nL 
Sharpened glass pipette, 10° to 
coronal plane, 100 µm spaced 
Ketamine + 
Dexmedetomidine Striatum 5.0 22 s 
Droplet 
Enzyme-LIF 
228 
MD  
(4 mm long) 1 µL/min 100 mM 
Syringe pump + 
reverse dialysis Continuous Dialysis membrane Isoflurane Cortex  ~4 - CE-ED 
41 MD 1 µL/min 60 mM Syringe pump + 
reverse dialysis 333 nL Dialysis membrane Urethane Hippocampus ~5 12 - 18 s CE-LIF 
166 
MD  
(2 mm long) 0.3 µL/min 145 mM 
Picospritzer + 
microinjection 200 nL 
Fused-silica tubing,  
glued w/ probe, 1 mm above 
probe tip, 150 µm spaced 
Ketamine + 
Domitor Striatum 4.3 9 - 12 s 
Droplet  
CE-LIF 
205 
MD  
(0.5 mm long) 0.1 µL/min 75 mM 
Picospritzer + 
microinjection 200 nL 
Fused-silica capillary, glued w/ 
probe, ~0.5 mm above probe tip, 
45 µm spaced 
Ketamine + 
Dedetomidine Striatum 16 10 s 
Droplet  
CE-LIF 
89 
µFab ceramic 
electrode array - 70 mM 
Picospritzer + 
microinjection 133 nL 
Sharpened glass pipette, glued w/ 
probe, 50-100 µm spaced Urethane Striatum 2.9 2 s Amp 
  
- ʺ ʺ ʺ ʺ ʺ Cortex 4.2 2 s ʺ 
  
- 120 mM ʺ ʺ ʺ ʺ Striatum 6.7 3 s ʺ 
  
- ʺ ʺ ʺ ʺ ʺ Cortex 8.0 2 s ʺ 
229 
Enzyme coated 
carbon fiber 
electrode 
- 120 mM Picospritzer + 
microinjection 500 nL 
Sharpened glass pipette,  
~100 µm spaced Equitensine Striatum 1.5 8 s Amp 
  
- ʺ ʺ 1 µL ʺ ʺ ʺ 2.3 ʺ ʺ 
  
- ʺ ʺ 2 - 3 µL ʺ ʺ ʺ 4.0 ʺ ʺ 
Abbreviation list: µFab = microfabricated; PP = push-pull; MD = microdialysis; MS = mass spectrometry; CE = capillary electrophoresis;  
LIF = laser-induced-fluorescence; ED = electrochemical detection; Amp = amperometry   
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 The in vivo experiments illustrated capability of the miniaturized analytical method 
for high spatiotemporal resolution and multiplexed neurochemical monitoring. Based on 
these initial studies, a number of improvements are herein discussed for future development. 
In the course of in vivo experiments, we occasionally observed disturbance of segmented-
sampling flow that led to flow blockage or eventual clogging. This flow disturbance may also 
led to imbalance of sampling flow rates (i.e. pull flow is slower than push flow) that could 
result in lower-than-expected relative recoveries of analytes. The origin of the cause of flow 
disturbance is still not clear. Nevertheless, we found that flow disruption was typically 
initiated at the probe orifices where they were in contact with living tissues. The cause of this 
disruption might be due to aggregations of cell particulates, blood clot, tissue debris, or glial 
cells230. Future work will involve modification of design of probe orifices in order to mitigate 
this issue. In addition, it is possible that variations in intracranial pressure (caused by several 
factors, such as surgery procedure and brain exposure to local room pressure117), flow rate of 
CSF231,232, and viscosity of sampled fluid233,234 can affect to flow disruption. Although these 
variations were not previously reported to be an issue in other push-pull studies72,73,227, their 
negative effects on device operation might become significant in miniaturized sampling with 
segmented flow (i.e., when active sampling area and fraction volumes are extremely small). 
Further work is required in order to understand these effects. Development and use of 
integrated, automated pressure controller and flow meter will help to accordingly adjust 
microfluidic flows and overcome the above issue
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Conclusion 
 In this work, we have demonstrated potential utility of the miniaturized analytical 
technology that is pertinent to multiplexed monitoring chemicals in living tissues at high 
spatial and temporal resolution. The spatial resolution of the microfabricated sampling probe 
is approaching that of a single carbon fiber microelectrode. The temporal resolution of the 
system is comparable to the state-of-the-art technology for in vivo neurochemical sampling. 
By microfabrication, an additional channel can also be integrated directly within a probe for 
microinjection of a stimulant. Besides chemical delivery, this additional channel can be 
further used for other purposes, such as reagent addition, or flow-segmentation that allows 
sub-second temporal resolution. Based on similar microfabrication technologies, it is also 
possible to integrate the probe with other features, such as electrodes for electrophysiological 
recording and optical waveguides31,235 for optogenetics. Furthermore, the miniature sampling 
system or droplet-based microfluidic devices developed in this work are easily amendable to 
integrate with other microfluidic analytical systems, such as immunoassays159, enzyme 
assays73,236, electrochemistry219,224, and capillary electrophoresis166,221 (as also demonstrated 
in the next chapter). Nevertheless, the direct infusion MS assay provides an effective way to 
measure multiple neurochemicals in samples with nanoliter volumes. Advances in the assay 
and instrumentation will also yield better sensitivity as well as allowing simultaneous 
detection of many more chemicals. Besides in vivo neurochemical monitoring, the 
technology developed here may also be adaptable to other microenvironments (such as other 
organs and cultured cells) that require chemical monitoring and drug delivery at high 
spatiotemporal resolution. 
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Chapter 4  
Microfabricated Sampling Probes Coupled to  
Droplet-Based Microchip Electrophoresis 
 
Introduction 
 Sampling methods are versatile for studying neurochemistry since they can be 
coupled to a variety of appropriate analytical assays. The assays often require a separation to 
reduce selectivity demands on the detector. Neurochemicals in brain dialysates or perfusates 
have routinely been studied using high performance liquid chromatography (HPLC) coupled 
to detectors such as electrochemical, fluorescence, and mass spectrometric (MS)37. In one 
comprehensive assay, samples were derivatized with benzoyl chloride prior to analysis by 
HPLC-MS, allowing simultaneous measurement of multiple neurotransmitters and 
metabolites45,237. Although the HPLC-based method is powerful, it has poor temporal 
resolution as this method typically requires large sample volumes (microliters) and long 
separation time (minutes).  
 A more suitable separation method for high temporal resolution monitoring is 
capillary electrophoresis (CE) or microchip CE. Comparing to HPLC, the CE-based method 
requires much smaller sample volumes (less than a few hundred picoliters) and resolves 
neurotransmitters within seconds71,165. With the use of high speed CE separation coupled to 
laser-induced fluorescence (LIF) detection, analysis of a large number of samples collected 
within intervals of seconds was made possible. In this case, temporal resolution was limited 
only by broadening of sample zones due to Taylor dispersion154. Although using short 
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connecting tubing helped to mitigate the band-broadening issue41,156,238,239, it was infeasible 
for experiments in awake animals or in clinical settings. A preferable approach to address the 
zone broadening issue is to use segmented flow or droplet microfluidics. As demonstrated in 
Chapter 3 and other previous reports73,159,166, droplet microfluidics has proven to be an 
effective approach to preserve temporal resolution from sampling and to manipulate large 
numbers of small volume samples.  
 Our group has previously reported utility of microchip CE coupled to droplet-based 
sampling for monitoring neurochemical dynamics165,166,240. In these systems, sample droplets 
were extracted (“desegmented”) before electrokinetic-gated injection, providing high 
separation efficiency (excess of 2 × 105 plates made possible) with good injection 
reproducibility (~5 - 6% RSD for serial injections). Although these systems were effective, 
there were still limitations. First, for flow desegmentation, the previously developed systems 
relied on modification of glass surface on the chip. This process involved surface chemistry 
patterning, which added more complexity to fabrication procedure. Second, the CE chips 
yielded long separation times (i.e., 20 – 50 s), which could limit temporal resolution. An 
offline format may be used to allow droplet analysis without loss of temporal resolution by 
pumping droplets into the CE chip at a low flow rate166. However, this approach had 
limitation in terms of throughput and flexibility in operational flow rates, restricting its 
potential use for online or real-time chemical monitoring. Lastly, the previously developed 
interfaces were primarily intended for use in microdialysis sampling, which inherently had 
poor spatial resolution. Our goal in this work is to overcome the above limitations.  
 Here we reported a combination of the microfabricated push-pull probe with 
compatible droplet-based microchip CE interface for monitoring amino acid neurochemicals 
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at high spatiotemporal resolution. Using a 5-way PDMS manifold, samples were collected 
from the microfabricated probe, segmented, and simultaneously derivatized with 
naphthalene-2,3-dicarboxaldehyde (NDA) and potassium cyanide (KCN). A novel extraction 
device was consequently developed to allow reliable and robust extraction and transfer of 
aqueous droplets into microchip CE. The microchip CE developed here enabled rapid 
separation (< 3 s) of multiple amino acid neurochemicals. The integrated system was proven 
to be suitable for multiplexed neurochemical measurement, providing ~11 s temporal 
resolution at a sampling rate of 50 nL/min. 
 
Experimental 
Chemicals and materials 
Unless otherwise specified, all chemicals were purchased from Fisher Scientific 
(Fairlawn, NJ) or Sigma Aldrich (St. Louise, MO) and were certified ACS grade or better. 
Solutions were prepared with HPLC-grade water or water purified by a Milli-Q system 
(Millipore, MA). Teflon HPFA tubing were purchased from IDEX Health & Science (Oak 
Harbor, WA). Fused silica capillaries were purchased from Molex (Phoenix, AZ). Epoxy 
glues were purchased from Loctite (Westlake, OH) for regular 5-min Epoxy, and ITW 
Devcon (Danvers, MA) for 5-min Epoxy (gel-type) and 2-Ton Epoxy. Polydimethylsiloxane 
(PDMS) was purchased from Curbell Plastics (Momentive® RTV 615, Livonia, MI). 
Artificial cerebrospinal fluid (aCSF) contained 145 mM NaCl, 2.68 mM KCl, 1.01 mM 
MgSO4, 1.40 mM CaCl2, 0.45 mM NaH2PO4, and 1.55 mM Na2HPO4, adjusted to pH of 7.4 
with 0.1 M NaOH. NDA was purchased from Life Technologies/ Invitrogen (Carlsbad, CA). 
Glass slides with chrome masks were purchased from Telic (Valencia, CA). 
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Microfabricated probe and holder 
Microfabricated push-pull probes were fabricated using the same method, as 
previously described in Chapter 3. In this work, backside of the probes was further etched in 
order to yield thinner probes. The final probes had a dimension of 11 mm long, 83 µm wide, 
and ~50 µm thick (Figure 4.1). The fluidic capillary connected to the probe port for pull flow 
was 2 cm long of 40 µm i.d. / 150 µm o.d.  
 
 
Figure 4.1 Thin microfabricated push-pull probe 
 
A probe holder was used to handle and plumb the probes to connection tubing. A 
design and procedures to microfabricate the holder were similar to what described 
previously115. Alternatively, as a means to reduce time and cost of fabrication, probe holders 
were fabricated using a 3D printer, 3D System’s Projet 3500 HD Max (Rock Hill, SC). The 
bio-compatible, acrylic-based resin (“M3 Crystal”) was used for printing the devices. The 
printer provides the xyz resolution between 16 - 32 µm layers with the accuracy of 25 – 50 
µm per inch of part dimension. For post-processing, the printed parts were soaked in soapy 
water at 60 °C overnight, rinsed with water while sonicating, and air-dried.  
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Sample derivatization  
 NDA in excess CN- was used as a fluorescent tag for amino acid neurochemicals. 
Reagent and buffer solutions were prepared using procedures based on the previous 
reports165,205, with slight modifications. Methanol was used as a solvent for NDA instead of 
acetonitrile in order to form more stable droplets. Buffer used for preparing the reagents was 
20 mM sodium tetraborate, 0.9 mM hydroxyproply-β-cyclodextran, pH = 10. NDA solution 
(10 mM) was prepared in a 50:50 mixture (v:v) of methanol and the buffer. Excess CN- was 
prepared using potassium cyanide (20 mM) with 0.5 M EDTA in the buffer. 
 
Flow segmentation and reagent addition 
A 5-way PDMS manifold was coupled to microfabricated probes for flow 
segmentation and simultaneous addition of two reagents. The PDMS chip was fabricated 
using the procedures described in Chapter 3, with slight modifications in device design and 
channel size. In this work, the 5-way junction was designed for 1) sampling, 2) flow 
segmentation, 3 & 4) addition of 2 reagents, and 5) droplet collection. At the junction for 
droplet generation, the channel size was 100 µm wide × 100 µm tall. The overall scheme of 
the system is illustrated in Figure 4.2A.  
The first inlet of the chip was attached to a fluidic capillary of the sampling probe. 
The second inlet was connected to a 3 cm length of 50 µm i.d. capillary which was placed in 
a vial containing 50:1 (v:v) solution PFD:PFO for flow segmentation. The third and fourth 
inlets were attached to 9 cm length of 20 µm i.d. capillaries placed in vials of reagents. The 
fifth inlet of the manifold was connected to a 3 cm length of 150 µm i.d. / 360 µm o.d. Teflon 
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tubing (fixed tubing). This fixed tubing was connected to another 30 cm length of 150 µm i.d. 
/ 360 µm o.d. Teflon tubing (removable tubing) via a PDMS union. Pull flow was achieved 
by applying a -130 mmHg vacuum to the outlet of thee Teflon storage tubing, providing a 
sampling rate of 50 nL/min. For push-pull perfusion, push flow with desired flow rate was 
performed using a syringe pump. The push flow rate was validated using a flow meter while 
the pull flow rate was monitored by measuring droplet frequency and size. Using the 
described system, ~3 nL aqueous droplets were generated. Based on flow resistance of the 
inlet capillaries, mixed reagents were added at 30% of total aqueous droplet volume and 
volume ratio of aqueous to oil was ~1:3.  
 
 
Figure 4.2 A) Illustration of the droplet generator with reagent additions, driven by a vacuum (the image was 
not drawn to scale). B) A photograph of the manifold connected to a microfabricated push-pull probe. The 
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holder was made by 3D-printing. C) An experiment with food dyes was performed to aid visualization. When 
sample was switched from a blank to red dye, color change was observed within 1 - 2 droplets (D) Switching of 
Glu concentration, resulting in a rise time of ~3-5 s at a sampling rate of 50 nL/min.  
To initially test temporal resolution of the system, the microfabricated probe was 
coupled to the PDMS manifold for flow segmentation and addition of NDA and KCN This 
system was used for sampling of glutamate standard in aCSF solution in a stirred vial. The 
solution was then switched from 2 µM to 4 µM. Offline analysis of derivatized droplets were 
performed using the LIF detection system described below. 
 
Fabrication of a Teflon -based device for droplet extraction 
Passive droplet extraction was accomplished using a hybrid of Teflon and fused silica. 
A schematic of fabrication procedure for the Teflon device is shown in Figure 4.3. The 
fabrication method was based on drilling Teflon PFA tubing and sealing with PDMS chip. A 
100 µm wide × 100 µm tall PDMS tee, “Tee I”, was fabricated using soft lithography 
techniques. As the Teflon tubing was small and extremely slippery, this tee was used to 
fasten and secure the Teflon tubing prior to drilling. A 4 cm long of 150 µm i.d./ 360 µm o.d. 
Teflon tubing was reinforced with 150 µm o.d. polyimide-coated fused silica capillary prior 
to insertion into the PDMS tee (Figure 4.3A). The PDMS tee with inserted Teflon tubing was 
placed on a flat glass slide for support. A 150 µm diameter drill bit (Kyocera Tycom, Costa 
Mesa, CA) was used to extend a 150 µm hole through the wall of fixed Teflon tubing (Figure 
4.3B). After drilling, another 150 µm o.d. fused silica capillary was inserted into the extended 
hole to ensure straight and through drilling (Figure 4.3C). The 150 µm capillaries were then 
slid back and forth through the drilled hole in order to remove debris. The Teflon tubing with 
drilled hole was removed from the Tee I and inserted into a new and clean PDMS tee, “Tee II” 
(Figure 4.3D). To facilitate insertion of 360 µm o.d. Teflon tubing while accommodating 
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proper sealing with connection to 150 µm o.d. extraction capillary, the PDMS Tee II was 
designed to have cylindrical channels of 220 µm i.d. intersected with 100 µm i.d. (220 µm 
channel fitted with 360 µm o.d. tubing while 100 µm channel fitted with 150 o.d. capillary). 
This PDMS tee was fabricated using a pour over method previously described221. After 
insertion of the Teflon tubing into the 220 µm inlet of Tee II, the extended hole was aligned 
with the 100 µm inlet prior to removal of the reinforcing capillary. The final Teflon device is 
illustrated in Figure 4.3E. For droplet extraction, the Teflon device was connected to a fused 
silica capillary attached to the CE chip. 
 
Figure 4.3 Fabrication of a Teflon-based device for droplet extraction. A) Insert Teflon tubing into “Tee1”, B) 
Drill a 150 µm diameter hole on Teflon tubing, C) Clean debris, D) Insert the tubing into “Tee 2”. All the 
procedures were carried out under a microscope. “Tee 1” was used to hold Teflon tubing in place and aid the 
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drilling process. Fused-silica capillary was used to reinforce Teflon tubing and protect the tubing wall from 
damage. “Tee 2” was used to seal the device and align drilled Teflon tubing with the fused-silica extraction 
capillary that was attached to the CE chip (Figure 4.4A). 
Microchip electrophoresis 
 A design of the CE chip is shown in Figure 4.4. Glass CE chips were fabricated using 
lithographic patterning and HF wet etching. Fabrication of glass CE chips was described in 
detail elsewhere221. Briefly, one glass slide was etched to 100 µm for insertion of extraction 
glass capillary. A second glass slide was etched to 100 µm for extraction capillary insertion 
and 3 µm for all channels. Separation channel was 3 cm long, 36 µm wide × 3 µm deep. 
Access holes were then drilled with a 500 µm drill bit (Kyocera Tycom, Costa Mesa, CA) 
before sonicating the glass slides in water for 30 minutes for debris removal. Photoresists and 
chrome masks on the glass slides were then stripped off prior to piranha and RCA cleaning 
processes. Slides were then triple-rinsed with water. The two slides were sandwiched and 
their channels for insertion of extraction capillary were aligned under a microscope. The 
chips were baked at 80 °C for 3 hours, inspected for defects, and annealed at 610 °C for 8 
hours. Reservoirs and ports (IDEX Health and Science, Oak Harbor, WA) were attached 
above the access holes using 2-Ton Epoxy. A side of the glass chip was polished so that the 
channel for inserting extraction capillary were 0.5 mm long. A 2 mm long of 30 µm i.d. / 150 
µm o.d. glass extraction capillary was inserted into the insertion channel and waxed in place.  
 Prior to use, all reservoirs and channels were filled with electrophoresis buffer (10 
mM sodium tetraborate buffer with 0.9 mM hydroxyproply-β-cyclodextran, pH = 10) and all 
air bubbles in the chip were removed. Voltages were applied using power supplies (Spellman, 
Hauppauge, NY) with a high-voltage relay (Kilovac, Santa Barbara, CA) for performing 
electrokinetic-gated injection241 (+7 kV and -9 kV, with injection time between 30 to 50 ms). 
Detection of derivatized amino acids was done on-chip via confocal laser-induced 
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fluorescence at the end of separation channel. 440-nm line from a 10 mW solid-state laser 
(CrystaLaser, Reno, NV) directed through a 436 ± 10 nm band-pass filter was used for 
excitation. Emission was filtered through a 490 ± 10 nm band-pass filter and detected by a 
photon counting detector (Thermo Oriel, Stratford, CT). Voltage supply, high-voltage relay 
time, sample injection time, peak integration time, and data collection were controlled by an 
in-house LabVIEW program (National Instruments, Austin, TX). Data was analyzed using 
Cutter 7.0222, Excel 2013 (Microsoft, Redmond, WA), and Matlab (R2016a, MathWorks, 
Natick, MA).  
 
 
Figure 4.4 Schematic of droplet extraction device coupled to microchip CE 
 
In vitro characterization 
 The probe coupled to the PDMS manifold was dipped into a vial of aCSF containing 
standard solution of amino acid mixtures, including γ-aminobutyric acid (GABA), arginine 
(Arg), aspartate (Asp), glutamate (Glu), glutamine (Gln), glycine (Gly), serine (Ser), and 
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Taurine (Tau). In this study, fluorescein was also added into a reagent vial of KCN (the final 
concentration of fluorescein in the vial was 10 µM) for quantification of the percentage of 
reagents in droplets. Step changes of standard solutions were made via pipetting while the 
solution was rapidly stirred. After collection of derivatized droplets, offline analysis of 
droplets was performed by connecting the Teflon storage tubing to the hybrid device for 
droplet extraction-CE using a PDMS union. The other end of the Teflon tubing was 
connected to a syringe pump. Droplets were pumped into the analysis chip at 170 nL/min, 
yielding 1 electropherogram per ~1 droplet. 
 
Results and Discussion 
Thinner probe  
 Microfabricated push-pull probes has allowed chemical monitoring at high spatial 
resolution and have potential for minimizing tissue damage115.  In this work, we further 
explored applicability of thinner probes to sampling. As shown in Figure 4.1, the thickness of 
these probes was smaller than that of previously reported microfabricated push-pull probes115 
(i.e. 50 µm versus 70 µm). The probe contained three 11 mm long buried channels of ~15 - 
17 diameter, which encompassed with 25 µm thick top wall and 5 µm thick bottom wall. 
Side-walls were 10 µm thick for the first and second channel, and 4 µm thick for the third 
channel. Connecting the probe inlets with fluidic capillaries to a syringe pump, water 
perfusion was achieved up to 2 µL/min (higher flow rates were not attempted) with no 
failures or wall ruptures (n = 4). This result indicated that 4 - 5 µm wall thicknesses were 
sufficiently strong for device operation at high flow rates. It also suggested possibility for 
future development of smaller probe designs. Based on the above results and estimation of 
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microchannel back-pressure (i.e., ~30 psi), 5 µm wall thickness should be suitable for 
aqueous perfusion through a 5 mm long channel of 10 µm diameter at a flow rate of 500 
nL/min. With these dimensions of channels and walls, sampling probes containing two 
channels can be made as small as 35 µm wide × 20 µm thick. The potential to develop such 
tiny probes will lead to accessibility of chemical monitoring in small brain regions and 
reduce tissue damage during probe insertion that may confound measurements74.    
 
Sample derivatization and on chip reaction with flow segmentation 
 NDA reaction was used for derivatization of amino acids in samples because this 
reaction yields stable fluorescent adducts with high quantum efficiency and reasonably fast 
reactions (i.e., less than 6 min.)242,243. In this work, methanol was selected to be used as a 
solvent for NDA instead of acetonitrile166,205. This was because our initial tests using a tee for 
reagent addition indicated that use of methanol yielded a more stable droplet formation (see 
Figure 4.5). On the other hand, acetonitrile-contained droplets tended to drag along the 
surface of PDMS chip during droplet breakoff, leading to improper reagent addition as well 
as droplet coalescence. We then tested the amino acid-NDA reaction using a microplate 
fluorimeter and found no difference in terms of fluorescent signals and reaction kinetics 
when methanol was used as a solvent, as compared to acetonitrile results (n = 3; data not 
shown). We also confirmed that the reaction was completed within 6 min, which was in 
agreement with our previous report165. Therefore, methanol was a suitable solvent for use in 
this study.  
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Figure 4.5 Effects of organic solvent contents on droplet formation 
 
 As illustrated in Figure 4.2, a 5-way PDMS manifold was utilized for simultaneous 
flow-segmented sampling and reagent addition of NDA and CN-. Fused silica capillaries, 
which inserted into the manifold, were utilized as channels for reagent delivery. Use of the 
fused silica capillaries for reagent additions was necessary as their hydrophilic surface 
accommodated droplet formation with uniform composition166. As discussed in Chapter 3, 
flow rates of each solution were regulated based on flow resistance of each capillary while a 
constant vacuum was applied at the end of the Teflon storage tubing. The system used in this 
study was designed to add a mixture of reagents to samples at 30% of total volume. Droplets 
were generated at ~1:3 aqueous: oil volume ratio. The 100 µm PDMS junction produced a 
train of aqueous droplets with fraction volume of ~3 nL prior to collection in a removable 30 
cm long, 150 µm i.d. Teflon storage tubing. Based on the above parameters, at a sampling 
rate of 50 nL/min, a mixture of reagents was added at 22 nL/min while oil flow rate was 231 
nL/min. With the total flow rate of 303 nL/min, a 30 cm long of 150 µm i.d. Teflon storage 
tubing (total volume of ~5 µL) allowed ~17 min of droplet collection time. Since this transit 
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time was longer than the 6-min reaction kinetics, completion of the NDA reaction with 
amino acids was ensured prior to the subsequent assay. The relatively large oil spacers (as 
compared to what used in Chapter 3) were used to accommodate speeds of droplet extraction 
and CE separation.  
 Precipitation with the NDA reaction is often a problem165,242. Our initial tests in a vial 
or a microplate indicated that precipitates started forming at about 10 min after mixing the 
NDA with CN- reagents. To prevent this problem, the on-chip system was designed to mix 
NDA and CN- solutions just immediately before their addition to amino acid samples. Next, 
we found that having sufficient amount of amino acids in samples was necessary to avoid 
precipitates because the amino acid adducts helped to stabilize the reaction mixture. Finally, 
we also observed that use of the droplet system mitigated the precipitation issue, as opposed 
to the reaction with continuous phases. We believed that this was due to 1) oil carrier phase 
protected the walls of the device from reagent adsorption and eventual accumulation of 
precipitates, and 2) steady recirculating flow within droplets facilitated fast and consistent 
mixing during droplet moving244. With all these considerations (mix reagents freshly, add 
sufficient amounts of amino acids into samples, and use on-chip segmented flow), 
derivatized droplets were consistently generated with no precipitates over a long period 
(stable for at least 2 h). 
 
Test of temporal resolution 
In this work, we used a relatively small dimensions of fluidic capillary (2 cm long, 40 
µm i.d. versus 5 cm long, 50 µm o.d. used in the previous chapter) to demonstrate potential 
for improved temporal resolution at low flow rate (i.e., 50 nL/min). Tests of temporal 
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resolution were performed by using the probe-manifold system for segmented flow sampling 
of Glu and addition of the derivatizing agents. As shown in Figure 4.2D, a step change in Glu 
concentration was observed within 1 - 2 droplets at a sampling rate of 50 nL/min, 
corresponding to 3 - 5 s temporal resolution.  
 
Droplet extraction  
 Prior to droplet analysis by microchip CE, flow desegmentation was required in order 
to remove the carrier phase (i.e., fluorinated oil) from the droplet stream because the oil 
phase was non-conductive and interfere with the assay. This process could be achieved in a 
passive approach, which relied on surface chemistry and pressure balance of channels for 
extraction. To elucidate working conditions, a channel with hydrophilic surface was used for 
extraction of aqueous phase while a hydrophobic channel was used for extraction of oil phase. 
Proper design and selection of channel dimensions were also critical to balance capillary 
force and backpressure for favoring reliable extractions. In our previous reports165,166,205, 
droplets were extracted across a shallow “extraction bridge” connected to the CE chip. This 
extraction bridge was fabricated by silanization of a microfabricated glass channel. However, 
this surface-patterning step was laborious and the hydrophobicity of the surface diminished 
over time. An alternative and simpler approach was to use a hybrid device containing 
channels with different native properties, e.g., glass (hydrophilic) for aqueous extraction and 
PDMS (hydrophobic) for oil extraction221. 
 We initially explored several designs and configurations of a hybrid interface made of 
a network of PDMS channel and a fused silica capillary, similar to that described 
previously221. However, we often experienced an issue with surface fouling of PDMS, 
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resulting in unreliable droplet extraction. Especially for extraction of aqueous mixtures that 
contained an organic solvent, we found that the device stopped functioning only after a few 
minutes of use. Consequently, we developed a droplet extraction device based on a 150 µm 
i.d. Teflon tubing, as shown in Figure 4.3. In this device, a drilled hole on the Teflon tubing 
was aligned with a fused silica capillary that was attached to the glass CE chip using a PDMS 
tee (Figure 4.3E & Figure 4.4A). Through experimentation, proper dimensions of the device 
interface were found to be 2 – 2.5 mm long of 30 µm i.d. fused silica capillary for aqueous 
extraction, and 5 - 7 mm long at the end of 150 µm i.d. Teflon tubing for oil extraction. With 
these ranges of dimensions, pressure resistance in each tubing was balanced so that reliable 
droplet extraction were attained (i.e. entire aqueous droplet enter glass capillary only while 
entire oil droplet enter Teflon tubing only). Figure 4.6 shows an illustration and an example 
of droplet extraction. Furthermore, due to stability and non-adhering property of the Teflon 
surface, droplet extraction was stable over 3 - 4 h without interruption. Longer times may be 
possible; but, were not attempted.  
 The extraction system developed in this work provided a convenient way to reliably 
separate aqueous phase from oil phase prior to CE injection. Due to superiority of the Teflon 
PFA surface, the Teflon device could also be reused for many experiments. With optimized 
tubing dimensions discussed above, this extraction system facilitated use of a wide range of 
droplet flow rates (tested from 90 to 3000 nL/min). Therefore, this system might be suitable 
for incorporating into different types of microfluidic analytical systems that require phase 
separation (e.g., droplet-based CE for neurochemical monitoring162,165 or high-throughput 
analysis221,245,246, and droplet-based (MALDI)-MS for complex protein analysis247).  
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Figure 4.6 A) Illustration of a side-view of the Teflon-fused-silica interface for droplet extraction. B) An 
example of droplet extraction, series of images showed extraction of aqueous droplets when it contacted the 
fused-silica surface. 
 
Microchip CE 
 After droplet extraction, aqueous samples filled the glass extraction channel before 
directing towards the sampling channel and the injection cross of the CE chip by 
electroosmotic flow (EOF) using applied electric field, as illustrated in Figure 4.4. A cross 
buffer flow connected to high positive voltage through a relay was used to gate the sample 
stream towards a waste reservoir and to provide fresh separation buffer. The gaiting flow was 
then momentarily shut off by switching the relay, allowing a small volume of sample to be 
92 
 
injected into the separation channel. In this approach, the extraction channel served as a 
reservoir for supplying samples to the CE inlet. The small volume of the extraction channel 
(i.e., < 2 nL) allowed each droplet to completely fill it and wash the previous plug prior to 
serial injections. 
 In this work, we attempted to further push the limit of separation time by using a 
microchip CE with small (36 µm wide × 3 µm deep) and short (3 cm long) separation 
channel. This shallow channel efficiently dissipated the heat, accommodating application of 
remarkably high electric field at 2652 V/cm. By using 10 mM sodium tetraborate buffer at 
pH 10, a separation of less than 3 s with adequate separation efficiency and reproducible 
injections (peak height RSD of below 6 % for 50 serial injections) was routinely achieved for 
separation of 8 amino acids and fluorescein dissolved in aCSF. An example of the rapid 
separation is shown in Figure 4.7A. With optimization of the injection and integration times, 
LODs were typically 100 – 200 nM for amino acids. Comparing to our previously-reported 
microchip CE for monitoring amino acid neurochemicals165,166,205, the microchip system 
developed here provides significant improvement in separation time. This improvement will 
allow droplet analysis at higher throughput, and open more possibilities for multiplexed 
neurochemical monitoring at high temporal resolution. Future improvement in efficiency 
may be performed by using a higher electric field, which is currently limited by the effect of 
Joule heating in the CE channel and arcing at electrodes occurred when high voltage applied. 
Development of an on-chip cooling system and better insulator for electrode would mitigate 
the mentioned limitation.  
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Figure 4.7 A) an example of electropherogram for separation of fluorescence-labelled amino acids and 
fluorescein. B) In vitro monitoring of neurochemical dynamics. The integrated system was used for sampling, 
flow segmentation, reagent addition, droplet extraction, and microchip CE analysis.   
 
In vitro characterization  
 To demonstrate suitability of the integrated system, we monitored rapid changes of a 
mixture of amino acid neurochemicals in vitro. In this study, fluorescein was added with a 
reagent for quantification of the percentage of reagents in aqueous droplets. In an offline 
format, a collected droplet train was pumped into the extraction-CE device at a flow rate of 
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170 nL/min, allowing one aqueous droplet to be extracted at ~4 s (3.2 nL aqueous droplet 
with 9.6 nL oil spacer). Consequently, approximately one electropherogram could be 
observed per an extracted droplet using 4 s interval time between CE injections. Figure 4.7B 
showed peak heights of each separated compound from serial injections. Based on the 
average of peak height values of fluorescein, the reagents were added at 34% of the total 
volume. These values fell within the expected range as the device was designed to add 
reagents at 30% of the total volume. Using the integrated system, over 200 sample droplets 
could be successively analyzed. Peak height RSDs ranged from 6 – 10 % (e.g., 6.1 ± 1.4 % 
for Glu, 7.5 ± 1.5 % for GABA, and 8.7 ± 1.6 % for Arg, n = 3 device sets; at least 30 
samples each). The variation in peak RSD might be caused by differences in dissociation 
constants and NDA interactions.  
 As compared to the previous reports165,240, the slightly higher RSD in this study was 
likely due to the use of lower flow rate in each step (i.e., 72 nL/min versus > 600 nL/min for 
sampling with reagent addition; and 170 nL/min versus > 2000 nL/min for droplet extraction). 
The lower flow rate used during sampling could lead to less stability in droplet formation as 
droplets had greater chance of dragging along the PDMS chip’s surface. For droplet 
extraction, the lower flow rate used, the smaller sample volume filling the gap between 
extraction capillary and separation channel during sample accumulation time. This factor 
might generate a less uniform concentration zone of sample at the inlet of separation channel, 
leading to less reproducible injections248. In spite of that, the resulting RSD values were 
reasonable, considering every analytical steps involved from sampling to detection. Linear 
calibration curves corresponding to the experiments were achieved for all compounds (Figure 
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4.8), demonstrating that the integrated system could potentially be adapted for in vivo 
neurochemical monitoring.  
 
 
Figure 4.8 Calibration curves resulting from Figure 4.7B. Each point was an average of ~30 samples with a 
standard deviation as the error bar. 
  
 During switching concentrations of amino acids, 10% to 90% step changes were 
observed within 4 - 5 electropherograms, corresponding to 11 - 13 s rise time at a sampling 
rate of 50 nL/min with reagent addition rate of 22 nL/min. This resulting rise time was 
slower than what expected (i.e., < 5 s resolution when test the system without droplet 
extraction-CE device). This meant that the further loss in temporal resolution occurred after 
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sample extraction. We suspected that the delay in rise time was due to a dead volume at the 
CE inlet (see Figure 4.9). This dead volume could lead to further diffusion and mixing during 
sample transfer prior to CE injections. Modification of the chip design to minimize the dead 
volume will mitigate this issue. Nevertheless, the integrated system overall worked reliably, 
and still yielded adequate temporal resolution.  
 
 
Figure 4.9 Dead volume at the CE inlet caused diffusion and mixing prior to CE injection. This dead volume 
led to further loss of ~8 s. 
  
 Based on these initial results, several improvements are discussed for future 
development. In the course of these experiments, we experienced some difficulties that 
should be addressed. The microchip CE-based method had low tolerance of air bubbles. The 
CE chip can stop functioning when air bubbles entered the separation channel. Large air 
bubbles (e.g., > 5 nL) can also adversely alter balanced pressure at the extraction tee, leading 
to improper droplet extraction. Although careful considerations of the procedures to avoid or 
remove trapped bubbles were performed during preparation of any reagents and solutions, 
connection tubing, and chips, we still occasionally observed the presence of air bubbles 
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within the system. Future implementation of the integrated device for bubble removal would 
be helpful to solve this problem249,250. As the CE chip contained an extremely small channel 
(i.e., 36 µm wide × 3 µm deep), it was susceptible to clogging. Integration of an inline filter 
within the storage tubing or use of the dialysis sampling probe223 may reduce chances of 
clogging due to dust, debris, and protein. Future work will also investigate whether a CE chip 
with slightly deeper channel (e.g., 4 - 5 µm deep) is less prone to clogging, while still 
allowing adequately fast separation. Additionally, the CE method required the procedures for 
conditioning the chip prior to analysis. Our current procedures involved several manual steps 
of removing air traps from the chip before rinsing and refilling the channel with solutions for 
multiple times. This process can be burdensome because of the manual process. The small 
channel also necessitated high pressure for perfusion of solutions. Future development of an 
automated perfusion system and use of a high pressure driven pump will be useful for the 
process of chip preparation.  
Conclusion 
 In this chapter, we have developed the droplet-based CE interface that was 
compatible with the microfabricated sampling probe. The integrated system allows fast and 
multiplexed measurement of amino acid neurochemicals at high spatiotemporal resolution. 
We have initially explored the possibility to fabricate smaller probes. Coupled the probe to 
the PDMS manifold with optimized channel and tubing, numerous samples and multiple 
reagents at nanoliter scale could feasibly be manipulated by using only one driving vacuum. 
The hybrid Teflon-fused silica interface provides a simple, reliable, and robust way to couple 
segmented-flow sampling to a CE-based system. The microchip CE system with reduced 
separation channel size is particularly effective for rapid separation of multiple analytes. The 
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improvement in speed of separation demonstrated here will accommodate online or real-time 
chemical monitoring without compromising temporal resolution. Future development in 
software and instrumentation will further yield improved separation efficiency and detection 
sensitivity. In the microchip CE-based approach, it is also possible to miniaturize optical 
detection system (see Appendix D); ultimately creating a compact and portable platform that 
enables on-site chemical monitoring as well as parallel analysis. Moreover, the microfluidic 
analytical platform developed in this work has flexibility in its range of operating flow rates. 
It is therefore applicable to be coupled to various types of miniature sampling systems159,223 
as well as other droplet microfluidic analytical devices160,161.    
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Chapter 5  
Strategies for Improving Recovery of 
Microfabricated Dialysis Probe 
 
Introduction 
 Microdialysis is an essential tool for in vivo chemical monitoring25,26,28,71. This 
technique has been widely used because of its ease of operation and feasibility for coupling 
to various analytical methods that allow studies covering a wide range of substances37,71. 
Despite advantages of the technique, conventional dialysis probes are typically made by 
assembly leading to several limitations: 1) large size (probe diameters are over 220 µm), 
resulting in inevitable tissue damage and poor spatial resolution; 2) limited flexibility in their 
designs; and 3) tedious to make by hand. To overcome these limitations, our lab has used a 
microfabrication approach to develop miniaturized dialysis probes223, as demonstrated in 
Chapter 2.  
 The use of microfabrication in Si allowed construction of the dialysis probe that was 
6-fold smaller in size and sampling area. Coupling the probe to an LC-MS assay45,237, its 
utility was demonstrated in vivo by monitoring 14 neurochemical at basal concentrations. 
The probe yielded 2 – 7% relative recovery at a perfusion rate of 100 nL/min. Although 
effective for detection of many neurochemicals, the low recovery was a main drawback of 
the microfabricated probe. In contrast to the experimental results, computational fluid 
dynamics simulation (COMSOL modeling) of the membranes indicated recovery of 98% 
based on high-density straight pores (i.e., 30%) and use of a low flow rate. Hence, the model 
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suggested that the actual porosity of the fabricated membrane was lower than expected. 
Causes of this discrepancy were unclear. Nevertheless, we suspected that the lower-than-
expected porosity was due to the factors described below. 
 In our fabrication process, nanoporous anodic aluminum oxide138,127,128,139 was 
adapted to directly integrate semipermeable membranes onto microchannels (see Figure 5.1 
for summary). The process relied on using a 400-nm thick layer of AAO mask with 50 – 70 
diameter pores for etching through a 2-µm thick layer of poly Si underneath (Figure 5.1A – 
C). As the pores in the AAO mask were not always perfectly uniform, the etch rates could be 
inconsistent across the substrate. As a result, incomplete pore formation in the poly Si layer 
may be obtained. Next, in our previous study, we found that the 2.4-µm thick membrane 
(combined AAO and poly Si layers) was insufficiently strong to withstand backpressure 
during flow. We consequently increased a physical strength of the membrane by replacing 
the 400-nm thick AAO layer with a 3-µm thick layer of AAO (Figure 5.1D – F). Although 
this thick layer strengthened the membrane, it can reduce porosity because its formed pores 
may not necessarily align with the earlier formed pores in the poly Si layer. Finally, during 
the backside etching step (Figure 5.1G), the front side of the device wafer must be mounted 
on another substrate (“carrier wafer”) using a wax that was soluble in hot water. As a surface 
of the porous membrane was directly exposed to the melted wax during mounting, the pores 
could be clogged. Even though this wax was removed by hot water during the latter step, 
some pores may remain clogged due to the wax residues. Our aim in this study is to mitigate 
these possible issues. 
 In this chapter, we initially examined possible causes of eventual low recovery by 
characterization with scanning electron microscopy of the probes fabricated by the original 
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method. We accordingly modified probe processing to mitigate those causes. Using the 
modified procedure, our preliminary results suggested potential for improvement in recovery 
of neurochemicals by over 6 folds. Herein possible directions for continued refinement in the 
fabrication process are also suggested. 
 
 
Figure 5.1 Summary of the original process for membrane fabrication. A & B) 400 nm thick of Al was 
deposited onto Si microchannels prior to anodization to form AAO mask. C) DRIE was used for etching the 
poly Si layer to form poly Si membrane. D - F) To provide sufficient strength, 400 nm thick layer of AAO was 
remove and instead coated with a 3 µm thick layer of Al prior to another anodization. G) Backside etching with 
DRIE was used to define probe thickness prior to probe release.   
 
Experimental 
Chemicals and materials 
Unless otherwise specified, all chemicals were purchased from Fisher Scientific 
(Fairlawn, NJ) or Sigma Aldrich (St. Louise, MO) and were certified ACS grade or better. 
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Solutions were prepared with HPLC-grade water or water purified by a Milli-Q system 
(Millipore, MA). Fused silica capillaries were purchased from Molex (Phoenix, AZ). Epoxy 
glues were purchased from Loctite (Westlake, OH) for regular 5-min Epoxy, and ITW 
Devcon (Danvers, MA) for 5-min Epoxy (gel-type). Crystalbond Adhesive, (Crystalbond 555, 
soluble in water at 55°C), was purchased from Structure Probe (West Chester, PA). Artificial 
cerebrospinal fluid (aCSF) consisted of 145 mM NaCl, 2.68 mM KCl, 1.10 mM MgSO4, 1.22 
mM CaCl2, 0.50 mM NaH2PO4, and 1.55 mM Na2HPO4, adjusted pH to 7.4 with 0.1 M 
NaOH.  
 
Device fabrication and preparation 
The overall procedures included 1) channel formation, 2) membrane formation, and 3) 
probe release and assembly to a holder. Detailed microfabrication and design of a 
microdialysis probe were previously described223. Device fabrication was performed at the 
LNF at the University of Michigan. Probes were imaged after each fabrication step by using 
scanning electron microscope (SU8000 SEM, Hitachi, Tokyo, Japan). The anodizing process, 
probe release, and assembly to the holder were conducted in our laboratory. 
 Membrane formation. Illustration of an overview of the modified process for 
preparation of membrane is shown in Figure 5.2. Steps for formation of the 400-nm thick 
AAO mask (Figure 5.2A – C) were the same as the original process. Instead of coating the 
membrane with a 3-µm thick AAO (Figure 5.1D – F), a 2-µm thick layer of Ag was used to 
protect the membrane without removal of the 400 nm thick AAO (Figure 5.2D).  
 Through the AAO mask, the polysilicon layer was etched by DRIE at – 15 °C (STS 
Pegasus 4, SPTS, Newport, UK). Ag was deposited using an e-beam evaporator (Cooke 
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Evaporator, Cooke Vacuum Products, South Norwalk, CT). For the Ag deposition step, the 
wafer was tilted at a 30° angle during deposition to prevent a blockage of membrane pores. 
Prior to using the probe for sampling, the Ag protective layer on the membrane was removed 
by wet etch with 0.1 M Fe(NO3)3 for 45 min (Figure 5.2F). 
 
 
 
Figure 5.2 Summary of the modified fabrication process. A - C) 400 nm thick Al layer was deposited over the 
formed channels prior to anodization. The 400 nm thick AAO layer was used as a mask for DRIE of the poly Si 
layer. D) To protect the membranes from damage and wax clog, a 2 µm thick layer of Ag was coated. The 
wafer with embedded membranes was attached to a carrier wafer using a mounting wax prior to DRIE for probe 
thinning (D, inset). E & F) Individual probes were released in hot water. Ag layer was removed later by wet 
etch. 
Probe assembly to a holder and connection tubing. A holder was used to connect the 
probe to standard fused silica capillaries for fluid transfer. Full description of holder 
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fabrication and assembly was previously provided115,223. In this study, the procedure for 
probe assembly was modified to facilitate wax removal at the probe inlet/ outlet. An 
illustration of the procedure is shown in Figure 5.3. The probe was trimmed with a razor 
blade at ~1 mm from the end of probe ports to remove wax that had entered the opening 
(Figure 5.3A). Capillaries of 2.5 cm length with 180 µm i.d. / 360 µm o.d. were attached to 
the holder using a regular epoxy resin. Probe ports were inserted into the capillaries and 
sealed with a gel-type epoxy resin (ITW Devcon, Danvers, MA). At this step, epoxy seal was 
covered only at the jointed region between the probe ports and capillaries (see Figure 5.3B, 
red area). This seal was sufficient for temporary fluid transfer while allowing surface areas of 
the probe in contact with hot water. In this way, proper heat transfer was ensured for 
dissolving any remaining wax in the latter step.  
According to the manufacturers, the epoxy resin can withstand temperatures up to 
~90 °C while the wax is soluble in water at 55 °C. To remove wax residues from the probe, 
the assembled device including capillaries was submerged in hot water (at 75 °C) while 
perfusing hot water through the probe at 200 nL/min for 30 min (Figure 5.3C). The 
assembled device was then dried overnight before complete sealing with an epoxy resin 
(Figure 5.3D). Flow through the probe was driven by a Chemyx syringe pump (Stafford, TX). 
For fluid transfer and sample collection, 20 - 30 cm of 100 µm i.d. / 360 µm o.d. fused-silica 
capillaries were directly connected to the inlet/outlet capillary of the probe via a 360 µm-
diameter Teflon union.  
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Figure 5.3 Overall procedures for wax removal. A) The inlet and outlet of the probe were trimmed to minimize 
wax clog. B) Probe ports were inserted into standards capillaries prior to partially sealing with an epoxy resin. C) 
Hot water was used to remove wax residues. D) After wax removal, the packaged device was dried overnight 
prior to complete sealing with an epoxy resin. 
 
Recovery test  
For study of probe relative recovery, probes fabricated by the modified process were 
compared to the probe fabricated by the original process. Initial recovery tests were 
performed by using the probes for sampling a 100 µM fluorescein solution at different 
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perfusion rates (i.e., 400, 200, 100, and 50 nL/min) in a stirred vial at room temperature. 
Fluorescence was recorded downstream using a conventional fluorescent microscope system 
with an arc-lamp source and CCD camera. The probes were then dipped into a well-stirred 
vial containing: 0.5 μM dopamine (DA), 3-methoxytyramine (3-MT); and 1 μM serotonin (5-
HT) 3,4-dihydroxyphenylacetic acid (DOPAC), ɣ-aminobutyric acid (GABA), and 50 μM 
taurine (Tau) in aCSF at 37˚C. The aCSF was supplemented with 0.25 mM ascorbate to 
protect against oxidation of analytes. After an equilibration time of 30 min, dialysates were 
collected in 20 min fractions with a perfusion rate of 100 nL/min. Dialysate samples were 
derivatized with benzoyl chloride and analyzed by LC-MS, as described previously in 
Chapter 2.  
 
Results and Discussion 
Even though the original fabrication method was successful, it was still imperfect as 
the probe yielded low recovery. By characterization with SEM images of previously 
developed probes, we found several possible sources of reduced porosity and eventual low 
recovery (see Figure 5.4). Further discussion of these causes and refinement of the 
procedures were described below. 
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Figure 5.4 Exampled SEM images of probes fabricated by the original process. The images revealed several 
possible causes of low recovery, including A) incomplete pore formation (the arrows indicated unetched depth 
of 500 - 700 nm); B) non-aligned pores between the poly Si and thick AAO layers; C) wax clog reduced 
membrane porosity and necessitated high pressure required for flow (prohibiting use of high porous membrane). 
SEM images in B&C were courtesy of W.H. Lee. 
 
Incomplete pore formation and etch longer 
We observed incomplete pore formation in some parts of the underneath poly Si layer 
(for example, see Figure 5.4A). This incomplete formation was likely due to variations in 
morphology of the etched poly Si substrate and the AAO mask. The variation in thickness of 
the poly Si layer occurred due to equipment variabilities during multiple deposition and 
etching steps. Although our previous target thickness of the poly Si layer was 2.2 µm, we 
found that the final thickness could vary from 2.2 to 2.7 µm (suggesting a range of ~20% 
deviation above the target thickness). Furthermore, it has been shown that the poly Si film 
inherently has large grain size and rough surface251,252. As deposition of the following Al 
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layer was based on the poly Si layer, the variations in thickness and surface roughness of the 
poly Si layer can lead to formation of an uneven AAO mask (Figure 5.5A). Furthermore, pore 
sizes of the AAO mask were not always uniform. With our current anodization process, pore 
sizes could vary from 50 – 70 nm (Figure 5.5B). A combination of the variations in the 
substrate and mask can lead to differences in the etch rate across the wafer. For example, in 
plasma etching, the etch rate through narrower and thicker pores can be slower than that of 
wider and thinner pores99,253–255. Thus, the time required for thorough etch in some parts of 
the poly Si layer can be longer than expected.  
 
 
Figure 5.5 Non-uniformity in AAO mask. A) Uneven surface; and B) Variations in pore size and shape. Scale 
bars were 500 nm. 
 
 
 A straightforward approach to mitigate the issue of incomplete pore formation was to 
etch through the AAO mask with an extended time while using a slightly thinner poly Si 
layer. In this study, a target thickness of poly Si layer was 1.8 µm instead of 2.2 µm. The 
final thickness of the fabricated layer then ranged between 1.8 – 2.2 µm. Through several 
characterization runs (based on 10-min etching tests), we found that a typical range of etch 
rate through the poly Si layer with the 400 nm AAO mask was 0.12 to 0.14 µm/min. The etch 
time was consequently selected to be 22 min (representing 20% longer than the expected 
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time for complete formation). An example of the poly Si membrane with thorough etched 
pores was illustrated in Figure 5.6A.  
 
 
Figure 5.6 Representative SEM images of the membrane with overetch time. (A) shows complete pore 
formation; (B) shows incomplete pore formation. Circle indicated merging pores due to the undercut profiles. 
Arrows indicated tapered profiles with unetched depths; (C) illustrates imperfection profiles. Scale bars were 1 
µm for A & B, and 250 nm for A, inset. 
 
However, even with use of the extended etch time; incomplete pore formation was 
still found in some areas of inspected samples (Figure 5.6B). This result suggested that the 
etch rate in these areas was lower than expected. This discrepancy was likely due to 
variations in thickness and pore sizes of the mask, as discussed above. The etch rate can also 
decrease as the etching goes deeper because of depletion of the gas phase etchant by reaction 
with the substrate256–258. Additionally, angled pores on rough poly Si surface may lead to 
distorted etch profiles251. For example, tapered features of poly Si pores were observed 
during etching. Sidewalls of the pores also started to merge over time because of 
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undercutting profiles (see Figure 5.6B & C). These factors limited the maximal etching depth 
as too large merging pores can yield a fragile membrane. As a result, further etching of the 
poly Si layer was not attempted despite the existence of some incomplete pore formations.  
 Nevertheless, as compared to the membrane from the previous work (Figure 5.4A), 
we observed fewer non-opened poly Si pores in the membrane fabricated with the extended 
etch time. Overall, the unetched depths were less than that of the previous batch fabricated, 
i.e., 183 ± 65 nm versus 862 ± 210 nm (n = 8 samples). Therefore, we anticipated that the 
membrane in this study had porosity more than the previous membrane. Even though the 
membrane contained merged pores, we found no membrane collapse during the etching 
process. To minimize the risk of membrane damage during latter steps, we accordingly 
protected the membrane with non-porous Ag and reduced sources of high pressure required 
for flow as described in the next section.  
 Despite the fact that DRIE is nominally an anisotropic etch process, imperfections are 
common due to 1) artifacts induced by surface phenomena, and 2) distortions generated by 
reflection of reactive species at surfaces of the etched features251,259. As mentioned 
previously, we found that the AAO mask did not necessarily contain uniform and perfectly 
straight pores. The reactive species may reflect off the angled edges and distort the etched 
profiles. Besides this effect, it is also possible that ion charging can accumulate overtime at 
the silicon-insulator interface (i.e., poly Si-AAO in this case), resulting in undesired lateral 
etching260. Further work is required to understand mechanisms of these effects. Future 
optimization of DRIE parameters and mask alteration may prove useful to solve the 
problem261–263. Our ongoing work is to improve quality of the AAO mask by using a two-step 
anodization process127,136,264. This subject is further discussed in the later section. 
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Replacing thick AAO with Ag protective layer 
Another source of reduced porosity was the 3 µm thick AAO layer. Although this 
layer strengthened the membrane, the pores in this layer did not necessarily align with the 
pores in the poly Si layer that was formed earlier through the 400 nm AAO mask (Figure 
5.4B). This thicker AAO layer also had less straight pores as compared to a 400 nm thick 
AAO (Figure 5.4B, inset). Furthermore, during the step of backside etching, the porous AAO 
was directly exposed to the mounting wax, leading to clogged pores. As a result, porosity and 
eventual recovery could be diminished due to the use of thick AAO.  
 To overcome the above issues, we protected the membrane by using a 2 µm thick 
layer of nonporous Ag instead of using a 3 µm thick AAO (Figure 5.2C & D versus Figure 
5.1C - F). Ag was a chosen material due to its mechanical property, ease of fabrication and 
removal, and availability in our cleanroom facility. During the deposition process (i.e., 
physical vapor deposition), the wafer was tilted at ~30° angle to prevent the metal vapor from 
entering pores of the underneath membrane. The tilting approach was effective as we found 
that the deposited Ag layer completely laid on top of the membrane and did not block the 
pores (Figure 5.7). This Ag layer served to protect the pores from wax clogs as well as 
damage that may occur during late fabrication steps. Compared to the original process, the 
modified process has fewer overall steps, which was desirable to lessen chances of damage 
and contamination to the device, and to reduce the cost of fabrication. Additionally, the Ag 
layer provided the membrane with sufficient strength during the latter step of flow test. As a 
result, probes can be used without the addition of the thick AAO. 
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Figure 5.7 Ag protective layer on membrane. The inset showed a cross-sectional view 
 
Wax clog and modified removal process 
 The wax used during backside etching of the device could enter and block the 
channels through the inlet/outlet at the probe ports (Figure 5.4C, i) and the opening pores of 
the membrane (Figure 5.4C, ii). Wax clogs inside the pores reduced porosity, resulting in low 
recovery. Moreover, wax blockage within the system increased backpressure and 
necessitated high pressure required for flow. We observed that several probes ruptured 
during the process of wax removal. These probes might have contained high porous 
membranes, but they were too fragile to withstand the high operating pressure due to wax 
blockage. 
 As described in the previous section, the issue with wax that entered the system 
through the opening pores of the membrane was resolved by using the non-porous Ag 
protective layer. However, the wax could also enter system through the probe inlet/outlet, 
thus the process for wax removal was still required. Wax removal can be achieved by 
immersing the probe in hot water while perfusing water through the probe inlet. In our 
original process115,223, the procedures for wax removal were performed after the probe outlet 
was already connected with a long capillary (12 cm length) of 100 µm i.d. The packaged 
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device was also entirely sealed with an epoxy resin. We found that this approach made it 
difficult to remove wax completely from the system because 1) the wax can still enter and 
block the long connection tubing, and 2) the sealed epoxy created thermal insulation between 
the probe ports and hot water while heat was required to flow wax. Consequently, 
backpressure was unexpectedly high and the membrane often ruptured during flow. Indeed, 
~80% of the tested probes were broken during wax removal.  
 To mitigate the above problem, we modified the procedures in order to aid wax 
removal process. We first trimmed the probe at the end of its ports to minimize the amount of 
wax clog (Figure 5.3A). Next, we used a shorter and larger connection tubing to facilitate 
wax to flow out of the system (Figure 5.3B). The shorter length allowed the complete length 
of capillary to be submerged in hot water (Figure 5.3C). The larger capillary dimension also 
reduced the backpressure occurred during wax flow. Additionally, the partial epoxy sealing 
(red regions in Figure 5.3B & C) allowed exposure of the probe surface to hot water. Due to 
these reasons, efficient heat transfer from hot water was better achieved to dissolve wax 
residues in the system. Viscosity of the dissolved wax was also reduced due to increase in its 
temperature, thus lowering pressure required for the flow. As a result, as compared to the 
original process, we observed 3 - 4 times more probes that survived this wax removal process 
(6 out of 8 probes).  
 
Recovery test  
In vitro relative recovery was evaluated by comparing dialysate samples with samples 
taken directly from a stirred vial. Probes made by the original procedure (“old”) were used 
for comparison with the probes made by the modified procedure (“new”). Initial studies were 
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performed by sampling a fluorophore and testing relative recovery as a function of flow rate. 
As seen in Figure 5.8A, both types of probes had similar inverse relationship between flow 
rate and relative recovery, which was within our expectation. Nevertheless, the new probes 
yielded better recovery. For testing recovery of neurochemicals, we used a flow rate of 100 
nL/min as a practical choice to obtain sufficient sample volume and recovery. As shown in 
Figure 5.8B, recovery was improved 6 - 9 fold when sampling by the new probes. For 
example, recovery was increased from 5% to 28% for DA, 3% to 21% for GABA, and 4% to 
37% for 5-HT.  
The above results suggested the possibility of improving recovery by refining the 
fabrication procedures. However, the improved recovery reported here was still a few folds 
lower than the 98% recovery suggested by the model. Based on the previous discussions, the 
main reason for this discrepancy was due to incomplete pore formation of the membrane. In 
addition, the lower-than-expected recovery was indirectly caused by an unexpectedly high 
pressure during flow due to channel blockage. In other words, probes containing membranes 
with high porosity might be existed within the fabricated batch; but, they fractured before the 
recovery test because of the abruptly high pressure. Prior to the sampling procedure, ~25% of 
the probes were broken during wax removal, and ~30% of the remaining probes were broken 
after connecting to a long tubing for sample collection. These results indicated that variations 
in thickness and porosity of the fabricated membranes have remained. To improve upon these 
imperfections, future directions for continued refinement of the process are discussed below. 
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Figure 5.8 Comparison of recovery by probes made by the modified process and the original process. A) 
Relative recovery of fluorescein, sampling at different flow rates at room temperature B) Relative recovery of 
selected neurochemicals, sampling at 100 nL/min at 37˚C. Values were given as mean ± 1 standard deviation (n 
= 3 probes for both A & B). 
 
Future directions and potential 
 Based on these initial studies, a number of improvements are suggested for future 
development. As discussed above, uniformity of the AAO mask and poly Si substrate were 
critical to etch rate and depth, which relate to porosity and performance of the membrane. As 
it is difficult to control uniformity of the poly Si substrate (due to equipment limitation and 
its inherent property), a more favorable direction is to focus on improving uniformity of the 
AAO mask. To achieve this, future work will use two-step anodization process to form a 
mask that has a smoother surface and more ordered and straight pores127,264,136. Use of The 
two-step AAO mask may provide more consistent etch rates across the wafer, leading to 
more opening pores in the poly Si layer.  
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 Although longer etch time allowed increase in porosity, the maximal etching depth 
was still limited by the profile imperfections that caused pore merging overtime. Future work 
will focus on mask alteration to overcome this problem. Our preliminary results has revealed 
possibility of increasing the maximal etching depth by using a thinner, better quality mask 
(e.g., 150 nm thick AAO made by two-step anodization, see Appendix C). By this approach, 
it is possible to etch 3-µm thick poly Si layer thoroughly without merged pores while the 
etching depth has been limited to be < 2 µm. In addition, future work will investigate 
whether alteration of DRIE process parameters (e.g., RIE power, temperature, cycle times, 
pressures, and gas flows) can be performed to further push the limit of aspect ratio.   
 Furthermore, the integrated microfluidic system should have minimized backpressure 
to accommodate use of the enhanced-porous membrane without rupturing. As discussed 
previously, one major source of the high pressure needed for flow was the wax that entered 
the channels through the probe inlet and outlet. Although the cleaning method demonstrated 
in this work proved to mitigate the issue, the process was laborious involving manually 
trimming the probe and perfusing hot water through the channel. Hot water might also not 
necessarily dissolve all the wax residues. Some residues can be very difficult to remove as 
they might undergo cross-linking during the dry etching process. Future work will investigate 
whether different methods, such as decomposition at high temperature (as demonstrated in 
Chapter 3) and/or oxygen plasma ashing265,266, are more suitable for probe cleaning.  
In parallel, we will focus on modification in probe design to prevent the inlet and 
outlet of the probe from clogging. For example, a different design of probe outline (i.e., 
longer ports) can be used to close the inlet and outlet during the fabrication process. 
Trimming or wet etch will be performed to open the inlet and outlet just prior to assembly to 
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a holder. Additionally, channel designs will be modified to minimize backpressure (i.e., 
eliminate sharp turns/corners). Use of alternative backside etching methods (e.g., processes 
based on wet etch30,143) may also be explored to totally avoid usage of the mounting wax. 
 With the above suggestions, complete pore formation and straight pores could 
potentially be achieved, allowing fabrication of the membrane with truly high porosity and 
uniformity. We anticipate that these improvements will allow recovery approaching the 98% 
of the model. This recovery will enable detection of many more molecules with potentially 
reducing sampling areas. The membrane will also be stronger due to vertical etch profiles. 
Future development will facilitate fabrication of a thicker poly Si layer to increase a physical 
strength of the membrane. The AAO layer can eventually be removed to provide the final 
device with an improved integrity. Increase in the membrane strength will also accommodate 
reduction in channel sizes as the membrane can withstand more backpressure. With these 
improvements, the microfabricated probe can be made even smaller and a faster flow rate can 
be used to improve temporal resolution. 
 
Conclusion 
 In this chapter, we described three possible sources of low recovery from the 
microfabricated dialysis probes, including incomplete pore formation, non-aligned pores, and 
wax clog. We illustrated potential for improving recovery by modification of probe 
processing. Despite this improvement, the issue of incomplete pore formation has remained 
due to the limited maximum attainable etch depth caused by non-uniformity in the mask and 
substrate. Strategies for continued refinement in the process were accordingly suggested to 
overcome all the causes of low recovery and to further improve the probe performance. The 
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improvement in probe performance will open the door to development of next generation 
probes that enable new studies in neuroscience.  
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Chapter 6  
Summary and Future Directions 
Summary 
 This dissertation describes the development and utility of microfabricated sampling 
probes for multiplexed neurochemical monitoring with high spatial and temporal resolution. 
Two types of the sampling probes included microdialysis probe and push-pull perfusion 
probe. The probes made by microfabrication are at least 6 times smaller than standard probes 
made by assembly, thus allowing monitoring at substantially improved spatial resolution. 
Other advantages included scalability, design flexibility, mass production, and potential for 
monolithic integration with other neural interfaces. The microdialysis probe particularly has 
benefits of sample cleanup and ease of device operation. Even though the push-pull probe is 
more prone to clogging, it provides unprecedented spatial resolution, approaching to that of 
the smallest electrochemical sensors (see Table 6.1 for summary). The advantage of the 
sampling methods over other in vivo monitoring techniques stems from their capability of 
measuring a larger number of neurochemicals as well as feasibility of multiplexing. 
Furthermore, based on the concept of segmented flow for improving temporal resolution, 
external integration of a droplet microfluidic device enables temporal resolution as good as 
~5 s at a low sampling rate. This improved temporal resolution further utility of the method 
for recording rapid neurochemical changes that are typically required for behavioral or 
pharmacological studies (see Figure 6.1). Below is a brief summary of development and 
enhancement of the microfabricated probes described in this dissertation.    
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Microfabricated Microdialysis Probe 
 Microfabrication approach was used to create a monolithic, miniaturized 
microdialysis probe. An essential part of this work was adapting anodic aluminum oxide 
processing to develop an innovative method for direct formation of nanoporous membranes 
on microchannels. The microfabricated sampling probes was coupled to LC-MS for reliable 
monitoring of multiple neurochemicals in living rat brain at basal concentrations. The probe 
yielded 2 – 7% relative recoveries at a perfusion rate of 100 nL/min. Continued refinement of 
the fabrication process suggested potential for improving recovery by ~10 folds. The 
microfabricated probe has at least 3-fold better spatial resolution than a regular dialysis probe 
made by assembly of a smallest available membrane tubing. Moreover, the 6-fold smaller 
probe size will open the door to monitoring of small brain regions that are previously 
inaccessible by conventional dialysis probes.    
Table 6.1 Improvement in spatial resolution due to the use of microfabricated sampling probes. Spatial 
resolution is defined by an active surface area of chemical monitoring. The active surface area of sampling 
methods are compared to that of electrochemical sensors. The area of conventional dialysis probe is based on 2 
mm long, 220 µm diameter membrane tubing. The conventional push-pull probe is based on the probe made by 
Slaney et al73. The carbon fiber electrode is 50 µm long, 7 µm diameter. Enzyme coating layer for detection of 
non-electroactive molecules typically adds ~5 µm thickness. The microfabricated sensor is based on work by 
the Gerhardt group90. For sampling probes in particular, microfabrication has allowed reduction of sizes of the 
probe size, hence providing considerably improved spatial resolution. 
Probe type Active surface area (µm
2
) 
Conventional dialysis 1400000 
Microfabricated dialysis 440000 
Conventional push-pull 16000 
Microfabricated push-pull 1200 
Carbon fiber sensor  1100 
Carbon fiber sensor w/ enzyme coat 1900 
Microfabricated sensor 7500 
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Microfabricated Push-Pull Probe with Droplet-Based Microfluidic System 
 Since initial development of the microfabricated push-pull probe, device capability 
has been enhanced by incorporation of additional microfluidic functions. An extra channel 
was internally integrated into the probe for chemical delivery at high spatial resolution. 
Furthermore, other microfluidic devices were developed to perform further analytical 
procedures, including sample derivatization, flow segmentation and extraction, and 
separation. Probe-compatible interfaces were also created to enable interconnections between 
different microfluidic devices. These interfaces consequently allowed integration of the 
microfabricated push-pull probes with droplet microfluidic system before analysis of 
nanoliter droplets by microchip CE or direct infusion nano-ESI MS. Compared to 
conventional analytical methods, such integrated system offered 100-fold improvement in 
temporal resolution. The integrated miniaturized system ultimately enables multiplexed 
monitoring of rapid brain chemistry dynamics. Although this part of dissertation focuses on 
the push-pull probe, the same concepts and designs of the droplet-based system should be 
pertinent to the microfabricated dialysis probe as well.  
 
 
Figure 6.1 Improvement in temporal resolution by implementation of droplet-based microfluidic system. The 
diagram shows temporal resolution of neurochemical events and analytical methods at different time scales. 
Incorporation of droplet microfluidic system and miniaturized analytical techniques with sampling probe 
allowed improvement in temporal resolution of the method. Future direct integration of flow segmentation 
within a microfabricated sampling probe will further push the temporal resolution, as described below. This 
diagram was adapted from36.   
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Future Directions 
Building on the current generation probes, the next generation probes can be made 
even smaller to further push the limit of spatial resolution. Future monolithic integration of a 
tee within the probe will offer a possibility for chemical monitoring at sub-second resolution. 
Another intriguing aspect of the microfabricated probes is that the number of channels can be 
scaled up. Further, the multi-channel probes can be feasibly integrated with other neural 
sensing and control tools, such as electrophysiology and optogenetics. Such development 
will lead to innovative probes that open opportunities for new discoveries in brain research. 
 
Next Generation Sampling Probes 
Smaller. Further miniaturization is advantageous to improve spatial resolution and 
minimize tissue damage. In our current designs, push-pull probes are 80 µm wide, 70 µm 
thick, containing 20 µm spaced push-pull orifices (20 × 20 µm square) on buried channels of 
20 µm diameter. Dialysis probes are 160 µm wide × 50 µm thick, consisting of 4 mm long, 
2.4 µm thick membrane embedded on a 60 µm wide × 30 µm tall U-type channel. As 
discussed in Chapter 4, use of 5 µm wall thicknesses was suitable for push-pull probes with 
15 µm channel diameter. Thus, push-pull probes can readily be made as 45 µm wide × 25 µm 
thick, with 5 µm spaced orifices of 15 µm × 15 µm square. For dialysis probes, the equation 
below123,267 suggests that a theoretical maximum load (i.e., pressure that the membrane can 
withstand before collapse, ΔPmax) could be 2.8 MPa or ~400 psi for a 2 µm thick × 30 µm 
wide poly Si membrane with 30% porosity. 
∆𝑃𝑚𝑎𝑥 = 0.29 ∙ 𝐾 ∙ (
𝑡
𝑟
) ∙ 𝜎𝑦𝑖𝑒𝑙𝑑 ∙ √
𝜎𝑦𝑖𝑒𝑙𝑑
𝐸
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K is a non-perforated fraction of membrane, t is membrane thickness, r is half of membrane 
width, σyield is yield strength (1.2 GPa for poly Si268), and E is young’s modulus (160 GPa for 
poly Si269). Within a useful range of 0.1 – 2 µL/min flow rate, backpressure in a probe 
consisting of 2.2 cm long × 30 µm wide × 15 µm tall channel is estimated to be 20 – 400 psi. 
According to the above maximum load and the range of useful driving pressures, we 
anticipated that sizes of the channel and membrane could be reduced by half, after 
improvement in membrane morphology and prevention of unexpectedly high backpressure/ 
clogging. This size reduction will consequently allow fabrication of dialysis probes with a 
total size of 75 µm wide × 25 µm thick. 
 If needed, lower flow rates can be used to compensate for recovery loss due to further 
miniaturization of sampling area. For push-pull perfusion, 10 – 30 nL/min may be used 
instead of 50 nL/min. The lower flow rate not only improves recovery but also may cause 
less tissue disruption270. For dialysis, 50 nL/min may be used instead of 100 nL/min. Our 
preliminary data indicated that recovery of the microfabricated dialysis probe was improved 
by ~2-fold when using a flow rate of 50 nL/min versus 100 nL/min.  
 A layout of the system with further miniaturization is illustrated in Figure 6.2, dashed 
insets. Based on the dimensions described above, the next generation probes will be 6-fold 
smaller than the first generation microfabricated probes and at least 30-fold smaller than 
conventional probes. As compared to a standard dialysis probe containing a 2 mm long, 220 
µm diameter membrane, the next generation probes will offer improvement in spatial 
resolution by 1500-fold for push-pull and 10-fold for dialysis. 
Faster and more compact. Use of low flow rates is favorable to the miniaturized 
probes for recovery; however, lower flow rates lead to the poorer temporal resolution. To 
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mitigate this problem, temporal resolution can be preserved by using an external tee for flow 
segmentation (as demonstrated in Chapters 3 & 4). Although the external device has proven 
effective, it requires extra capillary length for connection, which can limit temporal 
resolution (i.e., best possible resolution is ~5 s at 50 nL/min). The integrated system can also 
be bulky, which is not ideal for small animals. To improve on this system, a tee for 
segmenting the sample stream will be monolithically integrated in the probe (see Figure 6.2).  
 Using microfabrication, this internal tee can be placed close to the sampling area (e.g., 
100 µm above the pull orifice; or 2 mm at the end of dialysis membrane). Such system will 
allow flow segmentation immediately after sampling, ultimately enabling a sub-second 
temporal resolution. Using the rise time equation73, temporal resolution could be 30 ms for 
push-pull (15 pL when sampling at 30 nL/min) and 890 ms for dialysis (740 pL when 
sampling at 50 nL/min). We estimated that the small channels will form droplets within a 
size of 6 pL – 10 pL (by calculating volume of droplets with 15 µm diameter, 15 - 60 µm 
long). To collect these small droplets, a 50-µm i.d. HPFA tubing (smallest size commercially 
available) can be used for coalescing the small droplets into bigger droplets (70 – 400 pL) in 
case the subsequent assay requires relatively large sample volumes. Otherwise, a 20-µm i.d. 
fused-silica capillary can be silanized and used for collection of sub-10 pL droplets. Another 
possible approach for collecting and manipulating small droplets is to use a PDMS or Teflon 
microfluidic chip271 with a channel in the size of 20 µm. 
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Figure 6.2 Layout of small sampling probes with integrated flow segmentation. Center is an overview of the 
integrated system. Left dashed inset shows push-pull probe. Right dashed inset shows dialysis probe (hatched 
red is membrane). 
 
Advanced Neural Probes 
Multi-channels. By microfabrication, more components can be combined to a 
sampling probe with high integrity and scalability. As demonstrated in Chapter 3, an extra 
channel can be embedded into a sampling probe for drug delivery (microinjection) to 
stimulate release of neurochemicals. Besides microinjection, the inclusion of multiple 
channels indicates other purposes, such as reagent addition or flow segmentation via an 
integrated tee. An additional channel can be used as a back-up channel for sampling in case 
the main channel defects or occludes during experiments. It is also possible to add more 
channels for monitoring chemicals at high spatially different locations.  
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Multifunctional probe. An exciting aspect of the microfabricated probes is that they 
are constructed by the same microfabrication technologies as other Si neural sensing and 
stimulating platforms, including electrophysiology272 and optogenetics31,273,274. Hence, it is 
feasible to develop multifunctional/ modal neural probes with combined microfluidic, 
electrical and optical functions.  
Optogenetics has emerged as an important tool for neuroscience due to its ability to 
manipulate neurons precisely275–277. In most studies, experiments have relied on using optical 
fibers for stimulation, which is consequently detected by behavioral observation or 
electrophysiological recording. Simultaneous monitoring neurochemical release can provide 
better insights into the neuronal effects278. However, only a few reports have demonstrated 
neurochemical monitoring during optical stimulation279–281. In these reports, measurements 
were achieved by using conventional dialysis probes, which were bulky and had poor spatial 
resolution. Microfabrication technologies will allow development of miniaturized sampling 
probes with integrated optical elements. 
Several efforts have attempted to miniaturize optogenetic neural probes (see 282–284 for 
reviews of different designs and interfaces). Two main approaches to integrate an optical 
function onto a Si neural probe include using 1) an optical waveguide connected to an 
external light source, and 2) µLEDs. Comparing between the two approaches, the optical 
waveguide approach offers more flexibility in selection of materials and wavelengths, and 
control of power output levels. However, this approach inherently has limitation in term of 
scalability. The minimum possible size of microfabricated waveguides has been at least a few 
tens of microns wide and ~10 µm thick285,286. This relatively large size restricted probe 
design and a number of recording and stimulation sites that can be integrated in a small probe. 
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For example, considering a probe size of 45 µm wide × 25 µm thick described above, 
integration of a microfabricated waveguide in this probe would require more than half of the 
space on the probe surface. The final probe thickness will also be increased remarkably (by 
~40%). On the other hand, the µLED approach is highly effective in terms of reducing the 
probe size and integrating multiple optical elements at high spatially different locations. 
Therefore, the µLED approach seems appealing, as our ultimate goal is to develop a 
miniaturized, highly integrated neural probe.  
The Yoon Group at the University of Michigan has reported integration of µLED 
onto a Si neural probe31. As compared to other µLED-integrated neural implants287,288, this 
work is more attractive due to its overall small probe size, monolithic integration, and the 
possibility for implementing on process flow of Si micromachining. In this report, 3 µLEDs 
at ~50 µm vertically apart could be integrated onto a shank along with 8 recording electrodes 
while maintaining a total dimension of 5 mm long × 70 µm wide × 30 µm thick. The 
thickness of each µLED was less than 0.5 µm thick and had an emission area of 150 µm2 (10 
µm × 15 µm). Four-shank probes were fabricated and tested in the hippocampal region CA1 
of both anesthetized and freely-moving mice. The probes has also proven suitable for uses in 
both acute and chronic studies. We believed that the key design and fabrication process of 
these probes can be adapted to combine with those of the microfabricated push-pull probes 
described above. 
 An example of a possible design for the combined microfluidic and optogenetic 
neural probe is illustrated in Figure 6.3. The probe thickness is 30 µm thick to accommodate 
fabrication of 15-µm diameter channels with ~5-µm wall thickness. Within a width of 85 µm, 
it is feasible to incorporate 4 microfluidic channels for segmented flow sampling and drug 
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delivery, 2 µLEDs for optical stimulation, and at least 4 electrodes for physiological 
recording into a single probe shank. The microchannels are embedded in a shank while the 
diodes and electrodes are constructed on a shank. The modified bevel design will allow 
opening of the microinjection channel at different axis/ angle to prevent interference between 
microinjection and sampling flows.  
 For the fabrication process, channel formation can be completed before deposition 
and etching steps for constructing µLED, electrodes and interconnection lines, and insulators. 
Sampling orifices, and probe shapes and thicknesses are subsequently defined by using 
plasma etching. Since the original procedures for microfabricating both probe types (i.e., 
sampling and optoelectronic neural probes) were previously conducted at the Lurie 
Nanofabrication Laboratory (LNF) at the University of Michigan, it is expected that all 
necessary microfabrication tools and resources are readily available.  
 The above-proposed neural probe will offer multifunctional capabilities to study the 
brain at high spatial control and at an unprecedented size-scale. The microfluidic channels 
allow multiplexed monitoring of neurochemicals as well as delivery of drugs and larger 
substances (e.g., viruses). The µLEDs enable light delivery for optogenetics to manipulate 
neuronal activities at subcellular levels. The microelectrodes can be used for 
electrophysiological recording and/or stimulation. By microfabrication, size of the electrodes 
can also be adjusted to facilitate electrochemical measurements. The multi-functionality of 
this advanced probe will open the door to new studies on dissecting both chemical and 
electrophysiological basis of neuronal functions and disorders. 
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Figure 6.3 3D schematic of the proposed design for multimodal/ functional Si neural probe, consisting of 4 
microfluidic channels with 2 micro-LED and 5 microelectrodes. 3 channels (yellow) are for push-pull sampling 
with flow segmentation. New bevel design facilitates placement of sampling orifices further down while 
allowing opening of another channel (dark red) for microinjection at different axis/ angle. Such positioning will 
allow sampling and chemical delivery without interference. LEDs (blue) and electrodes (green) are 
monolithically embedded on the microfluidic probe. Electrical and optical elements are less than 500 nm thick. 
Microchannels are 15 – 20 µm tall with 5 µm thick walls. Total size of the probe is 85 µm wide × ~30 µm thick. 
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Appendix A  
Step-by-Step Procedures for Microfabrication of Push-Pull Probes 
 Fabrication of push-pull probes were performed within a class 1000 cleanroom (LNF 
at the University of Michigan). The probes were fabricated from 525 µm thick N-type 100 
mm silicon wafers (Silicon Valley Microelectronics, Santa Clara, CA) using the procedures 
described below. Schematics of probe processing are shown in Figure A.1 - Figure A.4. 
 
Channel formation 
1. Clean surface of wafers using RCA clean process  
2. Deposit 1 µm oxide layer using thermal oxidation  
3. Pattern channels using lithography  
4. Remove oxide layer on channel patterns using RIE  
5. Etch 30 µm deep trenches with coated C4F8 wall using DRIE 
6. Etch 20 µm i.d. buried channels using XeF2 etch 
7. Removal C4F8 wall using RIE 
8. Remove photoresist using Nanostrip etch  
9. Clean surface of wafers using RCA clean process  
10. Deposit 3-4 µm poly Si for channel seal using LPCVD  
11. Deposit 500 nm oxide layer using LPCVD   
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Probe shape and orifices 
12. Pattern probe shapes using lithography (photoresist = 3 µm SPR 220)  
13. Remove 500 nm oxide layer on probe shape patterns using RIE or BHF wet etch  
14. Remove poly silicon layer on probe shape using DRIE  
15. Remove 1 µm oxide layer on probe shape using RIE  
16. Remove photoresist using Nanostrip etch  
17. Pattern probe shapes and orifices using lithography (photoresist =  10 µm AZ9260) 
18. Etch probe shapes for 100 µm depth using DRIE  
19. Remove 500 nm oxide layer on orifices using RIE  
20. Remove poly silicon layer on orifices using DRIE  
21. Remove 1 µm oxide layer on orifices using RIE  
22. Etch orifices to 25 µm depth using DRIE 
23. Remove photoresist using Nanostrip etch  
24. Mount the wafer on a carrier wafer using Crystalbond 555 adhesive 
25. Etch backside of the wafer until achieving desire thickness of 50 – 70 µm using DRIE  
26. Release probes in hot water 
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Figure A.1 Channel formation (Steps 1 – 11) 
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Figure A.2 Patterning and etching of probe shapes and orifices (Steps 12 – 16). 
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Figure A.3 Continued patterning and etching of probe shapes and orifices (Steps 17 – 21). 
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Figure A.4 Continued patterning and etching of probe shapes and orifices, following by backside etching and 
probe release (Steps 22 – 26)
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Appendix B  
Step-by-Step Procedures for Microfabrication of Microdialysis Probes 
 Fabrication of push-pull probes were performed within a class 1000 cleanroom (LNF 
at the University of Michigan). The probes were fabricated from 525 µm thick N-type 100 
mm silicon wafers (Silicon Valley Microelectronics, Santa Clara, CA) using the procedures 
described below. Schematics of probe processing are shown in Figure B.1 - Figure B.5.  
 
Channel formation 
1. Clean surface of wafers using RCA clean process  
2. Deposit 2 µm oxide layer using thermal oxidation  
3. Pattern channels using lithography  
4. Remove oxide layer on channel patterns using RIE  
5. Etch channel isotropically to 60 µm wide × 30 µm tall using XeF2 etch  
6. Remove photoresist using PRS2000 or Nanostrip etch 
7. Clean surface of wafers using acetone and IPA, and deposit 3 µm poly Si for channel 
seal using LPCVD 
8. Remove poly Si surface until the oxide layer expose using DRIE 
9. Remove 2 µm oxide layer using RIE or wet etch in BHF 
10. Clean surface of wafers using acetone and IPA, and deposit 2 µm poly Si for channel 
reseal using LPCVD 
11. Deposit 500 nm oxide layer using LPCVD 
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Probe shape and sampling areas 
12. Pattern probe shapes using lithography  
13. Remove 500 nm oxide layer on probe shape patterns using RIE or wet etch in BHF 
14. Remove photoresist using PRS2000 or Nanostrip etch 
15. Pattern probe shapes and sampling areas using lithography  
16. Etch probe shapes for 100 µm depth using DRIE  
17. Remove 500 nm oxide layer on probe shape patterns using RIE or wet etch in BHF  
18. Remove photoresist using PRS2000 or Nanostrip etch 
19. Etch poly Si sampling areas to 2 µm thick using DRIE  
20. Deposit 400 nm thick of Al using e-beam evaporator 
21. Form nanoporous AAO using anodization process 
22. Etch poly Si sampling areas through AAO mask using DRIE  
23. Remove 400 nm thick AAO mask using wet etch in Al etchant 
24. Deposit 3 µm thick of Al using e-beam evaporator 
25. Form nanoporous AAO using anodization process 
26. Mount the wafer on a carrier wafer using Crystalbond 555 adhesive 
27. Etch backside of the wafer to desire thickness of 40 - 50 µm using DRIE 
28. Release probes in hot water 
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Figure B.1 Channel formation (Steps 1 – 11). 
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Figure B.2 Patterning and etching of probe shape and sampling area (Steps 12 – 16) 
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Figure B.3 Continued patterning and etching of probe shape and sampling area 
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Figure B.4 Continued patterning and etching of probe shape and sampling area (Steps 22 – 25) 
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Figure B.5 Backside etching and probe release 
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Appendix C  
Two-Step Anodization Process for Membrane Fabrication 
 Our AAO mask for fabrication of the dialysis membrane has been made by one-step 
anodization process223. This process had limitation in quality of its formed structures, as 
demonstrated in Chapter 5. Consequently, variations in feature proximity and aspect ratio of 
the mask were often observed, especially when it was formed on rough poly Si surface. 
These factors ultimately led to inconsistent etch rate across the substrate and distorted etch 
profiles. In this work, we have adapted the two-step AAO process with the aim of improving 
quality of the membrane fabrication. Two-step anodization process has been reported to 
improve overall quality of the AAO127,136. The two-step AAO is based on a typical AAO 
processing with replication of anodization process. After first anodization, the first-step AAO 
is removed to expose highly periodic and indented surface. These sites allow formation of 
highly ordered and uniform pores in the second anodization.  
 This study was performed using a standard silicon substrate covered with a ~3 µm 
thick layer of poly Si using LPCVD. A schematic of the procedure for fabricating the two-
step AAO mask, in comparison with the one-step AAO mask, is shown in Figure C.1. Since 
the two-step process required removal of the initiated AAO, a thicker layer of Al (i.e., 1000 
nm) was coated on the substrate instead of a 400 nm thick Al. Anodization conditions were 
0.3 M oxalic acid at 60 V and 15 °C. For the first anodization in the two-step processing, 
optimization of the time must be performed as the final thickness was based on the thickness 
of this first step AAO (i.e., final thickness equals to the thickness of deposited Al subtracted 
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by the thickness of first step AAO). Removal of the first step AAO was carried out by wet 
etch using a mixture of 0.2 M chromic acid and 0.4 M phosphoric acid, at 60 °C for 30 min. 
After rinsing, the second anodization was performed as usual (i.e., in 0.3 M oxalic acid at 60 
V and 15 °C for 15 min; the longer time was generally used to ensure complete pore growth 
and ordering). Finally, for pore widening and barrier removal, the AAO was immersed in 
0.86 M phosphoric acid at room temperature for 55 min.  
 
 
Figure C.1 Fabrication procedures for A) two-step AAO mask and B) previously reported one-step AAO mask 
  
 With the above anodization conditions, we found that the first-step AAO layer was 
formed at ~5 nm/s. Anodization time of 120 s was used to create the first AAO layer with 
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600 nm thick. Hence, the final thickness of the AAO mask was 400 nm. This process allowed 
flexibility in controlling and modifying thicknesses of the final mask based on adjusting the 
anodization time (versus using several runs of PVD to deposit Al at different thicknesses). 
For example, in addition to the 400 nm thick mask, the anodization time in the first step can 
feasibly be adjusted to 150 s to fabricate a 150 nm thick AAO mask. Thus, this approach 
proved to be useful when one would like to alter the mask thickness during optimization of 
etching process, as demonstrated below.  
 An example of the SEM images for comparison between one-step AAO mask and 
two-step AAO mask fabricated on the rough poly Si substrate is shown in Figure C.2, A&B. 
As expected, the two-step AAO process produced more ordered and straight pores. 
Furthermore, due to the process of removal of the first-step AAO, the top surface of the two-
step AAO mask was more even and cleaner as compared to that of the one-step AAO. To 
investigate the effect of mask qualities on etching profiles, DRIE was used to etch the poly Si 
layer through the different AAO masks. As seen in Figure C.2, use of the two-step AAO 
mask yielded poly Si pores with more ordered and more vertical features. As a result, almost 
no merging pores at the upper sidewalls were observed when using the two-step AAO mask.  
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Figure C.2 Representative SEM images of AAO masks made by A) two-step processing and B) one-step 
processing. The mask A and B were used for DRIE of the underneath poly Si layer, resulting in C) and D), 
respectively. DRIE time was 15 min. Scale bars were 500 nm for A&B and 1 µm for C&D. 
  
 Although the quality of etched features was improved, tapered profiles still occurred 
in some etched pores (starting at the etching depth of 1.5 - 2 µm). This factor may eventually 
limit the maximal etching depth. In plasma etching, a thin mask is generally favorable to a 
thick mask because the thin mask has less propensity for etch stop and distortion of 
sidewall’s etched features251. Additionally, because of depletion of etching species as they go 
deeper, the etching is slower as the depth increases255. Thus far the AAO mask was selected 
to be used at a target of 400 nm thick. We accordingly further investigated whether a thinner 
mask can be used to improve upon the above limit of etching depth. A two-step AAO mask 
with a thickness of 150 nm was fabricated and used in DRIE through the poly Si substrate. 
An example of the etched poly Si pores is shown in Figure C.3. As seen, the thinner mask 
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facilitated formation of pores with vertical features, which was desirable. Furthermore, with 
the same etching time used above (i.e., 15 min), over 3 µm of the poly Si layer was etched 
thorough, indicating a faster etch rate when using a thinner mask. A combination of these 
features (more vertical profiles and faster etch rate) facilitated fabrication of a poly Si 
membrane with high aspect ratio nanopores, i.e., an aspect ratio of  > 50 was made possible 
while it was limited to < 30 in the previously fabricated membrane. 
 These initial findings illustrated potential utility of the 2-step AAO mask in formation 
of a high quality poly Si membrane. The process with a 400 nm thick mask should be 
suitable to fabricate 2 µm thick poly Si membrane with complete pore formation. Using a 
thinner mask, the process ensures desirable etched features and further allows fabrication of a 
thicker poly Si membrane, which can be advantageous to improve its physical strength. With 
these improvements, we anticipate that the poly Si membrane will be functional even without 
the AAO layer. The AAO layer can eventually be removed from the probe, resulting in the 
final membrane with improved integrity. While the procedure describe here is intended to be 
implemented in microfabrication of a dialysis probe, it is readily adaptable to fabrication of 
other analysis microsystems in need of nanoporous membranes118,289. 
148 
 
 
Figure C.3 High aspect to ratio nanoporous poly Si membrane, fabricated by using a thin AAO mask. 
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Appendix D  
Design and Microfabrication of a Miniature Fiber Optic Probe with Integrated Lenses 
and Mirrors for Raman and Fluorescence Measurements 
 
Reproduced with permission from Ngernsutivorakul, Cipolla et al. Analytical and Bioanalytical Chemistry 
2017, 409, 275-285. © 2016 Springer-Verlag Berlin Heidelberg. Equal authorship was awarded to 
Ngernsutivorakul and Cipolla. Specific contributions to this work from Ngernsutivorakul included device 
fabrication and characterization, and fluorescence detection in microfluidic systems 
 
Introduction 
Raman and fluorescence spectroscopies, are powerful analytical tools due to their 
high sensitivity, fast response, and information content.  One format for these techniques is 
based on fiber optic probes that incorporate lenses and mirrors on the probe tip for guiding 
light between sample and optical fibers. Probes can be placed directly on or into a sample 
providing convenient, sensor-like operation. Such probes have been used for pharmaceutical 
process monitoring290, on-site environmental analysis291,292, study of animal tissues in 
vivo293,294 and diagnosis during clinical endoscopy295,296. Although popular, the bulk of such 
systems can limit their application where miniaturization is needed. One area where 
miniaturized probes may be used is in biomedical Raman because the small size is useful in 
reducing invasiveness of clinical procedures and allowing measurements on smaller 
structures. Miniaturized probes could also enable measurements in other small environments, 
e.g. in microfluidic analytical systems.  
Miniaturized Raman probes have been made by assembly of compact optical 
components (e.g., lenses and filters) and fiber optics297,298. Such probes are commercially 
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available, but they are typically expensive because of costs associated with material handling 
and precise optical alignment at small scale. These approaches also limit the extent of 
miniaturization. Commercially-available Raman probes are typically 10 mm diameter or 
larger. Several miniaturized fiber optic probes with lenses have been reported that are 2 mm 
diameter299–301. The smallest lensed probes reported are 0.75 mm diameter but require a 
complex and tedious fabrication process including assembly and alignment of a bundle of 
125 μm diameter optical fibers, use of adhesives for bonding, and procedures for handling, 
grinding, and polishing micro-optical components302. For biomedical applications, 
sterilization protocols add mechanical requirements and manufacturing complexity. Routes to 
simpler fabrication and further miniaturization are of interest.    
Microfabrication has emerged as a useful approach for miniaturizing optical 
systems303–308. Microfabricated optics for chemical analysis have primarily been used in 
microfluidic chips. Through microfabrication, optics can be integrated into a microfluidic 
chip with precise alignment and produced en masse. The integrated devices have been used 
for a variety of applications including protein separation, DNA analysis, and flow 
cytometry309–311. Many designs utilize rapid prototyping in polydimethylsiloxane (PDMS) 
due to advantages such as low-cost and ease of fabrication312,313. Optical elements such as 
lenses and other waveguides can be fabricated using air-PDMS314–319 or liquid-liquid 
interfaces308,320–326. Typical designs use fiber optics to deliver light from the source and to 
collect signal from microfluidic channels327–332.  These systems are usually developed with 
extensive integration in mind and their sophisticated designs allow specific performance to 
be achieved; however, they also require fixed optics and therefore are not flexible in their use. 
In addition, the optics and the microfluidic systems must be manufactured simultaneously, 
151 
 
leading to more potential points of failure and complication in fabrication processes333. 
Although extensive precedence exists for microfabricated optical systems, little work has 
been reported on microfabricated free-standing probes. Such an approach may allow 
miniaturization of probes to enable Raman or fluorescence measurements in small spaces 
while also reducing the cost. 
We report microfabrication of miniaturized, freestanding optical probes that can be 
coupled to fiber optics for Raman or fluorescence measurements. The probes are over 100-
fold smaller than conventional Raman probes and are the thinnest lensed probes 
reported299,300,302. The miniaturized probes allow measurements in small spaces, e.g. on 
microfluidic devices. Finally, the potentially low cost of fabrication suggests the possibility 
of disposable probes that would facilitate at patient or in vivo diagnostics and other 
applications.  
 
Experimental 
Refractive Index (RI) Characterization and Optical Design 
The RI of PDMS (Sylgard 184, Dow Corning, Midland, MI) from 200 to 800 nm was 
measured on a flat surface of the polymer using an ellipsometer (Sopra GESP-5, Semilab, 
North Billerica, MA). For these measurements, a 1/4" thick slab of PDMS was cast against a 
glass plate and cured between 90 °C and 100 °C for 45 min according to the manufacturer 
directions (1:10 ratio of parts A:B).  
Zemax (Zemax LLC, Kirkland, WA) was used in non-sequential mode to model 
multimode glass optical fibers and air-gap optical elements in a PDMS device. The measured 
RI values of the PDMS were used to design lensed probes for collecting light from a liquid 
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sample outside the PDMS probe through 0.22 numerical aperture (NA) low-OH multimode 
optical fibers. Mirror elements were created using total internal reflection by designing the 
angle of incidence on the mirror elements to be greater than the critical angle. Molds forming 
the optics were designed to avoid high aspect ratio elements that would resist demolding of 
the final device. Lens and mirror properties (position, angle, height, thickness and curvature) 
were adjusted to maximize fluence arriving at the focal region of the probe. For simplicity, 
both the excitation and collection fibers were treated as fiber optic light sources in the model. 
An example of Zemax simulation is shown in Figure D.1A.    
 
Mask Design 
AutoCAD was used to design lithographic masks based on the optimized Zemax 
models. Additional features were incorporated such as skid-and-post structures for holding 
the fiber optics, a bounding box to act as the outer edge of the probe mold, and registration 
patterns for allowing spatial alignment of multiple feature layers. Three separate layers were 
designed and printed onto emulsion film masks with a 7 μm minimum feature size (Fineline 
Imaging, Colorado Spring, CO). These masks (Figure D.2) were used to sequentially expose 
each physical layer in the lithography process. An illustration of the fiber encapsulation 
features are shown in Figure D.1B, which shows skids made in the first lithographic layer, 
posts in the second lithographic layer, and the bounding box formed in the third lithographic 
layer, along with a fiber snapped into place after development of the unexposed SU8.  
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Figure D.1 Design of a microfabricated probe. A) Zemax simulation of the optical pathway of the probe 
coupled to a microfluidic system. The optics include mirrors (M) and lenses (L), which are designed to focus 
100 μm below the coverslip. Fiber 1 is used for guiding excitation light from a light source, which corresponds 
to 90° incidence, and Fiber 2 is used for guiding emitted light to a detector, which corresponds to 65° incidence 
(° incidence= angle at which the light ray strike the sample surface. L1 and M1 reflect and focus excitation light 
from Fiber1 onto a sample in a microfluidic chip. L2 and M2 gather and focus the emitted light to Fiber2. B) 
Drawing of a mold used to fabricate the PDMS probes. Mold is made from SU-8 photoresist on a Si substrate. 
The inset shows a cross-sectional view of the mold with fiber optic inserted.  The mold is fabricated from 3-
layers of SU-8. The drawings are color-coded by layer thickness. The blue layer (#1) is the thinnest and serves 
to hold the fibers at the proper height like “skids”. The green layer (#2) consists of the posts for guiding and 
holding the fiber in place. The green layer also creates the optics on the probe tip. The red layer (#3) creates the 
outer boundary of the mold and therefore defines the overall probe size. The fiber optic is inserted to act as part 
of the mold and create a defined space for the probes. The fiber optics are butted to the optical lenses. C) 
Drawing (left) and microphotograph (right) of PDMS probe created using mold in Figure 1B. The probe 
includes 2 fiber optics which are inserted through the guide created by the molding process. Optical components 
formed by air gaps (white-text label) created from the mold. The final overall probe dimensions are 1.1 mm 
wide x 0.52 mm thick.  
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Figure D.2 AutoCAD design of a representative probe (side-firing), showing layouts of 3 lithographic masks. 
The first lithographic layer (blue) includes the skids for lifting optical fibers from the mold. The second layer 
(green) consists of the posts for holding optical fibers, and optical components at fiber tips. The third layer (red) 
includes a bounding box, used as the outer edge of the probe. 
 
SU-8 master mold fabrication 
The master mold was microfabricated using SU-8 2075 photoresist (MicroChem, 
Newton, MA) on a 4-inch Si wafer (ID: 1116, University Wafer , Boston, MA). This mold 
consisted of 3 layers (see Figure D.1B). The first layer was created by spin-coating a 110 µm 
thick layer of photoresist onto the wafer, followed by a soft-bake process. The wafer was 
aligned to the photomask and UV exposed for 18 s at 17 mW/cm2. The photoresist layer was 
then post-exposure baked to polymerize the exposed pattern. The second and third layers of 
the device were created via a similar process. The second layer was 300 µm thick using an 
exposure time of 28 s, while the third layer was 110 µm thick with 34 s exposure time. Each 
subsequent exposure during the UV lithography process crosslinks all polymer in the lower 
layers, creating solid structures down to the silicon wafer substrate. After the final post-
exposure bake, SU-8 developer solution (MicroChem) with sonication was used to dissolve 
unexposed photoresist. The SU-8 mold surfaces were exposed to trichloro(methyl)silane 
(Sigma-Aldrich, St. Louis, MO) vapor to later aid the release of PDMS from the mold. All 
times and temperatures used for soft-bake and post-exposure bake were according to the 
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MicroChem SU-8 2000 processing guidelines for the cumulative thickness (see Table D-1 for 
specific used temperatures and times). 
 
Table D.1 Summary of specific conditions for soft-bake, exposure, and post-exposure bake processes. The 
baking processes were two-step processes, with 65 °C followed by 95 °C. The exposure energy was 17 mW/cm2. 
 
Thickness 
Soft bake 
Exposure 
Post-exposure bake 
65°C 95°C 65°C 95°C 
1 110  μm 5 min 20 min 18 s 5 min 10 min 
2* 2 × 150 μm 2 × 5 min 2 × 30 min 28 s 5 min 23 min 
3 110 μm 5 min 20 min 34 s 5 min 29 min 
*Layer 2 is 300 μm thick, created by spin-coating twice of 150 μm thick photoresist layer. The 300 μm thick 
layer was then exposed at once. 
 
Probe Fabrication  
A schematic summarizing the fabrication process of probe can be seen in Figure D.3. 
A pair of 2 m long segments of 105 μm core/125 μm clad/ 250 μm polyimide coated low-OH 
optical fiber (FG105LCA, Thorlabs, Newton, NJ) were used. A 4 cm segment at the end of 
each fiber was stripped to remove the polyimide, and then flat-cleaved using a wide-blade 
fiber scribe (F-CL1, Newport, Irvine, CA). The flat-cleaved optical fiber segments were 
manually positioned in the SU-8 skid-and-post mold structures so that the cleaved end of the 
fiber was in contact with a physical stop designed at the entrance of the optical system, as 
illustrated in Figure D.1B. A small volume of PDMS prepolymer (~1 mL Sylgard 184, Dow 
Corning, Midland, MI) was prepared in a 1:10 w/w ratio, mixed, and poured into the SU-8 
molds after insertion of the optical fibers. The wafer assembly was placed in a vacuum 
chamber to degas the PDMS. A glass microscope slide was pressed firmly into contact with 
the upper surface of the SU-8 mold to control the probe thickness. The silicon 
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wafer/SU-8 mold/PDMS/glass assembly was placed in an oven at 95 °C and allowed to cure 
for 45 min. The lensed fiber optic probes were removed from the mold by carefully 
separating the glass slide and SU-8 mold. An image of the final probe is shown in Figure 
D.1C. The free ends of the optical fibers were terminated with standard FC-PC connectors 
(F12073, Fiber Instrument Sales, Inc., Oriskany, NY) using low-fluorescence epoxy (EPO-
TEK 301, Epoxy Technology, Billerica, MA). 
 
 
Figure D.3 Illustration of microfabrication process for optical detection probe. The SU-8 mold was created on a 
silicon wafer by lithographic process and its surface was silanized for ease of PDMS release (A). A pair of 
optical fibers were inserted into the SU-8 skid-and-post mold structures (B) and a small volume of PDMS 
prepolymer was poured into the mold (C). A glass coverslip was pressed firmly into the contact with the upper 
surface of the SU-8 mold; hence, the thickness of the probe was defined by the height of the mold (D). The 
silicon wafer/SU-8 mold/PDMS/glass assembly was placed in an oven at 95 °C for 45 min to cure PDMS. A 
glass coverslip was then removed (E) and the probe was released by peeling of PDMS from the SU-8 mold (F). 
The probe was bonded with a cover layer of ~ 100 µm thick PDMS to prevent dusts and/or solvents from 
entering air gaps (G). 
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Probe optical characterization 
The transmission efficiency and spectral throughput characteristics of the microprobe 
were measured and compared against a probe consisting of two bare cleaved fibers. Light 
transmission through both probes was measured using an optical power meter (PM100, 
Thorlabs, Newton, NJ) and a 543 nm 1.5 mW He-Ne laser (25-LGR-193-249, Melles Griot, 
Carlsbad, CA). The transmittance of a NIST calibrated white light source (Hololab 
Calibration Accessory, HCA, Kaiser Optical Systems, Inc., Ann Arbor, MI) was measured 
using a spectrometer (USB2000, Ocean Optics, Dunedin, FL) to determine the spectral 
throughput characteristics of each probe from 200 to 800 nm with an integration time of 1 s. 
Reflectance spectra using one fiber as a source and the other as a collector were conducted 
using a fiber optic illuminator (Fiber-Lite 3100, Dolan-Jenner Industries, Woburn, MA) as 
the source and the same spectrometer, using Teflon as a high reflectance standard.  
 
Fluorescence measurement 
Characterization of the fluorescence performance of the probes was preliminarily 
conducted using a 543 nm He-Ne laser source and USB2000 spectrometer with integration 
times of 0.1 s to 0.5 s. The probe was placed in contact with a droplet of 10 μM resorufin on 
a silver-coated glass coverslip (EMF, Ithaca, NY) to determine the response of a bulk 
solution. To evaluate probe performance on a microfluidic chip, the probes were aligned to a 
PDMS microfluidic chip consisting of 60 μm deep × 100 μm wide channels, with a 100 μm 
thick cover layer of PDMS.   
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For other microfluidic fluorescence assays, the 543 nm He-Ne green laser or the 473 
nm blue laser source (473-ST DPSS laser, Sintec Optronics, The Spire, Singapore) were used 
with a photomultiplier tube detector (Model R1547, Hamamatsu, Japan), coupled to a 580 
nm (XF3022, Omega Optical, Brattleboro, VT) or a 535 nm emission filter (HQ535/50M, 
Chroma Technology Corp, Rockingham, VT). The voltage and amplifier gain of the PMT 
were set at 0.75 kV and 107 V/A, respectively. Initial data were collected with resorufin 
standards pumped through a fused silica capillary with 150 μm inner diameter × 360 μm 
outer diameter (Polymicro Technologies, Phoenix, AZ) and a 60 μm deep x 100 μm wide 
PDMS microfluidic chip. These data were used to determine the detection limit using a 249 
point (~1 s) boxcar smoothing.  
Figure 6.4 illustrates the arrangement of the probe for on chip fluorescence detection. 
The PDMS microfluidic chip was fabricated by soft lithography with a channel network 
design used for enzyme assay and similar to a previously published device334. Glycerol 
standard solutions (Sigma-Aldrich, St. Louis, MO) were diluted to concentrations of 14, 28, 
56, and 112 µM with Hank’s Balanced Salt Solution (Life Technologies, Carlsbad, CA) 
before on-chip mixing with free glycerol reagent (Sigma-Aldrich, St. Louis, MO) and 1 mM 
Amplex UltraRed (Life Technologies, Carlsbad, CA) in 35% DMSO. The solutions were 
pumped at 1 µL/min using a syringe pump (Chemyx, Stafford, TX). The channel was 
designed with serpentine mixing and incubation regions. The proprietary fluorescent product 
(similar to resorufin) was detected at the outlet by a microfabricated probe positioned on the 
chip. 
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Figure D.4 Position of probe for measuring fluorescence in microfluidic channels. A) Top-view layout of probe 
positioning on a PDMS-based glycerol assay chip; and B) image of the probe on the PDMS chip with 
comparison of probe size with a conventional microscope objective underneath the chip. C) Schematic of front-
view of the probe on a chip; and D) side-view of the probe on a chip and its experimental set-up for 
fluorescence detection. At probe tip, the arrows indicate the light pathways into the channel (blue) and from the 
channel (green). 
 
The same probe was used for on-chip fluorescence detection in glass-based 
microfluidic devices. Borofloat glass microfluidic devices were fabricated and conditioned as 
previously described335–337. An initial experiment was conducted by passing fluorescein 
standards through a 25 μm deep × 80 μm wide channel. For an electrophoresis experiment, 
the channels were filled with sieving media (an entangled polymer solution of proprietary 
composition, Ab Sciex, part 390953, Framingham, MA). FITC protein ladder (LC5928, 
Invitrogen, Carlsbad, CA) was diluted 1:10 in the sieving media to a final concentration of 
~0.1 mg/mL for each protein. The pinched injection method was used to introduce the 
sample in separation channel337. Size-based separation (separation field of 400 V/cm) was 
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recorded 4 cm downstream from the injection cross using the probe detection system. At 
detection, the channel size was 15 μm deep × 50 μm wide.  
For on-chip detection using the microfabricated probe, a stereotaxic frame (Model 
900, KOPF, Tujunga, CA) was employed to manipulate the probe and align it to the detection 
zone. An analog-to-digital converter (NI USB-6008, National Instruments, Austin, TX) was 
used for data acquisition and collection at 250 samples/s under control of LabVIEW (Version 
10.0.1, National Instruments). Data was processed in MATLAB (R2012b, MathWorks, 
Natick, MA).  
 
Raman measurement 
The efficacy of the probe for Raman experiments was demonstrated by collecting 
Raman spectra from water, DMSO, and a commercial aspirin tablet. A fiber-optic coupled 
Raman spectroscopy system (RamanRxn-1, Kaiser Optical Systems, Inc.) with a back-
thinned deep-depletion imaging detector (Newton DU920P-BR-DD, ANDOR Technology, 
Belfast, Ireland) was operated in full-vertical-binning mode to collect Raman spectra. A 100 
mW, 785 nm excitation laser was connected to the 65° incidence fiber, while the Raman 
signal was collected through the 90° incidence fiber channel. Raman spectra were collected 
with 5 s acquisition times.  
 
Results and Discussion 
Design and Fabrication of the Probes 
Our goal was to design a free-standing probe with integrated optics that could focus 
and collect light from outside the probe, be easily coupled to fiber optics, and have separate 
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input (e.g. excitation) and output (e.g. emission) paths. Figure D.1 illustrates the side-firing 
design that was fabricated and tested. The probe contains guides for inserting optical fibers 
precisely and optics at the probe tip for guiding light in and out of the probe.   
One consideration for precise design of optical elements is the RI of the PDMS, 
which can vary significantly depending on selected wavelengths, curing times, and 
temperatures. The measured RI values at 200 to 800 nm wavelengths ranged from 1.42 to 
1.58 for PDMS (Figure D.5). The RI change is particularly small between 400 and 800 nm. 
This small RI dispersion suggests the possibility of microfabricating PDMS lenses with low 
chromatic aberration at the wavelengths of visible light. On the other hand, the RI increases 
rapidly at the wavelengths of UV light (200 to 400 nm).  
 
 
Figure D.5 Refractive index of PDMS, Sylgard 184, from 200 to 800 nm. The PDMS was cured at 95 °C for 45 
min. 
 
The measured RI values were used with Zemax to design optical elements that were 
optimized for light in the range of 200 to 800 nm (Figure D.1A). The cylindrical optics (e.g. 
lens and mirrors) in the fabricated probe were designed to generate a line-shaped focus100 
µm below a coverslip. In the design, one fiber optic is used for excitation while the other is 
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for collection of emitted light. The probe generates focused light at 90° incidence for the first 
fiber and 65° incidence for the second fiber. Folding mirrors are incorporated so that the 
source and collection regions overlap as necessary for Raman or fluorescence measurements. 
The probe design has the benefit of maintaining the source and collection optical fibers along 
a common axis on a single side of the sample which facilitates having a small but robust 
probe. The side-firing design also avoids probe deformation during alignment to the sample.  
To accommodate two 125 μm diameter optical fibers, the width of these probes must 
be at least 400 μm, including the protective layers. In practice, a 90° side-firing probe 
incorporating two 30⁰ incidence total-internal-reflectance based mirrors requires a minimum 
width of approximately 1.1 mm based on the optimized Zemax model. These probes have a 
total thickness of approximately 500-600 μm, including an externally bonded 100 μm PDMS 
cover layer.  
We fabricated devices using inexpensive emulsion masks with a surface roughness of 
approximately 2 µm. The layer thicknesses are within 2% of the design values, and the 
optical features are within 2% of the target size. The aspect ratio has not been well optimized; 
instead, feature sizes are deliberately kept large to avoid issues with mold fabrication and 
demolding of the PDMS structures. Resulting probes were too small and flexible to be 
handled conveniently; thus, a holder was required for further experiments. In this study, we 
selected a commercially-available stereotaxic alignment system for use as a holder and a 
micro-positioner. The stereotaxic system allowed us to precisely manipulate probe position 
and to secure probe placement on/in sample substrates.  
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Optical Characterization of Probes 
To evaluate optical performance of the microprobe, a series of comparisons were 
made to a probe consisting of two cleaved bare fibers assembled side by side with identical 
FC connections. The optical throughput of the microfabricated probe was determined by 
injecting laser light at the FC fiber interface and measuring the optical power transmitted 
through the probe face. The bare fiber probe has 84% throughput while the probe with 
fabricated optics has 70% throughput. These results suggest that the majority of the 16% loss 
in the bare fiber is due to losses in injecting light through the FC connector, and in the 
microprobe an additional 14% loss is due to the probe optical elements. Reflection losses 
could potentially be further reduced by the use of coupling gels or index-matching fluids, 
which were not used in this case. To determine if any spectral artifacts are caused by the 
microfabricated optics, we compared white light throughput of the microfabricated probes to 
the throughput of a bare fiber using a spectrometer. The spectra are identical for both probe 
types, as illustrated in Figure D.6A, indicating no spectral artifacts are generated by the 
microoptical system.  
To compare the background scattering arising from the probe optics, a white light 
reflectance spectrum was collected with the probes pointing into free space in a dark room, as 
shown in Figure D.6B. The scattered white light background generated from the 
microfabricated probe is significant, while the bare fiber probe has no discernible 
background because the bare fiber probe has no interfaces which can scatter light from the 
excitation channel back into the collection channel. The 2 µm roughness causes elastic light 
scattering from the optical surfaces of the microfabricated probe. Next, the collection 
efficiency from a highly scattering material (Teflon) was measured. Both probe types have 
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approximately the same collection efficiency, with slightly different spectral collection 
efficiency due to wavelength-dependent light scattering effects. However, when collection 
efficiency is tested against a transparent PDMS slab, the bare fiber probe collects 3.3 times 
more signal than the microprobe. This difference occurs because the surface reflections from 
the PDMS slab are collected very efficiently by the two parallel fibers. The spatial offset 
between the excitation and collection paths in the microprobe allow little reflectance to be 
collected, with half of this reflectance arising within the microprobe as shown by the 
reflectance in air. 
 
 
Figure D.6 Spectroscopic performance of probe in comparison to bare fibers. A) Detection of white light 
through bare fibers (red) and through each lensed fiber (blue), showing identical spectral shapes. Data were 
offset for comparison. B) White light reflectance spectrum from varied materials. C and D) Laser excitation of 
10 µM resorufin with lensed and unlensed fibers immersed in the bulk solution (C) and in microfluidic channels 
through a 100 µm PDMS coverslip (D). The microfabricated optics’ focusing capability offset the reduced light 
transmission and resulted in stronger fluorescence on chip. 
 
When measuring fluorescence of resorufin in bulk solution, the bare fiber probe 
collects 2.2 fold more fluorescence than the microfabricated probe because of a higher 
overall collection solid angle (Figure D.6C). However, when measuring resorufin in a 
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channel buried 100 µm below the surface of the PDMS microfluidic device, the 
microfabricated probes detect fluorescence comparable to that of bulk solution, whereas the 
bare fiber probe returned no discernible fluorescence. This result is because the lensed 
microprobe focuses the light below the surface and into the channel. The bare fiber probe 
collects the excitation laser light reflected from the PDMS microchip so that the laser signal 
overwhelms any fluorescence (Figure D.6D). The much higher reflectance from the PDMS 
surface when using the bare probe is in agreement with the results shown in Figure D.6B, 
where the surface reflectance of the bare fiber probe is several fold greater than for the 
microprobe. The overall results indicate the utility of incorporating optics on a microprobe 
for collecting light from within a microfluidic sample.  
Numerical aperture (NA) is used to characterize the angles accepted through an 
optical system. In this case, the NA of the probe was defined as a certain angular range over 
which the probe can deliver light to and collect light from a sample. The NA of the probes 
made for this study were limited by the NA of the fiber, which was 0.22.  
 
Fluorescence Detection in Microfluidic Systems 
Fluorescence in microfluidics or capillaries (e.g., for capillary electrophoresis 
detection) is usually measured using microscopes or other external assembled optics. 
Alternatively, microfabricated optics can be built into a chip314,315. Here we evaluated the 
microfabricated probe to measure fluorescence within capillaries or microfluidic chips. For 
these experiments, the probe was positioned over a capillary (e.g., Figure D.7) or 
microfluidic chip (e.g., Figure D.4) with a laser coupled to the inlet and detector to the outlet 
of the probe.  
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Figure D.7 Probe detection on a glass capillary. a) Image of the probe on the 150 µm inner diameter x 360 µm 
outer diameter capillary. b) Trace of 52 nM resorufin switching with a blank. C) Calibration curve of 0.05 to 10 
µM resorufin, resulting in detection limit of 6 nM after 249 point boxcar smooth, acquisition rate of 250 
samples/sec. 
 
We initially tested the probe by detecting resorufin standards in a 150 µm inner 
diameter × 360 µm outer diameter fused-silica capillary. Figure D.7 illustrates the trace 
detected using the probe while passing plugs of 52 nM resorufin through the capillary. 
Responses to a series of concentrations from 0.05 to 10 μM were linear with R2 of 0.997. The 
limit of detection (LOD), determined as the concentration to give a signal 3 times the 
standard deviation of the blank, was 6 nM. These results demonstrate that the probe is 
suitable for fluorescence measurements within a capillary.  
The probe was then placed on a 60 μm deep × 100 μm wide PDMS chip for on-chip 
measurement of 0 to 75 μM resorufin standards. This range of standard concentrations was 
selected to match with the concentrations of proprietary fluorescent products in the following 
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enzyme assay. Fluorescence detection of different resorufin concentrations is shown in 
Figure D.8A. As shown in Figure D.8B, the fluorescence changes were linear with 
concentration with R2 of 0.990. The LOD was determined to be 100 nM. Next, we evaluated 
the performance of the probe to act as a detector for a microfluidic chip used for fluorescence 
enzyme assay. The probe was positioned over a PDMS chip used for continuous flow 
enzyme assay of glycerol. The signals of the fluorescent products from different glycerol 
concentrations pumped through the chip are shown in Figure D.8C. Each trace represents the 
signals upon switching between low and high glycerol concentrations. The fluorescence 
assay, using the probe as an optical probe, resulted in a linear response with R2 of 0.988, as 
shown in Figure D.8D. The calculated LOD was 700 nM for glycerol. With probe detection, 
analytical performance of the on-chip assay is comparable to our previously reported on-line 
enzyme assay using a fluorescence microscope for detection338 and other commercial 
glycerol assay kits339. Thus, in this case where the LOD is determined by the enzyme assay, 
the probe provides comparable LODs but in a compact and low-cost probe. 
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Figure D.8 Probe performance in 60 μm deep x 100 μm wide PDMS microfluidic chips. a) Trace shows 
detection of fluorescence changes from 0 to 75 μM resorufin. b) Calibration curve of resorufin concentrations 
corresponding to (a), resulting in detection limit of 100 nM (S/N =3). c) Probe detection of on-chip glycerol 
assay. Individual traces show alternating between low and high glycerol concentrations (0, 14, 28, 56, 112 μM, 
respectively). The features at the end of each peak (prominently in 112 μM) were due to pressure switching 
during syringe changes. d) Linear range of glycerol assay corresponding to (c). Deviation from the line at 14 
μM is inherent to the assay. 
 
The same probe was tested for fluorescence detection in glass microfluidic devices. 
The probe was positioned over a 25 μm deep × 80 μm wide glass microfluidic chip while 
pumping 0 to 100 nM fluorescein through the device. The trace in Figure D.9A illustrates the 
detection of fluorescent changes at different fluorescein concentrations. The resulting 
calibration curve was linear with R2 of 0.999, as shown in Figure D.9B. The LOD was 
determined to be 11 nM. The probe was then used for detection of microchip electrophoresis 
separation of a fluorescent protein ladder (Figure D.9C). The probe was placed on a glass-
based electrophoresis chip near the end of a 15 µm deep × 50 µm wide separation channel. 
The probe was able to detect the 7 separated proteins, as illustrated in Figure D.9D. Signal to 
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noise ratio was reasonably comparable to our previously reported assay using a conventional 
microscope system that used an arc-lamp source and CCD camera for detection340. The 
individual proteins are present at ~0.014 mg/mL in this example. While the sensitivity is not 
excellent, this measurement is in a challenging environment of a narrow channel with brief 
signals. The sensitivity is counter-balanced by the ease of the measurement; the probe is 
merely placed over the channel. This result demonstrates the suitability of the probe for 
measurement of non-discrete samples within shallow and narrow detection zones. 
 
 
Figure D.9 Probe performance in glass microfluidic devices. A) Trace shows detection of changes from 0 to 
100 nM fluorescein in a 25 μm deep x 80 μm wide glass microfluidic channel. B) Calibration curve of 
fluorescein concentrations corresponding to (A), resulting in detection limit of 11 nM (S/N =3). C) Image of the 
probe on a glass-based electrophoresis chip, demonstrating the feasibility of using probe as a plug and play 
device. D) Probe detection on the electrophoresis chip of a 0.1 mg/mL protein ladder with 15 μm deep x 50 μm 
wide detection channel, showing electropherograms of 7 separated proteins. Doublet feature of the first protein 
was due to degradation of sample and/or gel, or separation conditions. These discrepancies do not influence 
detection. 
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These applications of the probe illustrate a simple way to couple fluorescence 
detection to a chip. Although it is difficult to compare to different experiments, the LODs are 
comparable to other microfabricated devices with integrated optics and optical fibers (see 
Table 6.2)314,326–328,341–343. A significant limitation of the current design is lack of optical 
filters in the probe tip.  The LODs reported here could be improved by integrating optical 
filters directly onto the tips of the fibers, thus reducing fluorescence background due to light 
scattering that occurs along the fiber length344–346. Nevertheless, our probes have the 
advantage of focusing into small channels (down to 15 µm deep × 50 µm wide), enabling 
their use for a variety of applications, such as electrophoresis. Furthermore, the probes 
incorporate both excitation and emission fibers in parallel on the same side of the 
microfluidic device, which allows for simplified fabrication and requires less space for 
integration. Because the probes are standalone devices, they can be used for different 
applications on different chips by moving the probe from one device to another as a “plug-
and-play” detector. As the major microfluidic design characteristic is the coverslip material 
and thickness, a given design is reusable. Indeed the same probes could be used for all the 
experiments described above. Individual probes are easy to clean (using Scotch® Magic™ 
Tape), autoclavable, and reusable due to properties of the materials used.
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Table D.2 Comparison of microfluidic optical detection systems. A detection system typically includes light source, optical fibers/waveguides, and detector. 
Discrepancy of limits of detection (LOD) could be due to several variables, such as excitation and emission wavelengths, quality of light source and detector, 
types of filters, alignment and efficiency of waveguides, light pathways, and detection volume. 
Ref# LOD Analyte
a
 
Chip 
material Lens Mirror Light source 
Fiber 1
b
 
arrangement
‡
 Channel dimension 
Fiber 2
c
 
arrangement
‡
 Detector 
* 6 nM Resorufin 
Glass 
capillary   Laser, 543 nm  
Top,  
0° - 360° xy (150 µm i.d. × 360 µm o.d.) 
Same as  
Fiber 1 Filter w/ PMT 
 
100 nM Resorufin PDMS   Laser, 543 nm same as above (100 µm × 60 µm) same as above same as above 
 
11 nM Fluorescein Glass   Laser, 473 nm same as above (80 µm × 25 µm) same as above same as above 
327 25  nM Fluorescein PDMS   
LED, 494 nm w/ 
Filter 
Inside, 90° or 
270° xy (50 µm × 50 µm) No Fiber 2 
Filter w/ µAvalanche- 
photodiode 
328 44 pM
┼
 
Near-IR dye 
(NN382) PMMA   Laser, 750 nm Inside, 60° xy (150 µm × 75 µm) Inside, 240° xy 
Avalanche- 
photodiode 
314 17 µM 
FITC-labelled 
albumin PDMS   White lamp w/ Filter Inside, 90° xy (50 µm × 130 µm) Inside, 270° xy Spectrophotometer 
347 21 nM Rhodamine 6G PDMS   Laser, 532 nm No Fiber 1 (50 µm × 125 µm) Top, 90° xz Filter w/ Spectrometer 
348 120 nM Fluorescein PDMS   
LED, 475 nm w/ 
Filter No Fiber 1 (110 µm × 40 µm) 
Inside, 90° or 
270° xy Filter w/ PMT 
349 50 nM Fluorescein Glass   Laser, 473 nm 
Inside, 90° or 
270° xy (100 µm × 25 µm) No Fiber 2 Filter w/ PMT 
350 200 nM Fluorescein PDMS   
LED, 470 nm w/ 
Filter 
Inside, 180° 
xz (1 cm × 500 µm)
 ≠
  
Same as  
Fiber 1 Filter w/ Photodiode 
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Raman measurement 
To demonstrate another application, the same microfabricated probe was used to 
acquire Raman spectra. Figure D.10A illustrates Raman spectra of bulk solvents (water and 
DMSO). These solvents have been reported to not swell PDMS351; hence, we do not observe 
any carryover or interference with measurement. The probe allows detection of several major 
bands of DMSO over the much weaker scatter of water, for example C-S symmetric stretch 
at 668 cm-1, C-S antisymmetric stretch at 700 cm-1, S=O stretch at 1042 cm-1, and CH3 
degenerate deformation at 1420 cm-1. Placing the probe directly on an aspirin tablet allowed 
detection of the characteristic Raman bands of acetylsalicylic acid including the symmetric 
aromatic ring C-C stretching vibration at 1606 cm-1 and C=O stretching vibration of the 
carboxyl group at the shoulder peak of 1622 cm-1 as well as several other observed bands 
below 1500 cm-1, such as O-H bending vibration at 1296 cm-1 and C-H bending vibration at 
1045 cm-1 and near 1200 cm-1 (Figure D.10B). The Raman fingerprints are consistent with 
previous reports352–355. High background at < 600 cm-1 is caused by the silica of the optical 
fibers. Addition of optical filters to fiber optic tips would reduce this background.   
These results show that the microfabricated probes can be successfully employed as 
Raman probes. The overall size of microfabricated probes is comparable to the smallest 
reported lensed Raman probes302; however, the use of microfabrication simplifies the making 
of the probes and enables low cost, mass production, flexible probes, and disposability.  
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Figure D.10 Raman spectra collected using the microfabricated probe of: A) water and DMSO as bulk solvents, 
and B) an aspirin tablet, as shown in the inset. 
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Conclusions and Future Directions 
 Microfabrication using soft lithography is a viable and cost-effective way to 
miniaturize spectroscopic probes. The microprobes described here are only slightly larger 
than the optical fibers on which they are molded.  The microfabricated probes are thus 
smaller than commercial optical probes, enabling chemical measurements in tight spaces. As 
demonstrated, the probes are versatile as the same probe can easily be transferred between 
samples. Some modifications can further improve performance of the system and its ease of 
use. The probes can feasibly be coupled with thinner optical filters327,344–346, more compact 
light sources356,357 and detectors358, and other miniature optics316,345, resulting in more 
integrated, smaller, portable, low-cost analytical and diagnostic devices. Incorporation of 
filters in the tip would lower background and improve sensitivity. Better lithographic masks 
may be used as previously described to yield subwavelength optical quality surfaces314. 
Additional designs are possible. In principle other geometries could be fabricated such as 
reflectance on a single point, diffuse reflectance including a spatial offset, collimated 
transmission, diffuse transmission, and multiple-input multiple-output tomographic 
configurations.  
 With further development, a variety of further applications can be envisioned due to 
the size, cost, materials, and configuration of the probes. The probes may have excellent 
potential for biomedical endoscopy. The small probe size suggests potential for less-invasive 
endoscopy359,360. Compared to traditional endoscope probes, the devices are low cost to 
fabricate. The materials are compatible with autoclaving, offering a unique potential 
compatibility with biomedical applications requiring sterilization as compared to traditional 
assembled microprobes that require the use of adhesives and have materials with dissimilar 
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thermal expansion coefficients. The probes also have more potential for pairing with 
microfluidic devices. Pairing a microfluidic device with the probes illustrates a simple 
approach for coupling fluorescence to a chip. Because the probe is mounted to the device, 
optics do not need to be incorporated into a chip allowing flexibility of design. The low cost 
and facile mounting of the probes may facilitate multipoint detection on a chip, a possibility 
that was previously restricted because of microscope dimensions361,362. On-chip alignment 
markers and probe holders for interfacing the probes to microfluidic devices can be 
customarily made using microfabrication or 3D printing could be used to facilitate 
positioning on microfluidics. 
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